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ABSTRACT 
 
The bertha armyworm (Mamestra configurata) is a major pest of canola and other oilseed 
crops. A promising control agent for this species is the baculovirus Mamestra configurata 
nucleopolyhedrovirus (MacoNPV). Baculoviruses are insect-specific viruses. Infections initiate 
in the host midgut following ingestion of virus particles called occlusion bodies. For a productive 
infection to occur, the occlusion bodies must dissolve to release the infectious occlusion-derived 
virions. These virions must pass through the peritrophic matrix, a protein-chitin meshwork that 
lines the midgut of most insects and provides protection against abrasion and pathogen invasion. 
The mechanism by which the baculovirus virions transit the peritrophic matrix is unknown. 
Following the initial infection of midgut cells, a second virion phenotype, the budded virus, is 
released from infected cells and establishes a systemic infection within the insect. 
The 11K group of genes, which are conserved among baculovirus species and other insect-
infecting viruses, encode proteins with a predicted chitin-binding domain. The degree of 
conservation of these genes among insect-infecting viruses suggests that they may play a role in 
insect infectivity. It is possible that the gene products could be involved in an interaction 
between the baculovirus occlusion-derived virions and the peritrophic matrix or the chitin-
secreting cells of the midgut epithelium, and therefore may be involved in initial oral infectivity.  
The two 11K genes from MacoNPV (ORF 118 and ORF 164), and their homologues in a 
second species of baculovirus, Autographa californica multiple nucleopolyhedrovirus (AcMNPV 
[ORF145 and ORF150]) were expressed in a baculovirus expression system. The ability of the 
proteins, Maco118, Maco164, Ac145, and Ac150, to bind to chitin was assessed in vitro using 
chitin-coated beads. Each of the four proteins binds to chitin, and hydrophobic interactions 
mediate the binding. Other binding mechanisms are likely involved, but were not determined in 
this project.  
To determine the function of these proteins, a series of gene knockout and repair constructs 
was produced for AcMNPV ORF 145 and ORF 150 using an established bacmid system. An 
analysis of the knockout and repair constructs using quantitative real-time polymerase chain 
reaction showed that deletion of either ORF 145 or ORF 150 had no effect on the rate of budded 
virus production or viral DNA replication. Oral and injection bioassays were performed in 
Trichoplusia ni larvae to determine if there were differences in infectivity between the knockout, 
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repair, and wild type constructs. Injection assays, in which budded virus from each construct was 
injected directly into the insect haemocoel, therefore bypassing the midgut and peritrophic 
matrix, indicated that there was no statistical difference in infectivity between the knockout, 
repair, and wild type constructs at a dose of 15 TCID50 U per larva. Oral bioassays, in which 
larvae were fed occlusion bodies from each virus construct, indicated that there was no statistical 
difference in mortality rates between the knockout, repair, and wild type constructs.  
The results from this study indicate that although the baculovirus 11K genes are highly 
conserved among baculovirus species, and the 11K gene products from MacoNPV and 
AcMNPV interact with chitin, they are not required for oral infectivity in T. ni larvae, and likely 
serve another function in the baculovirus infection cycle.  
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1. GENERAL INTRODUCTION  
1.1. Importance of the Canadian agriculture industry 
The agriculture industry accounts for approximately 8% of the Canadian gross domestic 
product and employs approximately two million people (1). Canada is both a major importer and 
exporter of agricultural products, with annual imports and exports reaching $20.4 billion and 
$26.5 billion respectively (1). Grains, oilseeds, and grain and oilseed products account for 
roughly a third of Canada’s agricultural exports, or approximately $8.8 billion annually (1). 
Oilseed crops are grown for the oil produced within their seeds (2, 3). Oilseed crops such as 
canola (Brassica napus), flax (Linum usitatissimum), and mustard (Brassica juncea), are grown 
on the Canadian prairies in the provinces of Alberta, Manitoba, and in particular, Saskatchewan 
(3). Because these crops, especially canola, have such a large impact on Canadian agriculture 
and the Canadian economy, a significant amount of research has focused on how to maximize 
production, in particular mitigating crop losses due to insect pests.  
 
1.2. Influence of insects on the agriculture industry 
Insects have several impacts on the agriculture industry (4, 5). Some species pollinate crops, 
while other species enhance decomposition and nutrient cycling in the soil (4-6). Predatory or 
parasitic insects provide arthropod pest control (4-6). A recent study estimated that the annual 
economic value of insect services is $57 billion (US) (4). However, in spite of these benefits, 
insects also cause substantial damage to and fouling of agricultural crops, forest products, and 
manufactured and stored goods (5, 7). Annually, nearly 3 million tons of pesticides, worth an 
estimated $40 billion (US), are applied to commercial crops worldwide to reduce these losses 
(7). 
 
1.3. Pest management strategies 
Traditionally, chemical pesticides have been used to control pest populations (7, 8). Although 
chemical pesticides are convenient to use, they have several limitations. They are costly to 
develop and apply, and the length of time that they are effective is often quite short due to the 
development of resistance in the target species (7, 9). Furthermore, chemical pesticides can have 
a large impact on the environment. Pesticides can enter water supplies, and humans, wild and 
domesticated animals incur health problems by consuming tainted foodstuffs (7, 9-12). Recently, 
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there has been much concern about these issues, which has spurred demand for the development 
of more environmentally benign control strategies. 
A current trend in pest management is the adoption of more comprehensive approaches, such 
as integrated pest management (IPM). IPM systems rely on the concurrent use of multiple 
control strategies including habitat management, crop rotation, resistant crop varieties, chemical 
insecticides, and biological control agents (13). By reducing reliance on chemical insecticides 
and by targeting multiple physiological pathways in the pest, IPM systems reduce the likelihood 
of the development of resistance to a control agent (13, 14). The decreased dependence on 
chemical insecticides also reduces the environmental impact of insect control (13, 14). Biological 
control is an especially promising component of IPM as the agents are typically highly specific 
to target insects, thus having low or no toxicity to humans and non-target species (15). 
 
1.4. Biological control agents 
Biological control agents are naturally occurring “enemies” of a particular insect species (8). 
Biological control agents encompass a broad spectrum of organisms including parasitic and 
predatory insects, bacteria, fungi, nematodes, protozoa, and viruses, as well as natural products 
produced by these organisms (16). The goal of biological control is to produce and apply these 
natural antagonists to reduce the population of a pest species to a level at which the pest no 
longer causes significant economic damage (8). Ideally, biological control agents should be cost 
effective, with low environmental and non-target species impact, and should preferably be self-
sustaining in the environment (14). 
For a microbial biological control agent to be registered, it needs to undergo rigorous testing 
to demonstrate its efficacy against the target species and its safety for use near non-target 
organisms and in the environment (17). The first step in the development of a biological control 
agent is to gain an understanding of the biology of the control agent, including determining its 
host range (17). Biological control agents are selected based on their degree of specificity 
towards a single or small group of closely related target species (17). Many factors affect host 
range and it is possible that host cell components, such as membrane proteins and transcriptional 
and DNA replicative enzymes, may affect the ability of viral biological control agents to infect 
and replicate in a particular host (18). 
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1.5. Economically significant pests in Saskatchewan with the potential to be 
managed with biological control agents 
The bertha armyworm (Mamestra configurata) is a sporadic, but significant, pest of canola 
and other oilseed crops (Figure 1) (19). In outbreak years, this species can cause tens of millions 
of dollars in crop losses, as well as cost farmers upwards of $10 million in pesticide application 
(19). 
 
Figure 1. The life cycle of the bertha armyworm, a climbing cutworm.  
Reprinted from (20) with permission from North Dakota State University. 
 
The bertha armyworm is a noctuid lepidopteran (19). It completes six larval stages during the 
summer, overwinters as a pupa, then emerges as an adult the following summer (19). Although 
all larval instars can cause crop damage, up to 80% of the damage is caused by the 5
th
 and 6
th
 
instar larvae (19). The larger larvae consume leaf tissue and damage stems and seed pods (19). 
Current management strategies for the bertha armyworm include aerial application of broad-
spectrum chemical pesticides (19). These pesticides are not specific to this pest and can cause 
unwanted harm to beneficial insects (21). 
A virus that infects the bertha armyworm, Mamestra configurata nucleopolyhedrovirus 
(MacoNPV), was identified (22, 23). Although there is still much work to do to fully characterize 
this virus, MacoNPV has the potential to be used as a biological control agent to control bertha 
armyworm outbreaks (22, 23).  
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2. LITERATURE REVIEW 
2.1. The insect alimentary canal 
The insect alimentary canal is a continuous tube running from the mouth of the insect to the 
anus (5, 24). It functions as a conduit for food to travel through the insect and as a site for 
digestion and absorption of nutrients and water (5, 24). The alimentary canal is divided into three 
regions: the foregut, midgut, and hindgut (5, 24). 
The foregut is formed by an invagination of the ectoderm during embryogenesis, and is lined 
with a layer of cuticle (5, 24, 25). Peristaltic contractions of the muscles surrounding the foregut 
assist with the movement of the food bolus from the foregut into the midgut (26, 27). 
The midgut is of endodermal origin, and is not lined with cuticle (5, 24, 25). The midgut is 
lined with epithelial cells, which are one cell layer thick and rest on a basal lamina (26, 27). Four 
cell types are present in the midgut epithelium: endocrine cells, regenerative cells, goblet cells, 
and columnar cells (26, 27). The endocrine cells secrete compounds which relay information 
from the midgut to other cells within the insect (25). The regenerative stem cells replenish the 
other cell types (26, 28). Goblet cells regulate potassium levels within the midgut and 
haemolymph (25, 26, 29). The most abundant cell type, the columnar cells, possess many 
microvilli which increase the surface area available for absorption of nutrients and for secretion 
of digestive enzymes (26, 27). 
In most insects, the midgut is lined with a selectively permeable, acellular, cylindrical 
structure called the peritrophic matrix (PM) (5, 24-27). The PM consists of a highly ordered 
meshwork of chitin fibrils (a polymer of β–(1,4)-N-acetyl-D-glucosamine [GlcNAc]), along with 
other carbohydrates and a variety of structural and enzymatic proteins (30, 31). The structure and 
function of the PM are discussed in Section 2.2. 
Most digestion of carbohydrates, lipids, and proteins, and the absorption of the resulting 
nutrients occurs in the midgut (5). Any material that is not absorbed in the midgut, moves into 
the hindgut for further processing or defecation (5). 
The hindgut, like the foregut, is of ectodermal origin and lined with cuticle (5, 24, 25). The 
cuticle lining in the hindgut is thinner than in the foregut, as absorption of water and other small 
molecules occurs here (5, 24, 25). 
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2.2. Peritrophic matrix 
The PM is a tube-like structure that lines the midgut and surrounds the food bolus in most 
insects (5, 25, 27, 30, 31). The PM is selectively permeable, with pore sizes ranging from 4-10 
nm to allow for the discrimination of molecules of differing sizes (27, 32). These small pores 
allow enzymes to move from the epithelium into the lumen and for digestion products to move in 
the opposite direction, without compromising the structural integrity of the PM (5, 25, 27, 30, 
31).  
The PM is formed in two ways, described as Types I or II, though some insect species may 
use a combination of both (5, 27, 30, 31). Both types of PM are biochemically similar and serve 
the same functions (27). 
Type I PM is secreted along the entire length of the midgut by the columnar epithelial cells 
(30, 31). It can be produced either in response to the ingestion of a meal, or continuously 
throughout the insects’ life cycle (30, 31). This is the more common form of PM and it is found 
in Coleoptera, Hymenoptera, and larval Lepidoptera (5, 30, 31). Type II PM is secreted from a 
specialized structure called the cardia (5, 27, 30, 31). The cardia is formed at the anterior end of 
the midgut by an invagination of the foregut (5, 27, 30, 31). PM material is secreted from the 
cardia and is pressed into a thin, unbroken tube (5, 27, 30, 31). This type of PM is common in 
Dermaptera and Isoptera, as well as in larval Diptera (5, 27, 30, 31). 
Both Types I and II PM consist of a network of chitin fibrils (30, 31). Chitin is a major 
structural component of the PM (30, 33). Chitin is synthesized at the apical ends of the brush 
border microvilli by the enzyme chitin synthase which catalyzes the addition of GlcNac units to 
a chitin chain (30). These chitin chains associate with one another to form chitin microfibrils, 
which in turn associate with other microfibrils to form chitin bundles (30). These associations 
provide strength and structure to the chitin matrix (30). 
The strands of the chitin matrix are cross-linked by various PM proteins to provide additional 
structure and strength to the matrix (32). While the exact number of proteins associated with the 
PM is unknown, protein is estimated to account for 20-25% of the total mass of the PM (30, 31). 
Both Type I and Type II PM share similar protein compositions (30). 
There are four classes of proteins associated with the PM, serving either structural or non-
structural roles (30, 31, 34). One of these classes, the peritrophins, has been studied in the most 
detail (30). These proteins contain registers of 6, 8, or 10 cysteine residues in a highly conserved 
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spacing pattern which constitute the peritrophin A, B, or C domains, respectively (30). Protein 
folding is aided by the formation of disulfide bonds between the cysteine residues in these 
proteins (30). These bonds help to produce a three-dimensional pocket called the peritrophin 
chitin-binding domain (CBD) (30). The CBD is able to interact with chitin and thus PM proteins 
containing this type of domain are likely to be structural proteins (30). The structure of the CBD 
is discussed in detail in Section 4.1.2. 
The PM serves several physical and physiological functions (30). The first is to 
compartmentalize the midgut into three distinct regions: an ectoperitrophic space (adjacent to the 
midgut epithelium), an endoperitrophic space (within the midgut lumen), and an intra-PM 
compartment (5, 30). This separation allows for the segregation of digestive enzymes and 
processes, and increases digestion efficiency (5, 30). The PM also helps to retain digestive 
enzymes within the midgut so that they are not eliminated with the food bolus as it progresses 
from the midgut to the hindgut (25, 30). 
In the absence of a cuticular lining in the midgut, the PM physically separates the contents of 
the midgut from the epithelium (5, 24, 25, 30, 31). The PM protects the epithelial cells, both 
from abrasion by rough food particles and from penetration by pathogens or ingested toxins; 
however, some pathogens are able to circumvent this defensive structure (5, 24, 25, 30, 31). 
 
2.3. Baculoviruses 
The family Baculoviridae comprises a large group of diverse viruses that exclusively infect 
arthropod hosts (35, 36). The majority of baculoviruses infect lepidopterans, but they have also 
been isolated from dipterans and hymenopterans (35, 36). There are no closely related plant or 
vertebrate-infecting viruses and this specificity makes baculoviruses good candidates for use as 
biological control agents (37-41). 
Baculoviruses have circular, double-stranded DNA genomes ranging in size from 80 to 180 
kbp (35, 36, 42). Open reading frame(s) (ORF) are present on both DNA strands and the 
proportion of ORF is evenly distributed in either orientation (43). There are minimal gaps 
between adjacent genes, or even small overlaps, between the coding regions (35, 36, 44, 45). 
Baculoviruses encode 90 to 180 genes, of which 32 core genes are conserved among all species 
(43). With the exception of the ie1 gene, baculovirus genes do not contain introns (46). 
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Until recently, morphology of the occluded virus particles was the basis upon which 
baculoviruses were classified into two genera: Nucleopolyhedrovirus (NPV) and Granulovirus 
(GV) (35, 36). As the genomic sequences of more baculovirus species became available, the 
phylogenetic relationships between viruses are becoming more clearly defined (47). Currently, 
there are four described genera of baculoviruses: Alpha-, Beta-, Delta-, and Gammabaculovirus 
(47). Alpha- and Betabaculoviruses exclusively infect lepidopteran hosts, and these groups 
encompass the former NPV and GV genera, respectively (47). Deltabaculoviruses exclusively 
infect dipteran hosts and Gammabaculoviruses exclusively infect hymenopteran hosts (47) 
(Figure 2). 
 
Figure 2. Phylogenetic relationships among the four genera of baculoviruses: Alpha-, Beta-, 
Gamma-, and Deltabaculovirus. 
Phylogenetic relationships are based on amino acid alignment of the conserved core genes. The 
tree was produced using the neighbour-joining method and all branches have bootstrap values 
greater than 50%. Bootstrap values over 95% are indicated along the branches. Figure reprinted 
from (47) with permission from Springer Science and Business Media.  
 
The Alphabaculovirus genus is divided into two clades, the Group I and Group II NPV, 
based on their phylogenetic relationships (35, 43, 48, 49). Group I NPV possess 17 conserved 
genes that are absent from Group II NPV (49). In addition, the Group I NPV use GP64 as the 
major envelope fusion protein (EFP), whereas Group II NPV use the F protein (35, 36, 49). EFP 
is required for cell-to-cell transmission (50). 
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The Alphabaculovirus type-species is Autographa californica multiple nucleopolyhedrovirus 
(AcMNPV) (41). AcMNPV has a 133 kbp circular genome, encoding 156 ORF and was first 
discovered from the alfalfa looper, Autographa californica (35, 51). AcMNPV is the most 
studied of the baculovirus species and functions have been assigned to a large number of 
AcMNPV genes. AcMNPV has been identified as a potential biological control agent for 
greenhouse and crop pests (37, 52). AcMNPV has a relatively broad host range, infecting 43 
species in 11 families of Lepidoptera (53). 
MacoNPV is an example of a Group II NPV (22). It has a 155 kbp circular genome encoding 
169 ORF (22, 23). It was first detected in the bertha armyworm (M. configurata), a pest of 
canola crops (22, 23). MacoNPV has not been studied in as much detail as AcMNPV and there 
has been less progress made in characterizing the functions of its genes because of a lack of 
suitable cell line for in vitro studies. Because this baculovirus is a natural pathogen of the bertha 
armyworm, there is an incentive to better characterize this virus so it can be developed for use as 
a biological control agent. 
 
2.3.1. Baculovirus structure 
There are two phenotypes of baculovirus virions (35, 36). The occlusion-derived virus 
(ODV) is responsible for initiating an infection within the hosts’ midgut (35, 36, 54). The budded 
virus (BV) is released from infected cells and is responsible for propagating a systemic infection 
within an infected host (35, 36, 54). Both phenotypes carry the same genetic information and 
share a common nucleocapsid structure (35, 36). 
The nucleocapsid protein, P6.9 (NPV/Alphabaculovirus) or VP12 (GV/Betabaculovirus) 
forms a complex with the baculovirus DNA genome and it becomes condensed approximately 
100-fold into a compact and insoluble form (36, 54, 55). Structural proteins and enzymes form a 
capsid shell that surrounds the DNA-protein complex (35, 36, 54, 55). The capsid shell, which is 
flattened at the basal end and has a nipple-like structure at the apical end, has distinct polarity 
(36, 54) (Figure 3). 
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Figure 3. Structure of the baculovirus nucleocapsid.  
Viral DNA associates with a basic protein (P6.9) and is condensed. Other nucleocapsid proteins 
associate with the DNA-protein complex to form a capsid shell. Reprinted from (54) with 
permission from Elsevier. 
 
2.3.1.1. Occlusion-derived virus 
Within the ODV, nucleocapsids are surrounded by an envelope and there may be a single 
nucleocapsid (SNPV) or multiple nucleocapsids (MNPV) within the same envelope structure 
(Figure 4) (35, 36, 54). There are a variety of proteins associated with the ODV envelope (54). 
These proteins may function as host range determinants or as factors which increase infectivity 
(56). A group of envelope-associated proteins called per os/per oral infectivity factors (PIF) is 
discussed in Section 2.3.5.  
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Figure 4. Structure of an ODV with multiple nucleocapsids within the same envelope. 
The major ODV envelope proteins are indicated. The position of the proteins and the protein 
complexes indicated are speculative. Reprinted with modifications from (54) with permission 
from Elsevier. 
 
An occlusion body (OB), or polyhedron, is a proteinaceous structure that surrounds the ODV 
(35, 36, 54). OB serve to protect ODV from chemical and microbial degradation (35, 36, 54). OB 
also provide a stable reservoir of virus in the environment, which allows the virus to persist even 
when insect populations are low or absent (35, 36, 54). 
Alphabaculovirus (NPV) OB are 0.15 to 15 µm in diameter and are polyhedral in shape (35, 
36, 39, 54). Each OB contains many ODV, which may contain a single or multiple nucleocapsids 
(35, 36, 54). The proteinaceous matrix of NPV OB is composed primarily of polyhedrin (Polh) 
(35, 36, 54), which is the most highly conserved of the Alphabaculovirus proteins (36). 
Betabaculovirus (GV) OB are smaller than the Alphabaculovirus OB (150 nm in diameter) 
and each OB contains only a single ODV (35, 36, 54). GV OB are ovoid in shape and utilize 
granulin as the major matrix protein (35, 36, 54). The structure of NPV and GV OB is illustrated 
in Figure 5. 
PIF-0 
PIF-5 
PIF-4 
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Figure 5. OB morphology of the NPV and GV. 
The relative size difference between the NPV and GV is indicated. NPV OB containing ODV 
with multiple or single nucleocapsids are also indicated. Reprinted from (54) with permission 
from Elsevier. 
 
OB are surrounded by a porous, multi-layered calyx or envelope (35, 36, 54). In the alkaline 
midgut of a susceptible host, the porosity of the calyx allows anions to rapidly enter the OB, 
which causes the OB to dissolve and the ODV to be released (35, 36, 54). The small size of the 
pores prevents other potentially harmful substances from entering the OB (35, 54). 
 
2.3.1.2. Budded virus 
Once an infection has been established, the second virion phenotype, BV, is released from 
infected cells (35, 36, 54). Unlike the ODV envelope, the BV envelope is asymmetrical (35, 36, 
54). BV EFP, GP64 or F protein accumulates at the apical ends of the BV as part of a peplomer 
structure that protrudes from the BV envelope (35, 36, 54) (Figure 6). 
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Figure 6. BV structure. 
EFP is produced and accumulates in the host cell membrane. Nucleocapsids bud through the cell 
membrane and accumulate EFP at the apical ends. BV enter other cells via endocytosis. 
Reprinted from (54) with permission from Elsevier. 
 
2.3.2. Infection cycle 
Infection begins in a susceptible host with the ingestion of OB (35, 36, 54). The OB pass 
unaltered through the foregut and move into the midgut, which is an alkaline environment (35, 
36, 54). Here, the OB dissolve and the ODV are released (35, 36, 54). The ODV are able to pass 
through the PM in a manner that is not well understood (35, 36, 54) (Figure 7). 
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Figure 7. The baculovirus infection cycle. 
Reprinted from (54) with permission from Elsevier. 
 
Once through the PM, the envelope of the ODV fuses with the membrane of the columnar 
epithelial cells at which time the ODV release their nucleocapsid(s) into the midgut cells (35, 36, 
54). The nucleocapsid(s) then move(s) towards the nucleus where capsid un-coating, viral DNA 
replication and gene expression occur (35, 36, 54). 
When multiple nucleocapsids infect the same epithelial cell, as is the case with MNPV, some 
of the nucleocapsids move directly to the basal side of the epithelial cells and bypass the 
replication phase (35, 36, 54). From here, the nucleocapsids can bud through the plasma 
membrane as BV (35, 36, 54) (Figure 8). 
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Figure 8. The baculovirus infection cycle within a single epithelial cell. 
By bypassing the nucleus, and therefore viral gene expression and replication, some of the 
virions are able to pass through the epithelial cell and bud directly though the basal lamina. This 
process takes approximately 30 min, compared to 12 h or longer if the virion undergoes virus 
replication within the nucleus. This increases the speed at which a systemic infection can occur. 
Reprinted from (54) with permission from Elsevier. 
 
BV from infected cells enters the insect haemolymph or tracheal system, which facilitates a 
systemic infection within the host (35, 36, 54). At later times in the infection, BV production 
slows and nucleocapsids are instead enveloped and packaged into OB within the nucleus (35, 36, 
54) (Figure 9). 
At very late stages in infection, two viral proteins, chitinase and cathepsin, aid in the 
breakdown of the insects’ tissues and cuticle (35, 36, 54). Prior to death, infected insects may 
climb to the top of a the plant canopy (37, 57). As the cuticle is broken down, the insect liquefies 
and releases OB onto the canopy and soil, facilitating horizontal transmission to other susceptible 
hosts (35-37, 54). 
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Figure 9. Baculovirus infection cycle through early (0 to 6 hours post-infection [hpi]), late (6 to 
24 hpi), and very late (18 to 72 hpi) times. 
Following virus entry into a susceptible cell, the cell loses its cuboid structure and begins to 
round up. Gene expression and viral DNA replication begin at 6 hpi within the virogenic stroma, 
a de novo structure formed in the nucleus, in which nucleocapsids are produced. BV begins to 
bud from infected cells at 12 hpi. At late times post-infection (20-24 hpi), nucleocapsids become 
enveloped and are encapsulated within OB. At very late times post-infection (48 hpi and 
onwards), the infected cells lyse and release the viral OB (35, 36, 54). Reprinted from (54) with 
permission from Elsevier. 
  
 
2.3.3. Gene expression 
The large genome size of baculoviruses, paired with their complex infection cycle and 
substantial number of genes demands a coordinated system of gene expression (35, 36, 43, 44). 
Gene expression is temporally regulated, with genes being transcribed in the early (0-6 hpi), late 
(6-24 hpi), and very late (18-72 hpi) stages of infection (35, 43, 46). Gene products from earlier 
stages are required for the expression of genes from later temporal groups (43, 46). 
The transcriptional cascade begins with the expression of the early genes, which are 
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transcribed within the first 6 hpi and prior to the initiation of viral DNA replication (43, 46, 58). 
There are two subgroups of early genes: the immediate early genes (IE) and the delayed early 
genes (DE) (43, 46). IE genes are transcribed immediately following infection and do not depend 
on the presence of other viral proteins for their expression (43, 46). DE genes require the gene 
products of the IE genes to facilitate their expression (43, 46). Host-cell machinery is required 
for the expression of both IE and DE genes (46, 58). 
Typically, baculovirus genes are transcribed as a single mRNA; however, multiple transcripts 
sharing a common 3ʹ end, but different 5ʹ transcription initiation site, can be produced from a 
subset of genes (46). All baculovirus transcripts are capped at the 5ʹ end and are polyadenylated 
at the 3ʹ end (46). The length of the 5ʹ untranslated region (UTR) is typically quite short (< 150 
bp), whereas the length of the 3ʹ UTR varies widely (43).  
Early gene promoters consist of a TATA element, an initiator (INR) element, or both (43, 46, 
58). Deletion of, or mutations around the TATA element, results in a reduction or abolition of 
promoter activity and gene expression, suggesting that the TATA element is the main regulatory 
element for early gene expression (43, 46, 58). The conserved early gene INR motif, 
ATCA(G/T)T(C/T), contributes to the activity of the promoter complex, but can function 
independently if a TATA element is not present (46, 58). Early gene INR motifs overlap the 
transcript initiation site and are typically located within 25 to 31 bp of a TATA element (46, 58). 
Late genes are expressed between 6 and 24 hpi and require the onset of viral DNA replication 
and the prior expression of early viral genes to be expressed (43, 59, 60). Late expression factors 
(LEF), of which there are 19, can act as transactivators to assist late gene expression (61-63). 
Four LEF proteins associate to form a viral RNA polymerase (43, 60). Lef-8 and Lef-9 form the 
catalytic domain of the polymerase, whereas Lef-4 facilitates the addition of a cap to the 5ʹ end 
of late and very late expressed mRNA (43, 60). The function of p47, the fourth component of the 
viral RNA polymerase, is unknown (43, 60). Switching to a virally-encoded RNA polymerase 
from a host-encoded RNA polymerase may allow the virus to avoid competition with the host 
cell for resources and may optimize the expression of late and very late genes (59, 60). 
The promoter sequence for late genes, as with early genes, is highly conserved among 
baculovirus species (43, 44, 59, 60). The late gene promoter typically contains a 
((A/G/T)TAAG(A/G/T)) motif, which also functions as the transcription initiation site (43, 44, 
59, 60). Mutations in the conserved TAAG motif abolish late gene transcription, while mutations 
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in the nucleotides flanking this motif decrease the amount of transcription, but do not affect the 
temporal expression pattern of the gene (59, 60). 
Very late genes are expressed 18 to 72 hpi (59, 60). The very late gene promoter contains the 
conserved sequence ATAAG(A/G/T) followed by a “burst” sequence which is highly AT-rich 
(59, 60). Mutations within the burst region may affect the levels of gene expression, but have no 
effect on the temporal expression patterns of very late genes (59, 60). 
Several baculovirus genes are expressed throughout the infection cycle (43, 59). These genes 
are preceded by both early and late promoter sites (59). The promoter sites may overlap (e.g., 
TATATAAG), but typically the early promoter elements are located upstream from the late or 
very late promoter element (43, 59). 
 
2.3.4. DNA replication 
Baculovirus DNA replication occurs within a structure called the virogenic stroma which is 
located within the nucleus of infected cells (35, 64). The virogenic stroma is a de novo structure 
formed in response to baculovirus infection (35). Unique sequences in the virus DNA called 
origins of replication (ORI) help direct the host-cell replication machinery to the virus DNA at 
the expense of the host cell DNA (35, 65, 66). 
Baculoviruses contain two types of ORI: homologous repeat region (hr) ORI and non-hr ORI 
(35, 64-66). Hr ORI comprise an imperfect palindrome (30 bp) flanked by repeated DNA 
sequences (approximately 70 bp) (35, 64-66). The sequence of hr ORI is highly conserved within 
a baculovirus species, but can be quite variable among virus species (35, 44, 64-66).  
Non-hr ORI contain sequence repeats and palindromes (43, 65, 66). This type of ORI is not 
repeated throughout the genome (43, 65, 66). It is possible that early gene promoters and any 
DNA sequence that become unwound prior to DNA replication may also function as non-hr ORI 
(35, 65, 66). 
Replication proceeds from the ORI using either recombination-dependent replication, rolling-
circle replication, or a combination of the two (35, 65). Recombination-dependent replication 
allows for the concurrent initiation of DNA replication at multiple ORI (35, 65). Following 
replication of the entire genome, a final recombination event joins the ends of the replicated 
DNA together to form a covalently-closed circular DNA genome (35, 65). Rolling-circle 
replication is a unidirectional process which creates multiple copies of a circular genome (67). 
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This type of replication begins at a single ORI, and produces concataemers of linear, viral 
genomes which are later processed into multiple circular genomes (67). 
 
2.3.5. Genes required for oral infectivity 
A baculovirus infection is initiated by fusion of the ODV envelope with the microvilli brush 
border membrane of the columnar epithelial cells in the host insects’ midgut (35, 36, 54). 
Nucleocapsids are released into the cytoplasm of the epithelial cells, prior to migrating to the 
nucleus (54). Within the nucleus, the nucleocapsids un-coat, viral DNA replication and gene 
expression occur, and progeny virus are produced (35, 36, 54). 
As the cells of the midgut are continually sloughed and regenerated throughout the insects’ 
life cycle, they are not the ideal location for a productive infection to occur (54). Non-midgut 
tissues are better suited to baculovirus replication, as they are not sloughed from the insect (54). 
To reach these tissues, however, an infection must first be initiated in the midgut cells (54). A 
group of highly conserved core PIF genes are required for initiating infection in the midgut. 
PIF genes are conserved among every species of baculovirus and are members of the 32 core 
baculovirus genes (35). PIF proteins contain a transmembrane domain, which suggests that they 
are membrane-bound, and share homology with proteins in other types of insect-infecting 
viruses, suggesting that they are crucial for infection in invertebrate hosts (35). PIF are required 
for oral infection, but are not required for systemic infection within a susceptible host (35). 
Seven PIF have been identified. P74/PIF-0 (AcMNPV ORF 138) (68) and PIF-1 (56) are 
specific binding proteins involved in the establishment of primary infection within the midgut. 
Transcriptional analysis of P74 and PIF-1 from Spodoptera littoralis nucleopolyhedrovirus 
(SpliNPV) indicated that both genes are transcribed at very low levels during infection, 
suggesting that only small amounts of the resultant proteins are required for a productive 
infection to occur (69). PIF-2 (AcMNPV ORF 22) is associated with the ODV, but it is unclear if 
this protein localizes to the ODV envelope or nucleocapsid fraction (56, 70, 71). PIF-3 
(AcMNPV ORF 115) is not involved in the binding of the ODV envelope to the midgut 
epithelial cells, yet is still required for initial oral infectivity (56, 72). A hydrophobic region at 
the N-terminus of PIF-3 may be involved in targeting this protein to the nucleus for 
incorporation into ODV late in the infection (73). Deletion of this hydrophobic region abolishes 
the ability of the virus to establish a per os infection within the midgut (73). PIF-4 (AcMNPV 
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ORF 96), unlike the other described PIF, localizes to both the BV and ODV (74). PIF-5 
(AcMNPV ODV-E56/AcMNPV ORF 148) is associated with the ODV envelope (75). Deletion 
viruses lacking PIF-5 are unable to infect larvae when administered orally (75). However, the 
PIF-5 deletion-virus ODV was still observed to bind to the midgut epithelium, suggesting that 
PIF-5 is not required for this process and likely plays a role prior to, or after, the ODV envelope 
has fused with the midgut epithelium (75). Finally, PIF-6 (Ac68), like PIF-4, is associated with 
both the BV and ODV (76). 
Functional studies of the Helicoverpa armigera single nucleocapsid nucleopolyhedrovirus 
(HearNPV) PIF indicate that P74/PIF-0, PIF-1, PIF-2 and PIF-3 are required to be present in the 
same ODV as a complete wild type (wt) virion, or as co-occluded deletion mutants for oral 
infection to occur (77). Infectivity of the PIF-deletion mutants was not altered by the addition of 
Calcofluor, a compound that disrupts the structure of the PM, suggesting that the PM is not the 
target of the HearNPV PIF (77). 
Further to the HearNPV study, co-immunoprecipitation studies in AcMNPV determined that 
P74/PIF-0, PIF-1, PIF-2, PIF-3, PIF-4, PIF-6, Ac83 (P95; AcMNPV ORF 83), Ac5 (AcMNPV 
ORF 5), and Ac108 (AcMNPV ORF 108), but not PIF-5, form a complex on the surface of the 
ODV (76, 78, 79). Deletion of PIF-1, PIF-2, or PIF-3 completely abolishes the formation of the 
complex, but these three PIF still form a stable sub-complex when PIF-4 is absent (78, 79). 
Ac83, which was found to be loosely associated with the PIF complex, contains a CBD, and may 
play a role in facilitating interaction between the ODV envelope and the chitin fibrils in the PM 
or the chitin secreting cells of the midgut epithelium (78). 
 
2.3.6. Proteomics of the ODV envelope 
Proteomic analyses of the ODV of two Alphabaculoviruses and one Deltabaculovirus 
identified ODV-associated proteins that may be involved in host range determination, virulence, 
and oral infectivity (80-82).  
Forty-four proteins from the Group I Alphabaculovirus AcMNPV were identified as being 
ODV-associated (80). Interestingly, P74/PIF-0 was the only PIF determined to be an ODV-
associated protein (80). Another surprising discovery was the presence of F protein, the EFP 
used by Group II Alphabaculoviruses and Betabaculoviruses (35, 36). EFP are required for the 
attachment and entry of BV into host cells, but were not thought to be required for oral 
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infectivity (35, 36). It has been suggested that the presence of F protein as part of the ODV 
envelope in Group I Alphabaculoviruses may enhance oral infectivity by facilitating interaction 
of the ODV envelope with the membrane of midgut columnar cells (54, 83). A second study 
analyzed the protein composition of the Group II Alphabaculovirus HearNPV (48, 81, 84). This 
study identified 23 ODV-associated proteins (81). Twenty-one of these were also identified in 
the AcMNPV study, indicating that there is a high degree of conservation among ODV-
associated proteins between these two virus groups (81). 
Further to these studies, Peng et al. (2010) (84) conducted a series of yeast-two-hybrid 
experiments to determine the protein-protein interactions between the known ODV-associated 
proteins (84). Several interactions were detected between PIF proteins. PIF-2 interacted with 
ODV-E66 (AcMNPV ORF 46), 38K (Ac98; AcMNPV ORF 98) and PIF-3, whereas PIF-3 
interacted with PIF-5, ODV-E66, 38K, and with itself. Interactions with P74 (PIF-0) and PIF-1 
were not detected. These results, as well as the AcMNPV co-immunoprecipitation studies (78, 
79), suggest that the proteins involved in oral infectivity and their interactions with one another 
are quite complex. 
 
2.3.7. Baculovirus 11K genes 
In 2001, Dall et al. (85) employed a bioinformatics based approach to identify viral genes 
which allow certain viruses within specific virus families to infect insect hosts. Two criteria were 
established to identify these genes. First, the genes must be found in the insect-infecting 
members of a virus family, but be absent from the vertebrate-infecting members of the same 
virus family (85). Second, these genes must be found in at least two unrelated taxa of insect 
viruses (85). To identify these genes, a within-virus-family comparison of virus genomes was 
undertaken to identify genes which are present in the viruses that infect insect hosts, but are 
lacking from those viruses that infect vertebrate hosts (85). Using this subset of genes, a 
between-virus-family search was conducted to identify those genes which are present in more 
than one taxon of insect-infecting viruses (85). This approach identified six groups of genes 
which are common among insect-infecting viruses, but are lacking in vertebrate-infecting viruses 
(85). One of these groups, the 11K genes, is of interest as every baculovirus species 
characterized to date from the Alpha-, Beta-, and Gammabaculovirus genera, as well as many 
species of entomopoxvirus contain at least one member of this gene group (85, 86). This high 
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degree of conservation suggests that these genes may play a key role in allowing a virus to infect 
an invertebrate host (85-87).  
The 11K genes produce putative proteins of between 90 and 110 amino acids in length, with 
a predicted molecular weight of 11,000 D (85-87). Each 11K gene product has a hydrophobic 
amino-terminal domain, which is consistent with a membrane transit signal or signal peptide (85-
87). Each 11K gene product also contains a highly conserved motif called the peritrophin A CBD 
(85-87). The peritrophin A CBD comprises a register of six cysteine residues and three aromatic 
residues in a highly conserved spacing pattern, C
1
X13-20C
2
X5-6C
3
X9-19C
4
X10-14C
5
X4-14C
6
, where C 
is a cysteine and X is any amino acid other than cysteine (85-87). The three conserved aromatic 
residues are located between C
2
 and C
3
 (2 residues) and between C
4
 and C
5
 (1 residue) and 
extend into the chitin-binding pocket (30, 88). This motif is commonly found in proteins which 
interact with chitin, including the peritrophin class of PM proteins (30, 85). 
There are two subtypes within the 11K gene group: the 145-type and the 150-type (85-87). 
These names were derived from the 11K gene products produced from ORF 145 and ORF 150, 
respectively, from AcMNPV (85-87).  
The 145-type is a well-defined group, with members found in the Alpha-, Beta-, and 
Gammabaculoviruses (85-87). The phylogeny of this subgroup closely matches the phylogeny of 
the associated baculoviruses based on an analysis of a set of other unrelated baculovirus genes 
(85). 
The 150-type forms a less well-defined group than the 145-type (85-87). Some members of 
Alpha- and Betabaculovirus contain 150-type 11K genes (85). In some baculovirus species, the 
150-type 11K genes are phylogenetically more related to insect sequences than they are to viral 
sequences, suggesting that these genes may have been acquired via horizontal gene transfer 
between the virus and its host (85). 
Maco164 (MacoNPV ORF 164) has been identified as a homologue to Ac145 based on an 
analysis of amino acid sequences (22). Maco164 has a conserved peritrophin A domain and is 
similar in length to Ac145. There have been no studies on the function or temporal expression of 
this protein. 
Maco118 (MacoNPV ORF 118) has been identified as a homologue to Ac150 (22). Maco118 
does not have a defined peritrophin A domain, but it is highly cysteine-rich. It also differs 
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substantially in length from Ac150. Like Maco164, there have been no functional analysis 
studies done for Maco118. 
 
2.3.8. Previous studies on 11K proteins 
There have been two studies aimed at determining the function of Ac145 and Ac150. 
Specifically, these studies looked at the effect of knocking out either or both of the associated 
genes on oral infectivity. 
Lapointe et al. (87) used a two-pronged approach to study the function of Ac145 and Ac150. 
First, to determine if Ac145 and Ac150 were able to interact with chitin, they expressed both 
proteins in a bacterial expression system. Both Ac145 and Ac150 have a highly hydrophobic N-
terminus, which is consistent with a membrane transit signal. In developing their expression 
strategy, the Lapointe group opted to exclude the N-terminal 22 and 30 amino acids from Ac145 
and Ac150, respectively, to express the proteins without the membrane transit signal. They 
produced N-terminal glutathione S-transferase fusions with their truncated proteins and 
subsequently used glutathione-sepharose beads to purify the expressed proteins from the total 
cellular proteins. Using these purified, truncated proteins, they were unable to demonstrate 
chitin-binding under a variety of conditions. 
To determine the role that Ac145 and Ac150 play in the infection cycle, Lapointe et al. (87) 
produced deletion constructs to determine the effect of deleting Ac145, Ac150, or both together 
on oral and systemic infection. The deletion constructs were produced using transfer vector 
plasmids. Briefly, the region of the genome containing the gene of interest (GOI) was cloned into 
a transfer vector plasmid. The GOI was replaced with a gene encoding green fluorescent protein 
(GFP) in the transfer vector by homologous recombination. This construct was co-transfected 
with wt AcMNPV in insect cells to produce viral DNA with the GOI replaced with GFP. GFP 
was subsequently removed from the deletion virus by creating a second transfer vector plasmid 
in which GFP had been deleted by digesting the plasmid on either side of GFP and then re-
circularizing the plasmid DNA. This construct was then co-transfected with the GFP-tagged 
deletion virus to produce a deletion virus with no observable tag. 
Lapointe et al. (87) found no difference between the wt virus and the single or double 
deletion viruses when the virus was injected directly into the haemolymph of an insect. By 
injecting the virus into the haemolymph, the midgut, and therefore the PM, which is a barrier to 
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pathogenic microorganisms, is bypassed. In oral feeding trials, they found that the Ac145 
deletion mutant was 6-fold less infectious than wt when administered to Trichoplusia ni larvae, 
but as infectious as the wt when administered to Heliothis virescens larvae. The Ac150 deletion 
mutant was as infectious as wt when administered to either host. Interestingly, the Ac145 and 
Ac150 double deletion virus was 39-fold less infectious than wt in H. virescens larvae, but only 
6-fold less infectious than wt in T. ni larvae. From these results, they speculated that both Ac145 
and Ac150 play a role in primary infection, but do so in a host-dependent manner. 
Intrigued by the results from the Lapointe et al. study (87), Zhang et al. (86) produced their 
own set of Ac150 deletion constructs using transfer vector plasmids. Their constructs were 
produced in a similar manner to those of Lapointe et al., but they retained an hsp70/LacZ reporter 
tag to allow for tracking of their recombinant virus. As with the previous study, there was no 
difference between the deletion mutants and wt when the virus was injected directly into the 
haemolymph. In this study, the oral bioassays using the Ac150 deletion virus indicated that loss 
of Ac150 results in a 4.1-fold, 5.6-fold, and 18-fold reduction in infectivity compared to wt in 
Spodoptera exigua, H. virescens, and T. ni larvae, respectively. Zhang et al. suggested that 
Ac150 is similar to a PIF as it appears to have an effect on oral infectivity. 
These results differ from those of Lapointe et al. (87) who found no change in oral infectivity 
for Ac150 deletion viruses in H. virescens or T. ni larvae compared to the wt. Lapointe et al. were 
unable to demonstrate chitin-binding activity for either Ac145 or Ac150, even though both 
proteins are predicted to contain a CBD. As well, Lapointe et al. and Zhang et al. (86) obtained 
contradictory results as to the function of both Ac145 and Ac150 on oral infectivity. In light of 
these findings, my study aims to use novel approaches to determine the ability of Ac145 and 
Ac150 and their homologues in MacoNPV, Maco164 and Maco118, respectively, to bind to 
chitin and to clarify the role of these proteins in the baculovirus infection cycle.  
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3. PROJECT OBJECTIVES 
As reviewed above, it has been hypothesized that the 11K gene family, common to a variety 
of virus groups that infect invertebrate hosts, may be pivotal to the host range of these viruses. 
The overall objective of my project was to determine the function that the 11K genes play in the 
infection cycle of Alphabaculoviruses; more specifically, if they play a key role in oral 
infectivity by virtue of their containing a chitin-binding motif.  
To achieve this goal, several lines of investigation were developed with the specific goals as 
follows: 
A. To determine if the 11K gene products from MacoNPV and AcMNPV display chitin-
binding activity in in vitro assays, and if so, to study the mechanisms responsible for 
binding (Chapter 4). 
B. To map the transcriptional regulatory sites and temporal expression patterns for the 
AcMNPV 11K genes (Chapter 5). 
C. To create knockout viruses in which the AcMNPV 11K genes were deleted singularly or 
together and to monitor the effects of the loss of a gene(s) on the rate of BV production 
and viral DNA replication (Chapter 6). 
D. To determine the role of the 11K gene products in both oral and systemic infection in a 
susceptible host (Chapter 7).  
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4. ALPHABACULOVIRUS 11K PROTEINS: CHITIN-BINDING STUDIES 
4.1. Introduction  
4.1.1. Baculovirus expression system 
Baculovirus expression systems were developed to obtain high yields of heterologous protein 
expressed in insect cells (89, 90). As well, proteins produced in a eukaryotic system are more 
likely to be folded and modified to be biologically active (89, 90). To increase the speed and 
efficiency of expressing proteins in a baculovirus system, a bacmid based on the AcMNPV 
genome was created (89-91).  
Bacmids are large circular plasmids (89, 90). The bMON14272 (136 kbp) bacmid (Invitrogen 
Corporation, Carlsbad, CA) includes the coding sequence for the entire AcMNPV genome, as 
well as ORI for both bacterial and insect cells (89, 90). The ability for the bacmid to replicate in 
either bacterial or insect cells classifies it as a shuttle vector. As a shuttle vector, genetic 
manipulations to the bMON14272 bacmid can be carried out in bacterial cells, which have the 
advantage of fast generation time, before transferring the bacmid DNA into insect cells for 
protein expression (89-91).  
This system takes advantage of the presence of a non-essential, but highly expressed 
baculovirus gene, Polh (89, 90). Polh is the major OB protein (35, 89, 90). It is required for the 
production of OB, but not for baculovirus replication, BV production, or cell-to-cell transmission 
(35, 89, 90). The native Polh is under the control of a very strong promoter, which produces high 
protein yields at late times (> 24 hpi) (35, 89, 90). The native Polh ORF in bMON14272 has 
been replaced with a mini-attTn7 target site by means of homologous recombination (89, 90). 
The native Polh promoter was left intact upstream of the mini-attTn7 site (89, 90).  
A recombinant transfer plasmid, pFastBac1 (4.8 kbp, Invitrogen Corporation), carrying a 
GOI at the multiple cloning site is produced. The multiple cloning site of pFastBac1 is flanked 
by Tn7L and Tn7R sites (89-91). The transfer plasmid can be transformed into DH10Bac 
(Invitrogen Corporation) cells, which are Escherichia coli cells containing the bMON14272 
bacmid and a helper plasmid, pMON7124 (13.2 kbp), which encodes a transposase gene (89-91). 
The transposase drives a Tn7-mediated transposition event in trans between the Tn7L and Tn7R 
sites of the pFastBac1 transfer vector and the mini-attTn7 target site within the Polh locus of 
bMON14272 (89-91). This transposition event causes an insertion of the GOI from the 
pFastBac1 vector into bMON14272 at the Polh locus in frame with and downstream from the 
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native Polh promoter (89-91). Recombinant bacmid DNA is purified from the bacterial cells and 
transfected into insect cells in order to express the protein of interest (89-91).  
 
4.1.2. Chitin binding domains 
The peritrophin A CBD comprises a register of six cysteine residues and three aromatic 
residues in a highly conserved spacing pattern, C
1
X13-20C
2
X5-6C
3
X9-19C
4
X10-14C
5
X4-14C
6
, where C 
represents a cysteine residue and X is any amino acid other than cysteine (30). These CBD 
generally lack secondary structure and protein folding is facilitated by the formation of three 
disulfide bonds between C
1
 and C
3
, C
2
 and C
6
, and C
4
 and C
5
 (30). The conserved aromatic 
residues are located between C
2
 and C
3
 (2 residues) and between C
4
 and C
5
 (1 residue) (30, 88). 
The tertiary structure of the protein creates a binding pocket into which the aromatic residues 
extend (30, 92). Aromatic residues are involved in general saccharide binding (92) and chitin-
binding (30, 92) due to the formation of hydrogen bonds between the aromatic residues and the 
saccharide ligand (30, 92).  
 
4.2. Hypothesis 
The 11K gene products from MacoNPV (Maco118 and Maco164) and AcMNPV (Ac145 and 
Ac150) each contain a peritrophin A CBD (or are highly cysteine-rich). It is predicted that each 
protein will be able to interact with chitin in vitro via this domain. Compounds that disrupt the 
intramolecular disulfide bonds or the intermolecular hydrogen bonds are predicted to disrupt this 
binding.  
 
4.3. Materials and methods 
4.3.1. Analysis of amino acid sequences, protein motifs, and protein structure 
Ac145 and Ac150 were identified as 11K genes by Dall et al. (85) using a bioinformatics 
based approach. Maco118 and Maco164 were identified by Li et al. (22) as potential homologues 
of Ac150 and Ac145, respectively, based on similarities in their predicted amino acid sequences. 
To confirm this, the amino acid sequences for each of these proteins were obtained from the 
National Center for Biotechnology Information (NCBI) protein database (NCBI accession 
numbers: Ac145 NP_054176.1, Ac150 NP_054181.1, Maco118 NP_613201.1, Maco164 
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NP_613247.1) and alignments were produced using the Vector NTI Advance 11.0 AlignX 
application (Invitrogen Corporation).  
Protein motifs were identified in Ac145, Ac150, Maco118, and Maco164 using the meta 
search engine MOTIF (GenomeNet, Institute for Chemical Research, Kyoto University, Japan), 
which simultaneously queries multiple protein databases including PROSITE (Swiss Institute of 
Bioinformatics), Pfam (Wellcome Trust Sanger Institute, Genome Research Limited), and others.  
To determine whether the amino-terminal region of each protein contains a signal peptide or 
a transmembrane domain, the amino acid sequences were entered into the SignalP 4.0 Server and 
the TMHMM 2.0 server, respectively (both, Centre for Biological Sequence Analysis, Technical 
University of Denmark, Lyngby, Denmark).  
Three-dimensional protein models were produced for each protein using the homology 
modelling program, SWISS-MODEL (ExPASy, Swiss Institute of Bioinformatics, Lausanne, 
Switzerland) (93-95). A fully automated approach was used to model the structure for each 
protein. The amino acid sequence for each protein was submitted to SWISS-MODEL and a 
template protein was selected from the SWISS-MODEL template library by the software based 
on the query protein’s primary sequence. The resultant protein structures were visualized using 
the Vector NTI Advance 11.0 3D Molecule Viewer (Invitrogen Corporation).  
 
4.3.2. Protein expression 
Ac145, Ac150, Maco118, and Maco164 were expressed using the Bac-to-Bac® Baculovirus 
Expression System (Invitrogen Corporation) following the manufacturer’s protocol and as 
described below.  
Primer pairs were designed to amplify Maco118, Maco164, Ac145, and Ac150 (Table 1). The 
primers were designed such that the entire ORF, excluding the stop codon, was amplified. An 
EcoR1 restriction site was incorporated at the 5ʹ end of each forward primer and an Xba1 
restriction site was incorporated at the 5ʹ end of each reverse primer to allow for directional 
cloning of the PCR amplicon. The nucleotide sequence corresponding to the human influenza 
hemagglutinin (HA) epitope tag was also incorporated into each reverse primer between the ORF 
sequence and the Xba1 restriction site. A stop codon was incorporated in the reverse primer 
immediately following the HA-tag.  
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PCR amplicons were produced using either MacoNPV-A (90/2) genomic DNA (for 
amplification of Maco118 and Maco164) or the EcoR1 B fragment of AcMNPV E2 genomic 
DNA (for amplification of Ac145 and Ac150) as a template. Twelve nanograms of template 
DNA were used in a 25 μL reaction containing 1X Phusion HF buffer containing 1.5 mM MgCl2, 
0.4 mM dNTPs, 0.2 μM forward primer, 0.2 μM reverse primer, 3% dimethyl sulfoxide 
(DMSO), and 0.25 U Phusion High-Fidelity (HF) DNA polymerase (Finnzymes, Thermo 
Scientific, Vantaa, Finland). The PCR reaction mixture was incubated at 98
o
C for 30 s, followed 
by 35 cycles of 98
o
C for 10 s, 58
o
C for 30 s, and 72
o
C for 30 s. A final extension at 72
o
C for 10 
min was followed by incubation at 4
o
C. Five microlitres of each PCR amplicon were separated in 
a 1% agarose gel in Tris-acetate-ethylenediaminetetraacetic acid (TAE) buffer, stained with 
GelRed (Biotium Inc., Hayward, CA) to confirm that the amplicons were the expected size. All 
agarose gels referenced in this thesis were visualized using the Molecular Imager® Gel Doc
TM
 
XR+ System (Bio-Rad Laboratories Inc., Hercules, CA).  
The PCR amplicons were cloned into the multiple cloning site of the pFastBac1 (Invitrogen 
Corporation) plasmid. Briefly, 100 ng of each PCR amplicon and 100 ng of pFastBac1 vector 
DNA were digested using 1.5 U of Xba1 in 1 X React 2 Buffer (Invitrogen Corporation). The 
reaction mixture was incubated at 37
o
C for 1 h. The NaCl concentration of the reaction was 
increased from 50 mM to 100 mM and 1.5 U of EcoR1 was added to the mixture. The mixture 
was incubated at 37
o
C for an additional 1 h. The digestion products were separated in a 1% 
agarose gel in TAE buffer stained with GelRed. The digested amplicons and vector DNA were 
excised from the gel and DNA extracted using the QIAGEN Gel Extraction Kit (QIAGEN, 
Hilden, Germany) following the manufacturer’s protocol. The purified DNA was quantified 
using a Nanodrop 1000 spectrophotometer (Thermo Fisher Scientific Inc., Ottawa, ON). 
Digested and gel-purified PCR amplicons were ligated into the pFastBac1 vector by incubating 
insert DNA and vector DNA in a 3:1 ratio in 1X ligation buffer (Invitrogen Corporation) with 1 
U of T4 DNA ligase (Invitrogen Corporation). The ligation reactions mixtures were incubated 
overnight at 4
o
C.  
Three microlitres of a ligation mixture was transformed into a 25 μL aliquot of E. coli 
DH10B cells (Invitrogen Corporation) by electroporation. The cells were pulsed at 1.5 kV, 25 
μF, and 200 Ω using a Gene Pulser II electroporator (Bio-Rad Laboratories Inc.). One millilitre 
of low salt (5 g NaCl/L) Luria-Bertani (LB) broth was added to the cells immediately following 
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the pulse. The cells were allowed to recover at 37
oC for 1 h. Aliquots of 25 and 250 μL of each 
transformation were plated onto low salt LB plates supplemented with 100 μg/mL ampicillin 
(Amp). The plates were incubated overnight at 37
o
C.  
Several colonies were selected from the plates and used to inoculate 3 mL of low salt LB 
broth supplemented with 100 μg/mL Amp. The cultures were incubated overnight at 37oC with 
shaking at 225 rpm. Plasmid DNA was extracted from the cells using a standard alkaline lysis 
miniprep protocol (96) including an isopropanol precipitation of the DNA prior to re-suspension 
in 50 µL of TE (10 mM Tris-HCl pH 7.5, 1 mM disodium ethylenediaminetetraacetic acid 
[EDTA] pH 8.0) with 20 µg RNase A. The clones was screened by restriction digest with EcoR1 
and Xba1 as described above prior to Sanger sequencing at the National Research Council, Plant 
Biotechnology Institute (PBI), Saskatoon Canada, with primers P(Ph) Forward and SV40 poly A 
Reverse (Table 2).  
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Table 1. Primer pairs for amplifying Maco118, Maco164, Ac145, and Ac150 for use in the baculovirus expression system.  
Restriction sites are underlined with a single line in the sequence. The sequence corresponding to the HA-epitope tag is in bold text 
and stop codons are underlined with a double line.  
 
Primer 
Name 
Sequence Amplifies 
001 for 
007 rev 
CCGGAATTCATGTCAAAACGACTCTAC 
AGCTCTAGAGCATTAGGCGTAGTCGGGCACGTCGTAGGGGTATTCGGTTAATGCTGCGGCAATCGC  
Maco118 + HA tag 
003 for 
008 rev 
CCGGAATTCATGTGGTTGTTATTAGCA 
AGCTCTAGAGCATTAGGCGTAGTCGGGCACGTCGTAGGGGTATTCTAGTAACAGATTTTTGTAAAG  
Maco164 + HA tag 
2009 for 
2010 rev 
CCGGAATTCATGAATCAAATTC 
AGCTCTAGAGCATTAGGCGTAGTCGGGCACGTCGTAGGGGTATAGTAACAAGTTTCTATA 
Ac145 + HA tag 
2011 for 
2012 rev 
CCGGAATTCATGTTAAAACCCAACATG 
AGCTCTAGAGCATTAGGCGTAGTCGGGCACGTCGTAGGGGTAGTTTTGGTTAGCGGTAC 
Ac150 + HA tag 
 
 
 
Table 2. Primer pairs used for sequencing pFastBac1 clones or for amplifying the Polh locus of bMON14272 to confirm the presence 
of the correct PCR amplicon. 
 
Primer Name Sequence Amplifies 
P(Ph) Forward AAATGATAACCATCTCGC 
pFastBac1 multiple cloning site  
SV40 poly A Reverse GAAATTTGTGATGCTATTGC 
pUC M13 Forward CCCAGTCACGACGTTGTAAAACG 
Polh region of bMON14272 bacmid 
pUC M13 Reverse AGCGGATAACAATTTCACACAGG 
3
0
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The pFastBac1 plasmids (Amp
R
, gentamicin
R
 [Gen
R
]) containing the correct amplicon were 
transformed into MAX Efficiency DH10Bac chemically competent cells (Invitrogen 
Corporation). Fifty microlitres of chemically competent MAX Efficiency DH10Bac cells were 
mixed with 1 ng of a pFastBac1 expression construct in a 15 mL polypropylene tube (Ultident 
Scientific, St. Laurent, QC). The cells were incubated on ice for 30 min followed by a heat shock 
at 42
o
C for 45 s without shaking. The cells were incubated on ice for 2 min and then 900 μL of 
room temperature (RT) super optimal broth with catabolite repression (SOC) media was added to 
the cells. The cells were incubated at 37
o
C for 4 h with shaking at 225 rpm. Aliquots of 10 and 
100 μL of the transformed cells were plated onto low salt LB plates supplemented with 50 
μg/mL Kan, 7 μg/mL Gen, 10 μg/mL Tet, 50 μg/mL 5-bromo-4-chloro-indolyl-β-D-
galactopyranoside (X-gal), and 95.2 μg/mL isopropyl β-D-1-thiogalactopyranoside (IPTG) for 
blue/white colour selection. Plates were incubated for 48 h at 37
o
C. Several colonies were 
selected and used to inoculate 3 mL of low salt LB broth containing 50 μg/mL Kan, 7μg/mL 
Gen, and 10 μg/mL Tet. The cultures were grown overnight at 37oC with shaking at 225 rpm. 
Bacmid DNA was extracted from the cells using a standard alkaline lysis miniprep protocol (96). 
Bacmid DNA was screened using PCR to detect the correct insert as follows: approximately 100 
ng of bacmid DNA was used in a 25 μL reaction containing 1X PCR buffer (Invitrogen 
Corporation), 1.5 mM MgCl2, 0.4 mM dNTPs, 0.2 μM pUC M13 Forward primer, 0.2 μM pUC 
M13 Reverse primer (Table 2), and 1 U Taq polymerase (Invitrogen Corporation). The PCR 
reaction mixture was incubated at 95
o
C for 2 min, followed by 35 cycles of 95
o
C for 30 s, 55
o
C 
for 30 s, and 72
o
C for 3 min. A final extension of 72
o
C for 10 min was followed by incubation at 
4
o
C. The PCR products were separated in a 1% agarose gel in TAE buffer, stained with GelRed, 
to confirm that the correct size amplicon was produced.  
The insect cell line Sf9 (from parental strain IPLB-SF21 AE2), derived from pupal ovarian 
tissue of the fall armyworm (Spodoptera frugiperda), was propagated in Grace’s Insect Medium 
(GIM; Gibco, Carlsbad, CA) supplemented with 3,330 mg/L lactalbumin hydrolysate, 3,330 
mg/L yeastolate, 600 mg/L L-glutamine, 11 μg/mL Gen , and 10% foetal bovine serum (FBS). 
Cells were incubated at 27
o
C and passed twice weekly at a confluent cell suspension to media 
ratio of 1:5.  
Purified recombinant bacmid DNA was transfected into Sf9 cells. Briefly, 1.0 X 10
6
 Sf9 cells 
were dispensed into a 25 cm
2
 cell culture flask (Corning Incorporated, Tewksbury MA) in a total 
 32 
of 5 mL GIM and were allowed to adhere to the flask for 2 h at RT. In a 1.5 mL tube, 5 μL of 
Cellfectin II Reagent (Invitrogen Corporation) was incubated with 95 μL of GIM (without FBS 
or Gen) at RT for 30 min. In a separate tube, 1 μg of bacmid DNA was incubated in a total of 
100 μL of GIM (without FBS or Gen) at RT for 30 min. The 100 μL of bacmid DNA and GIM 
were mixed gently with the 100 μL of Cellfectin II and GIM, and this reaction mixture was 
incubated for 15 min at RT. During the incubation, the GIM was removed from the 25 cm
2
 flask 
and discarded. The cells were washed twice with 1 mL aliquots of GIM (without FBS or Gen) 
and the wash medium discarded.  
Following the 15 min incubation, 800 μL of GIM (without FBS or Gen) were added to the 
200 μL of bacmid DNA and Cellfectin II mix. The 1 mL total volume was transferred to the 25 
cm
2
 flask. The flask was rocked gently at RT for 6 h at which time the viral DNA and Cellfectin 
II inoculum was removed from the Sf9 cells and replaced with 5 mL of GIM (with FBS and 
Gen). The transfected cells were incubated for an additional 48 h at 27
o
C.  
Following the 48 h incubation, the cells were gently scraped from the bottom of the cell 
culture flask using a rubber cell-scraper (Ultident Scientific). The medium and cells were 
transferred to a 15 mL Falcon tube (BD Biosciences, Mississauga, ON) and the cells pelleted by 
centrifugation at 3000 rpm for 2 min in an Allegra X-12 bench top centrifuge (Beckman Coulter, 
Inc., Mississauga, ON). The supernatant containing the pass 1 BV (P1 BV) was transferred to a 
new 15 mL Falcon tube. The cell pellet was washed once with 1 mL of phosphate buffered saline 
([PBS] 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4, pH 7.5), pelleted at 3000 
rpm for 2 min and then re-suspended in 1 mL of PBS. Both the BV and cell pellet fractions were 
stored at 4
o
C.  
To increase viral titre, an infection was set up in Sf9 cells using the P1 BV obtained from the 
transfection assay. 1.0 X 10
6
 Sf9 cells were dispensed into a 25 cm
2
 flask in 5 mL total volume 
of GIM (with FBS and Gen) and the cells were allowed to adhere to the flask for 2 h at RT. The 
GIM was removed from the flask and discarded. Fifty microlitres of P1 BV were mixed with 950 
μL of GIM (with FBS and Gen) in a 1.5 mL tube. The viral inoculum was added to the flask and 
allowed to bathe the cells by rocking the flask gently at RT for 2 h. The viral inoculum was 
removed from the flask and replaced with 5 mL of fresh GIM (with FBS and Gen). The infected 
cells were incubated for 48 h at 27
o
C, following which the cells and media containing the pass 2 
BV (P2 BV) were collected as described above.  
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Viral DNA was extracted from the P2 BV by mixing 100 μL of P2 BV with 100 μL of lysis 
buffer (10 mM Tris-Cl pH8.0, 1 mM EDTA, 0.5% sodium dodecyl sulfate [SDS], 80 μg/mL 
Proteinase K) and incubating overnight at 50
o
C. Viral DNA was extracted one time using 200 μL 
of phenol:chloroform:isoamyl alcohol (25:24:1). The sample was mixed gently and centrifuged 
at 14,000 rpm for 8 min in a bench top microcentrifuge. The upper aqueous layer was transferred 
to a new 1.5 mL tube. This sample was mixed once with 200 μL of chloroform:isoamyl alcohol 
(24:1) and then centrifuged at 14,000 rpm for 8 min in a bench top microcentrifuge. The upper 
aqueous layer containing the DNA was transferred to a new 1.5 mL tube. The DNA solution was 
diluted 1:10 using sterile distilled water and 2 μL was used in a PCR reaction as described above 
using the pUC M13 Forward and Reverse primers. The PCR products were separated in a 1% 
agarose gel in TAE buffer, stained with GelRed, to confirm the presence of viral DNA 
containing the correct insert.  
A second infection was set up as described above in a 25 cm
2
 cell culture flask by infecting 
1.0 X 10
6 
Sf9 cells with 50 μL of the P2 BV to produce pass 3 (P3) BV with a higher virus titre. 
The infected cells were incubated at 27
o
C for 48 h and collected as described above.  
The P3 BV supernatant and cell pellet fractions were screened for expressed protein 
production. One hundred microlitres of P3 BV and half of the P3 cell pellet were transferred to 
new 1.5 mL tubes. Mock-infected Sf9 cells were used as a negative control to ensure that there 
was no cross-reactivity between cellular or media proteins and the detection antibody. Protein 
sample buffer (1 M Tris pH 6.8, 10% w/v SDS, 2.5 mg/mL bromophenol blue, 50% v/v glycerol, 
1% v/v β-mercaptoethanol [β-ME]) was added to each sample and the samples boiled for 10 min. 
The samples were immediately cooled on ice for 10 min and then centrifuged at 14,000 rpm for 5 
min to pellet any insoluble protein. Thirty microlitres of each sample were analyzed by SDS-
polyacrylamide gel electrophoresis (PAGE). The protein samples were separated in a 12% 
polyacrylamide gel with a 5% polyacrylamide stacking gel at 110 V for 90 min in a Mini-
PROTEAN® Tetra-Cell electrophoresis apparatus (Bio-Rad Laboratories Inc.).  
The separated proteins were transferred from the polyacrylamide gel to a nitrocellulose 
membrane (General Electric Company, Mississauga, ON) at 100 V for 60 min in a Mini Trans-
Blot® electrophoretic transfer cell (Bio-Rad Laboratories Inc.). The nitrocellulose membrane 
was blocked overnight at 4
o
C in 5% skim milk in PBS with 0.05% Tween-20 (PBS-T). The 
membrane was washed twice, 5 min per wash, with PBS-T. The membrane was then incubated 
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for 1 h at RT with gentle rocking with a 1:1000 dilution of HA.11 Clone 16B12 purified mouse 
monoclonal antibody (Covance Inc., Montreal, QC) prepared in 5% skim milk in PBS-T. The 
membrane was washed three times, 5 min per wash, with PBS-T and then incubated for 1 h at 
RT with gentle rocking with a 1:50,000 dilution of a goat anti-mouse IgG-horseradish peroxidase 
(HRP) conjugated antibody (Bio-Rad Laboratories Inc.) prepared in 5% skim milk in PBS-T. 
The membrane was washed three times with PBS-T and then developed with the Millipore 
Immobilon Western Chemiluminescent HRP substrate (EMD Millipore Corporation, Billerica, 
MA). The membrane was covered in plastic wrap and enclosed in a Spectroline Monotec 
lightproof autoradiography cassette with a Kodak X-Omatic intensifying screen (Krackeler 
Scientific Inc., Albany, NY). Kodak BioMax MR film (Kodak, Rochester, NY) was placed on 
top of the membrane for a variety of exposure times. The films were developed in a dark room 
using a Kodak M35A X-OMAT processor (Kodak).  
Each of the expressed proteins was purified from the total infected-cell protein preparations 
using an anti-HA-tag purification kit (MBL International Corporation, Woburn, MA). Infected 
Sf9 cells from a 75 cm
2
 flask (approximately 1.0 X 10
7
 cells) were washed twice with 5 mL 
aliquots of PBS. The cells were pelleted by centrifugation at 3000 rpm for 2 min in a bench top 
centrifuge and the supernatant discarded. The cell pellet was re-suspended in 1 mL of lysis buffer 
(25 mM Tris-HCl pH 7.5, 100 mM NaCl, 5 mM EDTA, 1% Triton X-100) and the cells lysed by 
sonication using a Misonix S-4000 sonicator (QSonica, Newtown, CT) with an amplitude of 50 
and pulse time of 15 s. The lysate was incubated on ice for 15 min and then centrifuged at 14,000 
rpm for 5 min in a bench top microcentrifuge to pellet any cellular debris. Five hundred 
microlitres of lysate were incubated with 20 μL of anti-HA-tag bead slurry in a spin column 
(MBL International Corporation). The cell lysate and beads were incubated for 1 h at 4
o
C with 
end-over-end rotation. The spin column was inserted into a 1.5 mL collection tube and 
centrifuged at 14,000 rpm for 10 s in a bench top microcentrifuge. The flow through containing 
unbound protein was saved for future analysis. The beads were washed three successive times 
with 200 μL aliquots of wash buffer (supplied with the purification kit) and each wash fraction 
was saved for future analysis. The spin column was transferred to a new 1.5 mL tube and 20 μL 
of HA elution peptide (2 mg/mL, supplied with the purification kit) was added directly to the 
beads in the column. The column was incubated at 4
o
C for 5 min and then centrifuged at 14,000 
rpm for 10 s to collect the eluate. A second elution was completed using another 20 μL fraction 
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of HA elution peptide. The beads were incubated for 1 min at 4
o
C and then centrifuged at 14,000 
rpm for 10 s. The two elution fractions were pooled and stored at -80
o
C for future analysis.  
 
4.3.3. Chitin-binding assays 
A chitin-binding assay was performed to determine if the expressed proteins interacted with 
the chitin beads. In this experiment, infected Sf9 cells from a 75 cm
2
 flask (approximately 1.0 X 
10
7
 cells) were re-suspended in 1 mL of lysis buffer and sonicated as described in Section 4.3.2. 
The total cellular lysate was incubated on ice for 15 min and cellular debris pelleted by 
centrifugation at 3000 rpm for 5 min in a bench top centrifuge.  
One millilitre of chitin magnetic-bead slurry (New England Biolabs Inc., Ipswich, MA) was 
transferred to a 1.5 mL tube. The beads were isolated using a DynaMag
TM
-2 magnetic rack (Life 
Technologies Corporation, Carlsbad, CA) and the supernatant discarded. The beads were washed 
three times with 1 mL aliquots of column binding buffer (500 mM NaCl, 0.02 M Tris-HCl pH 
8.0, 0.001 M EDTA, 0.05% Triton X-100) and the supernatant from each wash discarded. One 
millilitre of cell lysate was added to the washed chitin beads and incubated overnight at 4
o
C with 
end-over-end rotation. The chitin beads were isolated using the DynaMag
TM
-2 rack and the 
supernatant fraction, containing unbound protein, was transferred to a new 1.5 mL tube. The 
beads were washed 10 successive times with 1 mL aliquots of PBS. The supernatant from the 1
st
 
and 10
th
 wash steps were kept for future analysis. To elute any bound protein, the beads were 
boiled in protein sample buffer for 10 min. The samples were separated in a polyacrylamide gel, 
transferred to a nitrocellulose membrane, and probed using the monoclonal anti-HA antibody as 
described in Section 4.3.2.  
To determine the mechanism(s) involved in binding, various chemicals were assessed for 
their ability to release the chitin-bound protein. Infected Sf9 cells from a 75 cm
2
 flask were lysed 
by sonication, protein purified using the anti-HA tag purification kit, and incubated with 1 mL of 
washed chitin bead slurry overnight at 4
o
C as described above. The flow through was collected 
and the beads washed 10 times with PBS. One millilitre of PBS was added to the beads and the 
beads were divided into four equal fractions. The beads were isolated using the DynaMag
TM
-2 
rack and the PBS discarded. Each fraction was weighed to ensure that approximately the same 
amount of beads were in each of the four fractions. Various chemicals were added to each 
fraction in an attempt to liberate any bound protein. These included 500 mM NaCl, 2% SDS, 5% 
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β-ME, 1% Calcofluor White M2R (Sigma-Aldrich Co., Oakville, ON) or the following 
combinations: 2% SDS + 5% β-ME, 2% SDS + 1% Calcofluor, or 2% SDS + 5% β-ME + 1% 
Calcofluor. The samples were incubated for 1 h at RT with end-over-end rotation. Following the 
1 h incubation, the beads were pelleted and the supernatant removed. Fifty microlitre aliquots of 
the supernatant samples were transferred to new 1.5 mL tubes and protein sample buffer added. 
The bead fractions were washed once with 1 mL of PBS and then 100 µL of protein sample 
buffer and 100 µL of sterile water were added to each bead fraction. The supernatant aliquots 
and bead fractions were boiled for 10 min prior to separating in a polyacrylamide gel and 
detection by western blot as described in Section 4.3.2.  
The chitin-binding assays were validated using bovine serum albumin (BSA) (Invitrogen 
Corporation) as a negative binding control, and wheat-germ agglutinin (WGA) (Sigma-Aldrich 
Co.), as a positive binding control. A chitin-binding assay was performed by incubating 1 mg of 
BSA or 1 mg of WGA with 1 mL of pre-washed chitin bead slurry overnight at 4
o
C. The 
supernatant was removed from the beads as described above and the beads washed 10 times with 
1 mL aliquots of PBS. Protein sample buffer was added to the chitin beads and to aliquots of the 
supernatant and wash fractions and the samples were boiled for 10 min. The samples were 
separated in a polyacrylamide gel as described in Section 4.3.2, and visualized by staining with 
Coomassie Brilliant Blue or silver stain (Silver Xpress Kit, Invitrogen Corporation). A second 
binding assay was performed with WGA to determine the mechanism(s) involved in binding. 
This experiment was carried out using 2% SDS, 5% β-ME, 0.2% Calcofluor, or combinations of 
these to elute bound protein from the chitin beads. This experiment was performed as described 
above for Maco118, Maco164, Ac145, and Ac150.  
Chitin-binding assays were performed using one other HA-tagged protein to ensure that any 
binding that was detected was not due to an interaction between the HA-tag and the chitin beads. 
The protein used was MsOSP-HA, an oviposition-stimulating protein from the migratory 
grasshopper Melanoplus sanguinipes (97), which was expressed in the Bac-to-Bac® baculovirus 
expression system. MsOSP is a 242 amino acid protein that is not predicted to contain a CBD 
and is not cysteine rich (4 cysteine residues). Non-purified protein was incubated overnight with 
the chitin beads and bound-protein was released by boiling in protein sample buffer. A second 
set of chitin-binding assays was performed for MsOSP using 2% SDS, 5% β-ME, 0.2% 
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Calcofluor, or combinations of these to elute bound protein from the chitin beads. This 
experiment was performed as described above.  
 
4.4. Results 
4.4.1. Analysis of amino acid sequences, protein motifs, and protein structure 
AcMNPV ORF 145 was predicted to encode a 77 amino acid protein with a hydrophobic N-
terminus consistent with a membrane transit signal (85-87). The only protein motif predicted by 
the meta search engine MOTIF was a chitin-binding Type 2/peritrophin A domain between 
amino acids 11 and 69 as identified in the PROSITE profiles (prf) and protein families (Pfam) 
databases with e-values of 0.17 and 0.0012, respectively. Ac145 was not predicted to possess 
either a signal peptide (D score = 0.126, cut-off score = 0.450) according to the Signal P server 
or a transmembrane domain (expected number of amino acids in a transmembrane helix (TMH) 
= 0) according to the TMHMM server.  
AcMNPV ORF 150 was predicted to encode a 99 amino acid protein with a hydrophobic N-
terminus (85-87). Ac150 was also predicted to contain a chitin-binding Type 2/peritrophin A 
domain between amino acids 38 and 96, as identified in prf, Pfam HMMs local models (Pfam 
Fs), and Pfam HMMs global models (Pfam Is), with e-values of 4.5 X 10
-6
, 7.6 X 10
-13
, and 1.9 
X 10
-10
, respectively. Ac150 was predicted to contain a RGD integrin-binding motif at amino 
acids 29-31 as predicted by PROSITE patterns frequent match producers (freq pat). RGD 
domains are predicted to play a role in both cell attachment and in integrin-mediated signalling. 
Ac150 was not predicted to contain a signal peptide (D score = 0.411, cut-off score = 0.500), but 
it was predicted to have 1 TMH with amino acids 7 to 25 predicted to span a membrane 
(expected number of amino acids in a TMH = 19).  
MacoNPV ORF 164, the homologue of AcMNPV ORF 145, was predicted to encode a 92 
amino acid protein with a chitin-binding Type 2/peritrophin A domain between amino acids 29 
and 84. This was confirmed by prf, Pfam Fs, and Pfam Is, with e-values of 0.0026, 4.5 X 10
-7
, 
and 3.5 X 10
-5
 respectively. Maco164 was predicted to contain a signal peptide (D score = 0.811, 
cut-off score = 0.450) with a predicted cleavage site between amino acids 16 and 17. Maco164 
was not predicted to contain a TMH (expected number of amino acids in a TMH = 0).  
MacoNPV ORF 118 is substantially longer than its homologue, AcMNPV ORF 150, and 
encodes a putative protein of 249 amino acids. This protein was predicted to have a partial 
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chitin-binding Type 2/peritrophin A domain between amino acids 39 and 76 as determined by prf 
and Pfam Fs, with e-values of 16 and 3.2 X 10
-5
, respectively. Maco118 was not predicted to 
contain a signal peptide (D score = 0.360, cut-off score = 0.500), but it was predicted to contain a 
transmembrane domain between amino acids 5 and 27 (expected number of amino acids in TMH 
= 20).  
An alignment of the homologous proteins Ac145/Maco164 and Ac150/Maco118 indicating 
the location of the predicted chitin-binding/peritrophin A domains and other relevant motifs is 
provided in Figure 10.  
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 AcMNPV ORF 145   (1) ------------------MNQIHLKCHSDKICPKGYFGLNADPYDCTAYYLCPHKVQMFCELNHEFDLDSASCKPIVYDHTGS 
MacoNPV ORF 164   (1) MWLLLALLIVVKLVLFHKLKDMHYDIHTNKICPKGYYGLAPDPYDCDSYYICPDRVQFYCPHGQQFELTEQKCIEASLET--- 
                                                     *             *  ## *       *     #      * 
                                                     1             2      3       4             5 
   AcMNPV ORF 145  (66) GCTARMYRNLLL 
MacoNPV ORF 164  (80) GCIGRLYKNLLL 
                                                       *                  
                                                       6       
                
                                                                                                                          
 AcMNPV ORF 150    (1) MLKPNMLIIIFIIVCLFSIIIFTVLKSKRGDDDESDDGFSCYNKPIGVNFPHPTRCDAFYMCVGLNQKLELICPEGFEFDPDVK 
MacoNPV ORF 118    (1) MSKRLYKNILWLVVLLMVVLWAAVILWNTRRNNPYRPGITCNSYYLRN—-------------------DLLTCPEKYEFDNALQ 
                                                                                                                                                                        *                                       *      ##    *                           *             # 
                                                                                                                                                                        1                                       2              3                           4 
                                                                                                             
 AcMNPV ORF 150   (85)  NCVPISDYGCTANQN-------------------------------------------------------------------- 
MacoNPV ORF 118   (65) KCVPIDENGCTALAVPSTITAAEFTCTPTRLHKRSRDRPCQALVDCATDVSTYSAEGMCFKLTENDTFVEVECMQVPGCRYLD 
                                                                *                    *      
                                                                5                    6   
                                                                                                                     
 AcMNPV ORF 150   (99) ------------------------------------------------------------------------------------ 
MacoNPV ORF 118  (149) MVHVPLELTFNEVGAQHYDTFTCPVSLENNRFVRTTKQPCFIGMTCANDNNKTLLSCPYHWQCLDDHEDAAAEILCVPCWYYAR 
 
                                         
 AcMNPV ORF 150   (99) ------------------ 
MacoNPV ORF 118  (233) CQYMNAYTPVQAIAAALT 
 
Figure 10. Amino acid alignment of homologous 11K proteins.  
Panel A: Ac145 and Maco164 alignment. Panel B: Ac150 and Maco118 alignment. Conserved cysteine residues are indicated by an 
asterisk and are labelled 1 through 6 to indicate the 6 cysteine residues present in the CBD. The conserved aromatic residues, 
phenylalanine (F) and tyrosine (Y) are indicated by #. Non-similar amino acids are represented with black text on a white background. 
Similar amino acids are represented by black text on a grey background, and identical amino acids are represented by white text on a 
black background. The predicted cleavage site for the Maco164 signal peptide is indicated by a red arrow. The RGD motif in Ac150 is 
indicated in blue bold text.  
B 
A 
3
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The online homology modeling software SWISS MODEL was used to predict the tertiary 
structures of Ac145, Ac150, Maco118, and Maco164. The SWISS MODEL program identified 
the antimicrobial peptide Tachycitin (protein database identifier 1dqcA) from the horseshoe crab, 
Limulus polyphemus, as the best fit template for Maco164 (e-value = 4.1 X 10
-11
), Ac145 (e-
value = 1.5 X 10
-6
) and Ac150 (e-value = 9.4 X 10
-14
). A suitable template protein was not found 
for Maco118. Structural models for Ac145, Ac150, Maco164, and Tachycitin are provided in 
Figure 11.  
 
 
Figure 11. Protein structure model of the Tachycitin (A) protein from the horseshoe crab, 
Limulus polyphemus, compared to Maco164 (B), Ac145 (C), and Ac150 (D).  
The 6 cysteine residues (10 in Tachycitin) are highlighted on the protein backbone in yellow. 
The three key aromatic residues involved in chitin binding are indicated by the yellow stick 
figures extending into the chitin-binding pocket.  
 
4.4.2. Chitin-binding assays 
Preliminary chitin-binding assays were performed for each of the four expressed proteins. 
The results from these experiments showed that each of the four proteins interacts with chitin 
(Figure 12).  
 
 
 
 
 
A B C D 
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Figure 12. Preliminary chitin-binding assays for Maco118 (A), Maco164 (B), Ac145 (C), and 
Ac150 (D).  
Lane 1 is the flow through fraction, lane 2 is the first wash, lane 3 is the tenth wash, and lane 4 is 
the released protein. A size marker (kDa) is provided for reference on the right hand side of each 
panel. The western blots were probed with a 1:1000 dilution of a purified HA.11 Clone 16B12 
mouse monoclonal antibody followed by a 1:50,000 dilution of a goat anti-mouse IgG- HRP 
conjugated antibody. Expected protein sizes are 29.8 (A), 12.2 (B), 10.3 (C), and 12.6 (D) kDa, 
respectively.  
 
 A second set of chitin-binding assays was performed using HA-tag purified proteins in an 
attempt to determine the mechanism(s) involved in binding. Treatment with 2% SDS was able to 
release some, but not all of the bound protein from the chitin beads. Treatment with 0.5 M NaCl, 
5% β-ME, and 0.2% or 1% Calcofluor did not cause a release of any of the bound protein from 
the chitin beads (Figure 13). Following treatment with various compounds, protein was bound to 
each bead fraction, including that which was treated with 2% SDS. This indicates that there is 
likely more than one mechanism involved in binding these proteins to the chitin beads.  
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Figure 13. Chitin-binding assay to determine mechanisms involved in binding.  
Chitin beads were incubated with HA-tag purified proteins overnight. The chitin beads were split 
into equal fractions and a different chemical was added to each fraction. Lanes 1 through 5 are 
the eluates from treatment with 0.5 M NaCl (1), 2% SDS (2), 5% β-ME (3), 0.2% Calcofluor (4), 
and 1% Calcofluor (5). Lanes 6 through 10 are the eluates from boiling the chitin beads in 
protein sample buffer after treatment with the various compounds. These samples are in the same 
order as lanes 1 to 5. The western blots were probed with a 1:1000 dilution of a purified HA.11 
Clone 16B12 mouse monoclonal antibody, followed by a 1:50,000 dilution of a goat anti-mouse 
IgG- HRP conjugated antibody. The results for Maco118 are shown in panel A and Maco164 in 
panel B. A size marker (kDa) is provided for reference on the right hand side of each panel. 
Expected protein sizes are 29.8 kDa and 12.2 kDa for Maco118 and Maco164, respectively. The 
elution pattern for Ac150 was the same as for the Maco118 and Maco164. The level of 
expression obtained for Ac145 did not allow for this type of follow-up binding experiment.  
 
A third set of chitin-binding assays using combinations of 2% SDS, 5% β-ME, and 1% 
Calcofluor were performed. Protein was released following each treatment, which is consistent 
with the results from the second chitin-binding assay that showed that treatment with 2% SDS 
caused a release of some but not all of the bound protein. The addition of 5% β-ME or 1% 
Calcofluor to 2% SDS, or all three compounds together, does not appear to increase the amount 
of protein released from the chitin beads. The bead fractions were washed one time with PBS 
and then boiled in protein sample buffer to release any proteins that were still bound to the beads. 
Protein was released from each bead fraction, suggesting that another mechanism, which is still 
to be determined, is also involved in binding. The results from this experiment are presented in 
Figure 14.  
 
1 2 3 4 5  6 10 9 8 7 
A 
B 
 1 2 3 4 5 6 10 9 8 7 
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Figure 14. Second chitin-binding assay to determine mechanisms involved in binding. 
Chitin beads were incubated with HA-tag purified proteins overnight. The chitin beads were split 
into equal fractions and a different compound was added to each fraction. Lanes 1 through 4 are 
the eluates from treatment with 2% SDS (1), 2% SDS + 5% β-ME (2), 2% SDS + 1% Calcofluor 
(3), and 2% SDS + 5% β-ME + 1% Calcofluor (4). Lanes 5 through 8 are the eluates from 
boiling the chitin beads in protein sample buffer after treatment with the various compounds. 
These samples are in the same order as lanes 1 to 4. The western blots were probed with a 1:1000 
dilution of a purified HA.11 Clone 16B12 mouse monoclonal antibody, followed by a 1:50,000 
dilution of a goat anti-mouse IgG- HRP conjugated antibody. A size marker (kDa) is provided 
for reference on the right hand side of each panel. Expected protein sizes are 29.8 kDa for 
Maco118 (A) and 12.2 kDa for Maco164 (B). The elution pattern for Ac150 was the same as for 
the Maco118 and Maco164. The level of expression obtained for Ac145 did not allow for this 
type of follow-up binding experiment. 
 
The specificity of the chitin-binding assay was examined using BSA and WGA. BSA does 
not contain a CBD and is not expected to bind to chitin. WGA contains a CBD and is known to 
bind specifically to chitin (98, 99). BSA or WGA were incubated with chitin beads overnight and 
bound protein was released from the beads by boiling in protein sample buffer. As expected, 
BSA did not bind to the chitin beads. The majority of BSA was present in the flow through 
fraction as unbound protein. Some BSA was recovered following the 1
st
 wash of the chitin beads. 
No BSA was recovered in the 10
th
 wash fraction, or in the eluent from boiling the chitin beads in 
protein sample buffer. The results for the BSA binding experiment are provided in Figure 15. 
 
 
 
 
 
 
 
A B 
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Figure 15. BSA chitin-binding assay. 
Lane 1 is the flow through, collected following the overnight incubation of BSA with chitin 
beads. Lane 2 is the first wash, lane 3 is the tenth wash, and lane 4 is the eluate after boiling the 
beads with protein sample buffer. A size marker (kDa) is provided for reference on the right 
hand side of the panel. Expected protein size for BSA is 66.4 kDa. This gel was stained with the 
Invitrogen Silver Xpress Kit. 
 
As predicted, WGA bound to the chitin beads. As with the 11K proteins, some of the bound 
WGA was released from the chitin beads following treatment with 2% SDS and the 
combinations of compounds containing SDS. Each bead fraction retained some of the bound 
protein after treatment, suggesting that another mechanism is involved in the interaction. These 
results are consistent with the results from Maco118, Maco164, and Ac150. The results from this 
experiment are shown in Figure 16.  
 
 
Figure 16. WGA chitin-binding assay. 
Lanes 1 through 6 show the WGA fractions eluted from chitin beads using 2% SDS (1), 5% β-
ME (2), 0.2% Calcofluor (3), 2% SDS + 5% β-ME (4), 2% SDS + 0.2% Calcofluor (5), and 2% 
SDS + 5% β-ME + 0.2% Calcofluor (6). Lanes 7 through 12 are the eluates from boiling the 
chitin beads in protein sample buffer after treatment with the various compounds. These samples 
are in the same order as lanes 1 to 6. A size marker (kDa) is provided for reference on the right 
hand side of each panel. Expected protein size for WGA is 36 kDa. This gel was stained with the 
Invitrogen Silver Xpress Kit.  
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Chitin binding experiments using HA-tag purified MsOSP were performed to eliminate the 
possibility that the HA tag was involved in an interaction with the chitin beads. The results from 
this experiment indicated that MsOSP protein interacts with chitin. Treatment with 0.5 M NaCl 
does not appear to have an effect on binding. Treatment with 2% SDS caused a release of all 
bound protein from the chitin beads, whereas treatment with 1% Calcofluor causes some, but not 
all of the protein to be released from the chitin beads (Figure 17 A). Treatment with 
combinations of 2% SDS with 5% β-ME or 1% Calcofluor or all three together, also caused a 
release of all bound protein (Figure 17 B).  
 
 
Figure 17. Chitin-binding experiments using HA-tag purified MsOSP-HA protein.  
Panel A: First chitin-binding experiment. Lane 1: Neat HA-tag purified MsOSP, lane 2: Flow 
through, lane 3: wash 1, lane 4: wash 10, lane 5: chitin beads following treatment with 0.5 M 
NaCl, lane 6: supernatant from treatment with 0.5 M NaCl, lane 7: chitin beads following 
treatment with 2% SDS, lane 8: supernatant from treatment with 2% SDS, lane 9: chitin beads 
following treatment with 5% β-ME, lane 10: supernatant from treatment with 5% β-ME, lane 11: 
chitin beads following treatment with 1% Calcofluor, lane 12: supernatant from treatment with 
1% Calcofluor. Panel B: Second chitin-binding experiment. Lane 1: Neat HA-tag purified 
MsOSP, lane 2: Flow through, lane 3: wash 1, lane 4: wash 10, lane 5: chitin beads following 
treatment with 2% SDS, lane 6: supernatant from treatment with 2% SDS, lane 7: chitin beads 
following treatment with 2% SDS + 5% β-ME, lane 8: supernatant for treatment with 2% SDS + 
5% β-ME, lane 9: chitin beads following treatment with 2% SDS + 1% Calcofluor, lane 10: 
supernatant for treatment with 2% SDS + 1% Calcofluor, lane 11: chitin beads following 
treatment with 2% SDS + 5% β-ME + 1% Calcofluor, lane 12: supernatant for treatment with 2% 
SDS + 5% β-ME + 1% Calcofluor. A size marker (kDa) is provided for reference on the right 
hand side of the panel. Expected protein size for MsOSP-HA is 28.3 kDa. 
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4.5. Discussion 
Ac145 and Ac150 are predicted to encode small proteins of approximately 11 kDa in size, 
with a hydrophobic N-terminus, corresponding to a membrane transit signal, and a 6 cysteine 
motif called a peritrophin A CBD (85-87). As expected, both proteins contain a CBD according 
to the prf and Pfam databases. Neither Ac145 nor Ac150 was predicted to have a signal peptide 
using the Signal P server. This is not in contradiction with the presence of a predicted membrane 
transit signal, as signal peptides and membrane transit signals serve different purposes. A 
membrane transit signal targets a pro-protein to a cellular organelle, whereas a signal peptide 
targets a pro-protein to the endoplasmic reticulum to be processed before being transported out 
of the cell via a secretory pathway (100, 101). The lack of a signal peptide, and therefore lack of 
secretion from the infected cell, is consistent with the findings of Lapointe et al. (87) who 
detected Ac145 and Ac150 within the nucleus of infected cells.  
Zhang et al. (86) noted that Ac150 contains an RGD motif between the membrane transit 
signal and the CBD. This was confirmed in silico using the PROSITE freq pat database. RGD is 
an integrin-binding domain, which is predicted to play a role both in integrin-mediated signalling 
pathways as well as in cell attachment (102). The RGD motif has been shown to play a role in 
many cellular functions, including regulating gene expression, endocytosis, cell survival, and 
apoptosis (102, and references therein), though the exact role that the RGD motif plays in 
baculovirus infections remains to be determined (86, 102). 
Ac145 and Ac150 have been shown to be incorporated into BV as well as OB (87). 
Localization specifically to the nucleocapsid or envelope fraction of the BV or ODV has yet to 
be demonstrated for these proteins. Ac145, which lacks a transmembrane domain and is 
therefore not predicted to be membrane-bound, is predominantly found within the BV, but is also 
incorporated to a lesser degree into the OB (87). Ac150, which does contain a transmembrane 
domain and is therefore predicted to be membrane-bound, is found in similar abundance in both 
BV and OB (87).  
The presence of both Ac145 and Ac150 in the OB supports the hypothesis that these proteins 
may be required for initial oral infection of a host insect’s midgut. The differences in abundance 
of Ac145 and Ac150 within the OB may be indicative of different roles for each protein within 
the infection cycle, specifically during initial infection. For example, the presence of an RGD 
motif within Ac150 may enhance attachment of the ODV envelope to the midgut epithelial cells, 
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or may facilitate the uptake of viral DNA and gene expression within the nucleus. The 
significance of Ac145 and Ac150 localizing to the BV is not clear, but will be studied in more 
detail, along with the functions of both proteins in Chapters 6 and 7 of this thesis.  
The MacoNPV homologues to Ac145 and Ac150, Maco164 and Maco118, respectively, are 
predicted to contain a complete (Maco164) or partial (Maco118) CBD. Maco164 is comparable 
in size to Ac145, and these two proteins align well at the amino acid level. Maco164 was 
predicted to contain a signal peptide consisting of the first 16 N-terminal amino acids. This 
suggests that unlike Ac145, which is retained within the nucleus, Maco164 is likely secreted 
from the cell. Localization studies for Maco164 were not undertaken, and it is not clear what 
function Maco164 would have if secreted from the cell during the course of infection.  
Maco118 is substantially larger than its AcMNPV homologue, Ac150. Maco118 contains a 
partial CBD at the amino terminus, and it aligns well with Ac150 at the amino acid level in this 
region. Maco118 does not contain an RGD integrin-binding domain, but like Ac150, it is 
predicted to contain a transmembrane domain at the amino terminus. To date, localization studies 
have not been undertaken for Maco118. The functions of Maco164 and Maco118 will be studied 
in greater detail in Chapters 6 and 7 of this thesis.  
Ac145, Ac150, and Maco164 are predicted to have structures similar to that of the 
antimicrobial peptide Tachycitin from the horseshoe crab, Limulus polyphemus. Tachycitin is a 
known chitin-binding protein (103). It contains ten cysteine residues that form five disulphide 
bonds which promote the correct folding of the protein (103). Two aromatic residues, present as 
a “sandwich” platform, extend into a binding pocket (34, 103). These residues allow for an 
interaction to occur with the pyranose ring of chitin (104). A third aromatic residues protrudes 
into a secondary groove, but to date, there is no direct evidence that this residue is involved in 
the interaction with chitin (34). 
As Ac145, Ac150, and Maco164 are expected to be chitin-binding proteins, the similarity in 
predicted structure between these proteins and Tachycitin supports this hypothesis. As Maco118 
contains only a partial CBD and no other major motifs, it was not surprising that a suitable 
template structure was not found using the SWISS MODEL software. Lack of a suitable 
template does not indicate that Maco118 does not fold in a comparable way to the other 11K 
proteins, simply that there was no template protein with a similar primary sequence available on 
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which to base the predicted folding of Maco118. Further studies are required to determine the 
structure of Maco118.  
Ac145, Ac150, Maco164, and Maco118 were expressed in the Bac-to-Bac baculovirus 
expression system. Each protein was tagged with an HA-epitope tag at the carboxy terminus to 
allow tracking via western blot analysis. Protein expression levels were qualitatively the highest 
between 72 and 96 hpi for all proteins.  
Migration of the expressed proteins was close to what would be expected based on their 
molecular weights (Ac145 10.3 kDa, Ac150 12.6 kDa, Maco118 29.8 kDa, and Maco164 12.2 
kDa). With the exception of Maco118, which migrates as a protein doublet at 28 and 34 kDa, all 
other proteins run as a single discrete band. The Maco118 protein doublet could indicate post-
translational modification(s) or catalytic cleavage of the protein into alternate forms. In silico 
analysis of possible post-translational modification sites on Maco118 using the prediction 
software NetNGlyc 1.0 and NetOGlyc 3.1 (Centre for Biological Sequence Analysis, Technical 
University of Denmark), indicated a possible N-linked glycosylation site at amino acid 129, and 
possible O-linked glycosylation sites at amino acids 91, 93, and 249. Post-translational 
glycosylation or other modifications could explain the Maco118 protein doublet. Interestingly, 
Lapointe et al. (87) found that Ac150, the homologue of Maco118, migrated as a protein doublet 
when extracted from BV, but migrated as a single band of intermediate size when extracted from 
OB. As all protein expression experiments in this study used cell lysates and not BV, further 
work is required to determine if differential processing occurs in the BV and OB forms of Ac150 
and Maco118. 
Expressed proteins were purified from the total cellular milieu using an anti-HA tag 
purification kit. This kit greatly reduces, but does not eliminate, non-HA tagged proteins. To 
maintain the structure of the expressed proteins, the proteins were eluted from the anti-HA tag 
beads using purified HA peptide. This resulted in protein samples containing a considerable 
amount of free peptide. This prevented the accurate quantification of the expressed proteins 
using standard protein quantification assays. For all chitin-binding experiments, a set volume of 
infected cells was used in an attempt to standardize the amount of protein added to the chitin 
beads. It is recognized, however, that each protein may be expressed with varying efficiency and 
that different amounts of proteins were likely applied to the beads. As purified protein could 
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always be detected in the first wash fraction after binding, it was assumed that sufficient protein 
was used to saturate the chitin beads.  
The majority of chitin-binding assays described in the literature demonstrate chitin-binding 
in one of two ways. Both methods involve incubating an expressed or purified protein with chitin 
(beads, powder, or reconstituted chitosan) then either boiling the protein-chitin mixtures in 
protein sample buffer to release the bound protein (see(103, 105, 106)for representative 
examples), or using a spectrophotometric or a colourmetric assay to determine the amount of free 
protein before and after incubation with chitin (see(107-109)for representative examples). 
Although this can be informative in that it provides information on the ability of a protein to 
interact with chitin, it does not provide any details about the mechanism(s) involved in, or the 
specificity of, the interaction. The approach used in this study was to determine if the proteins of 
interest were in fact able to bind to chitin, and if so, to investigate the mechanism(s) involved in 
binding.  
Preliminary chitin-binding experiments using the expressed Ac145, Ac150, Maco118, and 
Maco164 indicated that all four proteins bound to chitin. Low levels of expression of Ac145 
were observed in comparison to Ac150, Maco118, and Maco164. Several attempts were made to 
optimize the level of expression of Ac145 to produce sufficient amounts of protein for further 
binding studies. Unfortunately, sufficient quantities of Ac145 could not be produced, and further 
binding studies were carried out using Ac150, Maco118, and Maco164 only.  
We predicted that the addition of compounds that disrupt the intramolecular disulfide bonds 
or intermolecular hydrogen bonds would likely interrupt binding, as disulfide bonds play a major 
role in the proper folding of the CBD (30, 88) and hydrogen bonds are involved in binding 
proteins containing a CBD to chitin (30, 92). It was expected that by treating the protein-bound 
beads with a disulfide bond reducing agent, such as β-ME, the protein would unfold and be 
released from the chitin beads. Treatment with up to 5% β-ME did not release of any of the 
proteins from the chitin beads. Likewise, neither treatment with NaCl (to disrupt potential ionic 
bonds), nor Calcofluor, a known chitin-binding compound (110), was able to release bound 
protein. This suggests that ionic bonds are not involved in this type of chitin-binding, and that 
Calcofluor may bind using a different mechanism than the 11K proteins or that the 11K proteins 
bind very tightly to the chitin beads so that Calcofluor could not compete for binding space. 
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The only compound that was able to release a portion of the bound protein was 2% SDS. No 
additional protein was stripped from the chitin beads when combinations of SDS with β-ME or 
Calcofluor or all three together were used. The ability of SDS to release some of the bound 
protein suggests that non-covalent interactions are a key factor in mediating binding. This 
finding supports the hypothesis that intermolecular hydrogen bonds or hydrophobic interactions 
exist between proteins containing a CBD and chitin. In addition, even though Maco118 does not 
contain a classic CBD, it is highly cysteine rich. As cysteine is a hydrophobic amino acid, it 
follows that this protein may interact with chitin via hydrophobic interactions. Combinations of 
SDS, β-ME, and Calcofluor could not release all of the bound protein, as demonstrated by 
protein remaining on the beads following elution with the various compounds. When the beads 
were boiled in sample buffer, more protein was released. This indicates that there is another 
mechanism involved in binding that has yet to be determined.  
Positive and negative controls were run to validate the chitin binding assays. BSA was used 
as a negative control for binding. This protein was not expected to bind to chitin, and binding 
experiments confirmed this hypothesis. WGA, a known chitin-binding plant lectin (98, 99), was 
used as a positive control for binding. As expected, chitin-binding was demonstrated for WGA. 
Like Ac150, Maco118, and Maco164, some of the bound WGA was released from the chitin 
beads following treatment with 2% SDS. Release of bound WGA was not enhanced by the 
addition of Calcofluor or β-ME, which suggests that the mechanism of binding of WGA may be 
similar to that of Ac150, Maco118, and Maco164.  
Chitin-binding assays were carried out using the HA-tagged MsOSP protein from the 
grasshopper Melanoplus sanguinipes to eliminate the possibility that the HA tag was involved in 
binding. MsOSP is predicted to be 242 amino acids in length (97). In silico analysis indicates 
that this protein is not cysteine-rich, but does contain a number of hydrophobic amino acids 
(40% of amino acids are hydrophobic). As MsOSP lacks a classic CBD, it was not expected to 
interact with chitin. An initial binding study using non-purified MsOSP indicated that there was 
an interaction between this protein and the chitin beads. Subsequent chitin-binding experiments 
indicated that treatment with 2% SDS released all bound protein into the supernatant fraction. 
Treatment with 5% β-ME caused MsOSP to precipitate out of solution and therefore no protein 
could be detected in either the supernatant or the bead fractions. Treatment with 1% Calcofluor 
caused some, but not all, of the bound protein to release. As treatment with 2% SDS released all 
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bound protein from the chitin beads, it does not appear that the addition of 5% β-ME and/or 1% 
Calcofluor to 2% SDS had an effect on protein binding. These results suggest that the interaction 
between MsOSP and chitin is mediated by non-covalent interactions. It also suggests that 
MsOSP binds to chitin via a similar mechanism to Calcofluor, but uses a different mechanism 
than the baculovirus 11K proteins. Based on these results, it does not appear that the HA tag is 
involved in the interaction between the expressed proteins and chitin.  
Lapointe et al. (87) looked at the ability of Ac145 and Ac150 to bind to chitin in vitro. They 
used various conditions including high pH (up to 10.5) to mimic the larval midgut environment 
and attempted to show binding in the presence of midgut juice. All of their attempts to 
demonstrate chitin binding failed. There could be several reasons why they were unable to 
demonstrate chitin binding. First, they expressed Ac145 and Ac150 in a bacterial expression 
system, pGEX-KG. This could be problematic as these proteins presumably rely on disulfide 
bonds between the cysteine residues for proper tertiary structure. This type of folding can 
sometimes be difficult to induce in bacterial expression systems resulting in mis-folded proteins 
(111-114). In addition, Lapointe et al. omitted the N-terminal 22 or 30 amino acid in Ac145 and 
Ac150, respectively, in the expressed proteins. In Ac150, this region contains the predicted 
transmembrane domain and RDG integrin binding motif. It is not clear how the loss of either of 
these motifs would affect chitin-binding, but as they constitute approximately one third of the 
full-length protein, it is reasonable to suggest that deletion of this region would adversely affect 
folding of Ac150. In addition, it appears that for Ac145 removal of the N-terminal 22 amino acid 
results in deletion of the first cysteine residue of the CBD. Thus, only five of the six-cysteine 
residues involved in forming the CBD were expressed. It is therefore not surprising that they 
were unable to demonstrate chitin binding for this protein.  
 
4.6. Conclusions and future research 
The 11K gene products from AcMNPV, Ac145 and Ac150, and from MacoNPV, Maco118 
and Maco164, bind to chitin. For Ac150, Maco118, and Maco164, the binding is mediated by 
hydrophobic interactions, but there is likely a secondary (and possibly other) binding mechanism 
involved in the interaction of the protein to chitin. The mechanism(s) involved in binding these 
proteins with chitin is similar to that of WGA, a plant lectin that is known to bind specifically 
with chitin. Further binding studies using other carbohydrate compounds, such as cellulose or 
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chitosan, should be conducted to ensure that the binding of Ac145, Ac150, Maco118, and 
Maco164 with chitin is specific. Optimization of expression of Ac145 should also be conducted 
to determine if this protein interacts with chitin via similar mechanisms to Ac150, Maco118, and 
Maco164.  
In vivo or in situ binding studies could be conducted to determine the localization of these 
proteins during infection. Binding studies using tagged (fluorescent or otherwise) proteins could 
be conducted to see if the proteins bind to the chitin fibrils of the PM, the midgut epithelium, or 
to other insect tissues during the initial stages of infection.  
Site directed mutagenesis could also be used to individually mutate each of the 6 cysteine 
residues or the 3 conserved aromatic residues in the predicted CBD and subsequently determine 
the effect on chitin binding. While this may not prove to be especially important in the case of 
these particular proteins and their role in infection, it may also be useful in developing a better 
chitin-binding assay to understand how proteins containing a CBD function. In particular, it 
would be interesting to determine if the aromatic residue predicted to extend into the secondary 
groove of the protein is involved in the interaction with chitin. There has been no direct evidence 
of an interaction between this residue and chitin or any other carbohydrate in the literature.  
What remains to be determined for the 11K proteins is the role that they play in the 
baculovirus infection cycle. These questions will be addressed in Chapters 5-7 of this thesis.  
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5. TRANSCRIPTIONAL ANALYSIS OF AcMNPV ORF 145, 149, and 150  
5.1. Introduction 
5.1.1. AcMNPV 
AcMNPV is the type species for the Alphabaculovirus genus. It is a large (133.9 kbp) double 
stranded DNA virus containing 151 ORF (51, 115). A significant amount of research has been 
conducted to determine the functions of the AcMNPV genes, with definitive functions being 
assigned for at least 60 of the ORF (115).  
The two 11K genes from AcMNPV, ORF 145 and ORF 150, have been studied previously 
(see Section 2.3.8 for a review). Homologues of AcMNPV ORF 145 have been identified in all 
Alpha-, Beta-, and Gammabaculoviruses (115). Homologues of ORF 150 have been identified in 
a few Alpha- and Betabaculovirus species (115). While neither Ac145 nor Ac150 appears to 
effect cell-to-cell transmission in in vitro or in vivo studies (86, 87), their role in oral infectivity 
remains unclear. The degree of conservation of these genes among baculovirus species suggests 
that they likely play an important role in the baculovirus infection cycle. 
Lapointe et al. (87) demonstrated that Ac145 and Ac150 are expressed from 24 hpi onwards, 
suggesting that ORF 145 and ORF 150 are late or very late genes. The locations of the 
transcription initiation and termination sites for these genes have not yet been mapped. The 
temporal transcription patterns and transcription regulatory regions of ORF 145 and ORF 150 
will be investigated in this chapter. An in silico analysis will be conducted to predict the location 
of their transcriptional regulatory motifs. The location of these motifs will be confirmed by the 
use of 5ʹ and 3ʹ Rapid Amplification of cDNA Ends (RACE). The temporal transcription patterns 
of these genes will be determined using northern blot analysis. An additional AcMNPV gene, 
ORF 149 will also be studied, as this ORF overlaps with ORF 150. AcMNPV ORF 149 is not 
highly conserved among baculovirus species and no functional analysis has been conducted for 
this gene (115). A detailed description of this gene region is provided in Section 6.3.1. 
5.2. Hypothesis 
AcMNPV ORF 145 and ORF 150 are predicted to be late or very late genes, with transcripts 
detectable by 24 hpi. Transcription initiation for both genes is predicted to begin at a late gene 
[(A/G/T)TAAG(A/G/T)] or a very late gene promoter (ATAAG).  
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5.3. Materials and methods 
5.3.1. Mapping the transcriptional regulatory sites for AcMNPV ORF 145, 149, and 150 
using 5ʹ and 3ʹ RACE 
The insect cell line TnHi5 (from parental strain BTI-TN-5B1-4 which was derived from 
embryonic tissue of the cabbage looper, T. ni), was propagated in GIM. Cells were incubated at 
27
o
C and passed weekly at a confluent cell suspension to medium ratio of 1:10.  
Two 25 cm
2
 cell culture flasks (Corning Incorporated) were inoculated with 1.0 X 10
6
 TnHi5 
cells per flask in 5 mL of GIM. The cells were allowed to adhere to the flask for 2 h at RT at 
which time the GIM was removed and discarded. P2 BV from AcMNPV strain E2 was added to 
each flask at a multiplicity of infection (MOI) of 5. The virus was allowed to bathe the cells by 
rocking the flask gently at RT for 2 h. The viral inoculum was removed from the flask, the cells 
washed once with 2 mL of GIM, and 5 mL of fresh GIM added to each flask. The flasks were 
incubated at 27
o
C. Infected cells and BV were collected from one flask at 4 hpi and from a 
second flask at 24 hpi as described in Section 4.3.2., with the exception that the infected cell 
pellets were re-suspended in 350 µL of RLT buffer (QIAGEN) and frozen at -80
o
C. The BV 
fractions were stored at 4
o
C.  
The infected cells were lysed by passing them several times through a 26-gauge sterile needle 
attached to a sterile, RNase-free syringe. Total RNA was extracted from the cell lysate using the 
QIAGEN RNeasy kit (QIAGEN) which included an on-column DNase 1 digestion to remove 
any contaminating genomic DNA. The RNA was quantified using a Nanodrop 1000 
spectrophotometer and RNA quality confirmed by separating 2 µL of each sample in a 1.2% 
agarose gel in 10 mM sodium phosphate buffer and staining with GelRed.  
The locations of the transcriptional start sites for Ac145, Ac149, and Ac150 were mapped by 
5ʹ RACE using the Invitrogen GeneRacerTM kit (Invitrogen Corporation). Briefly, 3 µg of total 
RNA was dephosphorylated to select against non-full length mRNA by incubating with 1 X calf 
intestinal alkaline phosphatase (CIP) buffer, 40 U of RNaseOUT
TM
, and 10 U CIP in a 10 µL 
total volume at 50
o
C for 1 h. The 5ʹ cap structure was removed from the full length mRNA by 
incubating the dephosphorylated RNA with 1 X tobacco acid pyrophosphatase (TAP) buffer, 40 
U of RNaseOUT
TM
, and 0.5 U TAP at 37
o
C for 1 h. The GeneRacer
TM
 RNA-oligo, which 
contains a priming site for the GeneRacer
TM
 5ʹ Primer and GeneRacerTM 5ʹ Nested Primer (Table 
3), was ligated to the 5ʹ end of the de-capped RNA and the RNA reverse transcribed to cDNA 
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using gene-specific primers (GSP) and SuperScript III reverse transcriptase (Table 3) as 
described in the GeneRacer
TM
 manual. RNA was removed by incubation with 2 U of RNase H at 
37
o
C for 20 min.  
The 5ʹ cDNA ends were amplified by PCR using a nested GSP (GSP 2) and the GeneRacerTM 
5ʹ Primer (Table 3) as follows: in a 50 µL total reaction volume, 0.6 µM GeneRacerTM 5ʹ Primer 
was mixed with 0.3 µM GSP 2, 1 µL of the reverse transcribed cDNA, 1 X HF PCR buffer 
(Invitrogen Corporation), 10 mM of each dNTP, 2 mM MgSO4, and 2.5 U of HF Platinum® Taq 
DNA polymerase (Invitrogen Corporation). A modified touchdown PCR method was used to 
amplify the cDNA ends. The reaction mixture was incubated at 95
o
C for 2 min followed by 5 
cycles of 95
o
C for 30 s and then 72
o
C for 1 min. This was followed by 5 cycles of 95
o
C for 30 s 
and then 70
o
C for 1 min, followed by 25 cycles of 95
o
C for 30 s, 65
o
C for 30 s, and 68
o
C for 1 
min. A final elongation step was carried out at 68
o
C for 10 min before holding the reaction at 
4
o
C. Five microlitres of each PCR product were separated in a 1% agarose gel in TAE buffer 
with GelRed to ensure that a single product had been produced.  
Nested PCR was performed to eliminate any non-specific PCR amplicons. The PCR reaction 
mixtures and the thermo cycling profile were the same as described above, except that 0.6 µM 
GeneRacer
TM
 5ʹ Nested Primer and 0.3 µM GSP 3 were used to prime the amplification. The 
nested PCR products were separated in a 1% agarose gel in TAE buffer with GelRed. The PCR 
bands were excised from the gel and the DNA was extracted using the QIAGEN Gel Extraction 
kit. 
The gel-purified PCR products were cloned into the pGEM®-T-Easy vector (Promega 
Corporation, Madison, WI) by mixing the pGEM®-T-Easy vector DNA and gel-purified PCR 
product in a 1:3 ratio with 1 X Rapid Ligation Buffer with 3 U of T4 DNA ligase in a 10 µL total 
volume at 4
o
C overnight. Three microlitres of a ligation mixture were used to transform a 25 µL 
aliquot of electrocompetent E.coli DH10B cells as described in Section 4.3.2. Plasmid DNA was 
extracted from the E.coli cells following a standard alkaline lysis protocol. Five microlitres of 
plasmid DNA were digested with 1.5 U of EcoR1 in a 10 µL reaction with 1 X React 3 Buffer 
(Invitrogen Corporation) at 37
o
C for 2 h. The digested DNA samples were separated in a 1% 
agarose gel in TAE buffer and visualized with GelRed to identify clones with an appropriately 
sized insert. Several clones were selected and sequenced at PBI with primers SP6 and T7 (Table 
3). 
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Table 3. Primers used to amplify the 5ʹ cDNA ends of Ac145, Ac149, and Ac150.  
Primer Name Sequence 
GeneRacer
TM
 RNA Oligo CGACUGGAGCACGAGGACACUGACAUGGACUGAAGGAGUAGAAA 
GeneRacer
TM
 5ʹ Primer CGACTGGAGCACGAGGACACTGA 
GeneRacer
TM
 5ʹ Nested Primer GGACACTGACATGGACTGAAGGAGTA 
AcORF 145 5ʹ RACE GSP 1  CATAGTAACAAGTTTC 
AcORF 149 5ʹ RACE GSP 1 TGCAAAACTGCCGTCGTC 
AcORF 150 5ʹ RACE GSP 1 GGTTAGCGGTACATCCATA 
AcORF 145 5ʹ RACE GSP 2 ACCCGCTGCCCGTGTGA 
AcORF 149 5ʹ RACE GSP 2 GGCAGCGGCGTCATGTTGGTAA 
AcORF 150 5ʹ RACE GSP 2 ATCAAATTCAAATCCTTCAG 
AcORF 145 5ʹ RACE GSP 3 GGCGGAGTCCAAGTCAAA 
AcORF 149 5ʹ RACE GSP 3 TGGGCGAGAAGGCGCATTTGT 
AcORF 150 5ʹ RACE GSP 3 TTGATTTAAACCGACACA 
SP6 Universal Primer ATTTAGGTGACACTATAG 
T7 Universal Primer TAATACGACTCACTATAGGG 
 
 
The location of the downstream polyadenylation sites for Ac145, Ac149, and Ac150 were 
determined by 3ʹ RACE using the GeneRacerTM kit (Invitrogen Corporation). One microgram of 
total RNA was used for each reaction. The RNA was reverse transcribed as described in the 5ʹ 
RACE section above, except that the GeneRacer
TM
 Oligo dT primer (Table 4) was used for each 
reaction instead of a GSP. The initial and nested amplifications of the 3ʹ cDNA ends were carried 
out as described above. The initial amplification was carried out using 0.6 µM of the 
GeneRacer
TM
 3ʹ Primer and 0.3 µM of the 3ʹ RACE GSP 1 primer (Table 4), and the nested 
amplification was carried out using 0.6 µM of the GeneRacer
TM
 3ʹ Nested Primer and 0.3 µM of 
the 3ʹ RACE GSP2 primer. The 3ʹ cDNA products were gel-purified and cloned into pGEM®-T-
Easy as described above, and several clones were sequenced with the SP6 and T7 primers.  
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Table 4. Primers used to amplify the 3ʹ cDNA ends of Ac145, Ac149, and Ac150. 
Primer Name Sequence 
GeneRacer
TM
 Oligo dT GCTGTCAACGATACGCTACGTAACGGCATGACAGTG(T)24 
GeneRacer
TM
 3ʹ Primer GCTGTCAACGATACGCTACGTAACG 
GeneRacer
TM
 3ʹ Nested Primer CGCTACGTAACGGCATGACAGTG 
AcORF 145 3ʹ RACE GSP 1  AAAGGGTATTTTGGCCTCAAC 
AcORF 149 3ʹ RACE GSP 1 ATGATATCTCTCCATTGTATGATCGC 
AcORF 150 3ʹ RACE GSP 1 TTTGAAATCTAAAAGAGGTGACG 
AcORF 145 3ʹ RACE GSP 2 TCTGTGTCCGCATAAAGTGC 
AcORF 149 3ʹ RACE GSP 2 ATGCGCTCCACGGCGCGCGTTGATACGG 
AcORF 150 3ʹ RACE GSP 2 TGGAGTAAATTTTCCGCATCC 
 
 
5.3.2. Northern blot analysis 
Six 75 cm
2
 flasks were inoculated with 3.0 X 10
6
 TnHi5 cells in GIM and the cells allowed 
to attach to the flasks overnight at RT. The GIM was removed and P2 BV from AcMNPV strain 
E2 added to each flask at an MOI of 5. The virus was allowed to bathe the cells by rocking the 
flask gently at RT for 2 h. The viral inoculum was removed and the cells washed once with 5 mL 
of GIM. The wash buffer was removed and 20 mL of fresh GIM added to each flask. This was 
recorded as time 0. The flasks were incubated at 27
o
C and infected cells and BV collected from a 
single flask at 3, 6, 12, 18, 24, and 48 hpi as described in Section 4.3.2., with the exception that 
the infected cell pellets were re-suspended in 350 µL of RLT buffer and stored at -80
o
C. The BV 
fractions were stored at 4
o
C. Total RNA was extracted from the cell pellets using the QIAGEN 
RNeasy Kit as described above. Purified RNA samples were stored at -80
o
C.  
Six micrograms of total RNA from each time point were mixed with RNA sample buffer 
(30% v/v glycerol, 1.2% w/v SDS, 18.5 mM NaPO4 dibasic, 21.5 mM NaPO4 monobasic, 0.25% 
w/v bromophenol blue, 0.25% w/v xylene cyanol) and diethylpyrocarbonate (DEPC)-treated 
water in a final volume of 20 µL. The RNA samples were denatured by incubating at 70
o
C for 10 
min and then immediately chilled on ice. The RNA samples, along with 3 µg of a RNA marker 
(Invitrogen Corporation), were separated in a 1.2% agarose gel prepared in TAE buffer at 80 V 
for 2 h and stained with EnviroSafe dye (Helixx Technologies, Scarborough, ON). The RNA was 
transferred to a Nylon Hybond-N+ membrane (GE Healthcare) by capillary blotting following a 
standard northern blot protocol (96).  
Strand-specific, 
32
P-labelled RNA probes were produced to detect the Ac145, Ac149, and 
Ac150 transcripts, as well as the VP39 (major nucleocapsid protein) and GP64 (EFP) transcripts. 
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Primers were designed to amplify small (approximately 200 bp) fragments from the 3ʹ end of 
each ORF (Table 5).  
In a 50 µL reaction volume, 30 ng of AcMNPV E2 genomic DNA was mixed with 1 X HF 
PCR buffer (Invitrogen Corporation), 10 mM of each dNTP, 2 mM MgSO4, 0.3 µM of each 
primer, and 2.5 U of HF Platinum® Taq DNA polymerase (Invitrogen Corporation). The PCR 
reaction mixture was incubated at 95
o
C for 2 min, followed by 35 cycles of 95
o
C for 30 s, 55
o
C 
for 30 s, and 72
o
C for 30 s. A final elongation step was carried out at 72
o
C for 10 min before 
holding the reaction at 4
o
C. The PCR products were separated in a 1% agarose gel in TAE buffer 
and stained with GelRed. The PCR amplicons were excised from the gel and DNA was extracted 
using the QIAGEN gel extraction kit. The PCR products were quantified using a Nanodrop 1000 
spectrophotometer.  
 
Table 5. Primer pairs used to amplify regions at the 3ʹ end of AcMNPV ORF 89 (vp39), 128 
(gp64), 145, 149, or 150 for use as a single-stranded, 
32
P-labelled probes for northern blot 
analysis. 
Gene-specific sequences are in black, the T7 RNA polymerase promoter region is in blue bold, 
and additional nucleotides to aid in binding of the T7 RNA polymerase to the promoter site are 
in red bold. The sequences for primers 2022, 2023, 2024, and 2025 were kindly provided by Dr. 
David Theilmann, Agriculture and Agri-Food Canada (AAFC), Summerland BC, Canada.  
 
Primer 
Name 
Sequence Amplifies 
1991 
2019 
AGGGTATTTTGGCCTCAACG 
AGTATTATGCTGAGTGATATCCCATACATGCGAGCCGTACACC 
AcMNPV ORF 145 
1994 
2020 
TTGCTTCATACGTCGAGATACC 
TCATAATACGACTCACTATAGGGTGCCGTCGTCAATACAACAC 
AcMNPV ORF 149 
1995 
2021 
GAATCAGACGACGGGTTCAG 
AGTATTATGCTGAGTGATATCCCTTTTGGTTAGCGGTACATCC 
AcMNPV ORF 150 
2022 
2023 
TCATAATACGACTCACTATAGGGTGCGCTTGGAATTAAAATTCGCT 
GCGTATCATGACGATGGATG 
AcMNPV ORF 89 (VP39) 
2024 
2025 
CATAATACGACTCACTATAGGGTCAGCTCCTCTTGAATATGCA 
AGCTGCGTGTCTGCTCATTA 
AcMNPV ORF 128 (GP64) 
 
T7 RNA polymerase was used to produce single-stranded RNA products from the double-
stranded PCR products. T7 RNA polymerase recognizes the T7 RNA polymerase promoter 
region, which was engineered into each reverse primer and uses this region as the initiation site 
for synthesizing RNA from the DNA template in a strand-specific manner. Five hundred 
nanograms of purified PCR product were incubated at 95
o
C for 10 min to separate the two 
strands. The DNA was cooled on ice for 5 min and then the denatured DNA mixed with 50 U 
 59 
RNaseOUT
TM
, 500 µM ATP, CTP and GTP, 10 µM UTP, 1 X RNA polymerase reaction buffer 
(New England Biolabs Inc.), 50 U T7 RNA polymerase, and 50 µCi of 
32
P labelled UTP 
(PerkinElmer Inc., Waltham, MA) in a final volume of 50 µL. The reaction mixture was 
incubated at 37
o
C for 80 min. Two units of high quality, amplification grade DNase1 (Invitrogen 
Corporation) was added to the reaction mixture and then incubated at 37
o
C for 15 min.  
The nylon Hybond-N+ membrane was placed in a hybridization bottle and pre-hybridized 
with 20 mL of hybridization buffer (7% SDS, 0.25 M NaPO4 dibasic, 0.25 M NaPO4 monobasic, 
and 1% BSA) for 21 h at 65
o
C. The probe was added to the hybridization solution and incubated 
with the membrane for 21 h at 65
o
C. The membrane was washed twice, 15 min per wash, with 2 
X saline-sodium citrate buffer (SSC) with 0.1% SDS at 65
o
C, and then once with 0.2 X SSC with 
0.1% SDS at 65
o
C for 50 min. The membrane was wrapped in plastic wrap and placed inside a 
Spectroline Monotec lightproof autoradiography cassette. Kodak BioMax MR film was placed 
on top of the membrane for a variety of exposure times and films developed in a dark room using 
a Kodak M35A X-OMAT processor. 
 
5.4. Results 
5.4.1. Mapping transcriptional regulatory elements 
Three potential transcription initiation sites were identified for Ac145 using 5ʹ RACE. The 
bolded nucleotide represents the end of the 5ʹ or 3ʹ RACE product. These sites are indicated as 
initiation site (a), (b), and (c), respectively, on Figure 18. Initiation site (a) is a GAAT motif, 
which overlaps with the G of the predicted Ac145 start codon (underlined). Initiation site (b) is a 
CTAA motif that is located 15 nt downstream from the Ac145 predicted start codon, and 
initiation site (c) is an AAAA motif located 33 nt downstream from the Ac145 predicted start 
codon. Two transcription termination sites were identified for Ac145 using 3ʹ RACE. 
Termination site (a) is a CAGTTG motif, and termination site (b) is a CGCGCG motif, which 
are located 12 nt and 84 nt downstream from the predicted Ac145 stop codon, respectively. A 
string of adenine residues was present following each of the termination sites.  
Three transcription initiation sites were identified for Ac149 using 5ʹ RACE. Initiation site (a) 
is an ATCA motif, site (b) is a CATA site, and initiation site (c) is a second ATCA site, located 
79 nt, 63 nt, and 61 nt downstream from the predicted Ac149 start codon, respectively. A single 
termination site was identified using 3ʹ RACE. The transcript terminates at a TGCTTT motif, 
7
6
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located 19 nt downstream of the predicted Ac149 stop codon. All transcripts that terminated at 
this location had a string of adenine residues appended following the TGCTTT motif.  
Two transcript initiation sites were identified for Ac150 using 5ʹ RACE. Transcript initiation 
site (a) is a GGCG motif located 411 nt upstream from the predicted Ac150 start codon. 
Initiation site (b) is an AATT motif located 57 nt downstream from the predicted Ac150 start 
codon. A single termination site was identified by 3ʹ RACE at a CTAACC motif located 5 nt 
upstream from the predicted Ac150 stop codon. A string of adenine residues followed the 
CTAACC motif. 
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Figure 18. Location of transcription initiation and termination sites for Ac145, Ac149, and Ac150 as determined by 5ʹ and 3ʹ RACE. 
The location of the predicted promoter motifs, which overlap the site of transcription initiation in most baculovirus genes, and the 
location of predicted polyadenylation signals are also indicated. The regulatory elements for Ac145 are indicated in Panel A, Ac149 in 
Panel B, and Ac150 in Panel C. If multiple initiation or termination sites were indicated by the RACE data, these were designated as 
site (a), (b), (c), etc.  
6
1
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5.4.2. Northern blot analysis 
Transcript sizes and temporal transcription patterns were determined for Ac145, Ac149, 
Ac150, Ac128 (gp64), and Ac89 (vp39) using northern blot analysis (Figure 19). Temporal 
expression patterns and transcript sizes for Ac128 (1.59 kbp early and 1.66 kbp late transcript) 
(116, 117) and Ac89 (2.2 kbp transcript) (118) have been previously determined, and these genes 
were included in the northern blot assay as control samples for early gene transcription (Ac128) 
and late gene transcription (Ac128 and Ac89). The RNA samples used for the northern blot 
analysis were denatured by heat-treatment prior to electrophoresis on an agarose gel. As the 
transcript sizes obtained for Ac128 and Ac89 were not the same sizes as reported in the literature, 
estimates of transcript size are provided as millimetres migrated from the origin as opposed to 
absolute size, as we could not ensure that the RNA remained denatured during electrophoresis in 
agarose gels that did not contain standard denaturing agents.  
Ac145 was transcribed from 18 hpi onwards. There appears to be one or more transcripts 
produced, with the predominant band migrating at 58 mm from the origin. Four different sized 
transcripts were produced for Ac149, migrating at 50 mm, 58 mm, 60 mm, and 67 mm from the 
origin. The 58 mm transcript was detected from 3 hpi to 6 hpi, while the 50 mm, 60 mm, and 67 
mm transcripts were detected from 18 hpi to 48 hpi. Five transcripts were detected for Ac150, 
migrating at 45 mm, 54 mm, 56 mm, 59 mm, and 64 mm. The 64 mm transcript was detectable 
from 18 through 48 hpi, with the other transcripts detectable from 24 through 48 hpi. Two 
transcripts were produced for Ac128, one that migrated at 58 mm from 3 to 12 hpi, and a second 
that migrated at 55 mm from 18 through 48 hpi. Finally, Ac89 produced a single transcript 
migrating 39 mm from the origin, which was present from 12 through 48 hpi.  
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Figure 19. Northern blot analysis to determine the temporal transcription patterns and 
approximate transcript sizes of AcMNPV ORF 145, 149, 150, 128, and 89.  
The numbers across the top of the gel (3, 6, 12, etc.) indicate hours post-infection. The distance 
migrated from the origin are provided in mm at the right hand side of each image.  
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5.5. Discussion 
In silico analysis was conducted prior to completing the 5ʹ and 3ʹ RACE studies in order to 
predict the location of potential transcription initiation and termination sites. The sequence 200 
nt upstream of the predicted start codon was scanned for the conserved early (CAGT), late 
(TAAG), or very late (ATAAG) promoters. Baculovirus promoter motifs typically overlap with 
the site of transcription initiation (43, 44, 46, 59, 60). The search was limited to 200 nt upstream 
of the start codon as the 5ʹ UTR for baculovirus genes tend to be less than 150 nt (43). If a 
CAGT early gene promoter was identified, a second search was conducted to locate an upstream 
TATA motif. A search was conducted in the 500 nt downstream of the predicted stop codon for 
each ORF to locate a polyadenylation signal (AATAAA). The 3ʹ UTR regions for baculovirus 
genes can be varied in length and 500 nt was selected as a starting point for locating the 
polyadenylation signal.  
A putative late gene promoter, (T)TAAG, was located 156 nt upstream of the predicted start 
codon for Ac145. There was no CAGT early gene motif within 200 nt of the predicted start 
codon. This agrees with the findings of Lapointe et al. (87) who found that Ac145 was expressed 
at late times post-infection. A putative polyadenylation signal was located 322 nt downstream of 
the predicted stop codon for Ac145. Using this information, the Ac145 transcript was predicted to 
be 723 nt and be expressed at late times post-infection.  
A CAGT early gene promoter motif was located 31 nt upstream of the Ac149 predicted start 
codon. A further search revealed a TATA motif 88 nt upstream from the Ac149 start codon. No 
late or very late gene promoter elements were identified within 200 nt of the Ac149 start codon 
suggesting that it is an early gene. A polyadenylation signal was located 58 nt downstream from 
the predicted stop codon. Based on the location of the TATA motif and polyadenylation signal, 
the predicted transcript size for Ac149 is 423 nt and is expected to be expressed at early times 
post-infection.  
Two possible late gene promoters were identified upstream of the predicted Ac150 start 
codon. One (G)TAAG motif was located 167 nt upstream of the start codon and another at 134 nt 
upstream. An early gene promoter was not identified within 200 nt of the start codon, suggesting 
that Ac150 is a late gene. This agrees with the work of Lapointe et al. (87) who determined that 
Ac150 is expressed at late times post infection. Several possible polyadenylation signals were 
located downstream from the predicted stop codon. These were located 1 nt, 6 nt, 30 nt, and 49 
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nt downstream from the predicted stop codon. It is possible that multiple transcripts are produced 
for Ac150, with predicted sizes ranging between 445 nt and 531 nt.  
The 5ʹ RACE data indicated that Ac145 is transcribed at late times (24 hpi) as expected. A 5ʹ 
RACE product was not detected at the 4 hpi time point. Several possible transcript initiation sites 
were identified. Site (a) was at a GAAT motif, which overlaps the G of the ATG predicted start 
codon. Site (b) was at CTAA site located 15 nt downstream of the predicted start codon, and site 
(c) was at an AAAA motif 33 nt downstream from the predicted start codon. These results were 
unexpected, as none of these motifs are classic baculovirus late gene promoter motifs. Although 
the 5ʹ RACE was completed using the Invitrogen GeneRacerTM kit, which selects for full-length 
transcripts by excluding transcripts that lack a 5ʹ cap, it is possible that 5ʹ RACE product was 
prematurely truncated for Ac145. The 200 nt upstream of the Ac145 start codon are highly AT 
rich (82%) and this could be problematic in terms of producing a full-length transcript through 
this region.  
The 3ʹ RACE data for Ac145 also did not agree with the predictions for location of the 
polyadenylation signal. The Ac145 transcript was found to terminate in two locations: one at a 
CAGTTG site located 12 nt downstream of the predicted stop codon, or at a CGCGCG site 
located 84 nt downstream of the predicted stop codon. A polyA sequence was appended to each 
3ʹ RACE product at these sites, suggesting that these may be true transcript termination sites. 
Using the experimentally located transcription initiation and termination sites, transcripts ranging 
in size from 211 nt to 316 nt are expected to be produced for Ac145. These sizes do not agree 
with the predicted transcript size of 723 nt. As the Ac145 RACE results indicated that transcripts 
did not initiate or terminate at conserved transcriptional regulatory sites, it is possible that the 
RACE results were truncated.  
Strand-specific northern blot experiments were used in an attempt to confirm the temporal 
expression patterns and transcript sizes of Ac145, Ac149, and Ac150. The northern blot results 
for Ac145 indicate that it is transcribed from 18 hpi through 48 hpi, which agrees with the RACE 
data that suggests that it is a late gene. As well, Lapointe et al. (87) determined that Ac145 is 
expressed at late times post infection. The predominant transcript migrated 58 mm from the 
origin. It is possible that other longer transcripts are also produced, but these bands were not 
easily distinguishable from one another on the northern blot. As Ac145 lies within the intron 
region of the IE-0 gene, and as Ac145 and IE-0 are in the same transcriptional orientation, it is 
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possible that the strand-specific probe designed for the northern blot analysis also anneals with 
the IE-0 transcript, which may explain some of higher molecular weight transcripts.  
The RACE data for Ac149 suggests that this gene is expressed both at early (4 hpi) and late 
(24 hpi) times. This agrees with the prediction that Ac149 is an early gene, based on the presence 
of an early gene promoter complex consisting of a TATA motif and CAGT motif located 88 nt 
and 31 nt upstream of the ORF 149 start codon, respectively. The nearest late gene promoter 
motif (TAAG) is located 365 nt upstream of the predicted Ac149 start codon. This motif was not 
identified in the initial search for promoter motifs as it is outside of the 200 nt window upstream 
from the start codon. Based on the 5ʹ RACE results obtained, it is impossible to say if 
transcription of Ac149 at late times post-infection initiates at this point.  
The 5ʹ RACE data for Ac149 indicated that transcription initiates at one of three sites: an 
ATCA site, a CATA site, or a second ATCA site, located 79 nt, 63 nt, or 61 nt downstream from 
the predicted start codon, respectively. ATCA is part of the conserved baculovirus early gene 
INR motif (46), ATCA(G/T)T(C/T). Although the CAGT portion of the INR motif is most 
commonly used as the site of transcription initiation for baculovirus early genes, it is possible 
that the transcription of Ac149 initiates at the ATCA motif. An ATCA motif is also part of the 
conserved gene promoter motif for many insect genes (119, 120). As baculovirus early gene 
transcription relies on host cell machinery, transcription initiation at a motif common to insect 
genes could facilitate this process.  
The Ac149 3ʹ RACE data indicates that transcription terminates at a TGCTTT site, which is 
19 nt downstream from the predicted stop codon and 33 nt upstream from the predicted 
polyadenylation signal. Sequence data from the 3ʹ RACE clones indicates that a string of 
adenines follows the TGCTTT site, suggesting that this is likely a true termination site of the 
Ac149 transcript.  
Northern blot analysis of Ac149 indicates that four distinct transcripts were produced. A 
transcript that migrated 58 mm from the origin is present from 3 to 6 hpi, and three transcripts 
migrating at 50 mm, 60 mm, and 67 mm were present from 18 to 48 hpi, which is consistent with 
the RACE data that suggests that Ac149 is expressed at both early and late times in infection. 
These results are significant because no studies have been completed for Ac149 or its 
homologues in other baculovirus species to determine its temporal transcriptional patterns or the 
location of the transcription initiation and termination sites.  
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The RACE data for Ac150 suggests that this gene is expressed at late times (24 hpi) in 
infection, which supports the findings of Lapointe et al. (87). RACE products were not detected 
for Ac150 at the 4 hpi time point. Experimentally, the 5ʹ RACE data suggests that transcription of 
Ac150 initiates at one of two locations: a GGCG motif located 411 nt upstream from the 
predicted start codon, or at an AATT motif located 57 nt downstream from the predicted start 
codon. Neither of these sites is a conserved baculovirus late gene promoter. If transcription 
actually initiated at the AATT motif it would result in a truncated protein with the nearest 
methionine residue producing a protein of 40 amino acids, which is not consistent with the 
expression results produced in Chapter 4 of this thesis or with the expression experiments of 
Lapointe et al. (87). It is likely that the transcripts initiated at this point were truncated during the 
5ʹ RACE process. The nearest late gene promoter motif to the GGCG transcript initiation site is 
located 353 nt upstream. If this site were used, it would produce a 773 nt 5ʹ UTR for Ac150, 
which is significantly longer than the typical 150 nt baculovirus 5ʹ UTR.  
Ac150 transcription terminates at a CTAACC site, which is 5 nt upstream of the predicted 
stop codon. A poly-A tail was appended to the transcript following the CTAACC motif, 
suggesting that this is the true transcript termination site.   Transcriptional analysis by northern 
blot indicates that five distinct transcripts are produced for Ac150. These migrate at 45, 54, 56, 
59, and 64 mm from the origin. The transcript that migrated to 64 mm is detectable from 18 hpi 
through to 48 hpi, while all others are present from 24 hpi through 48 hpi. This agrees with the 5ʹ 
RACE data and the findings of Lapointe et al. (87) which indicate that Ac150 is a late gene.  
 
5.6. Conclusions and future research 
Ac145 and Ac150 are late genes as confirmed by 5ʹ and 3ʹ RACE and northern blot. This 
agrees with the findings of Lapointe et al. (87) who determined that Ac145 and Ac150 are 
expressed at late times post infection. Ac149 is transcribed at both early and late times post 
infection. This is the first report of the temporal transcription patterns for this gene. As non-
denaturing agarose gels were used in the northern blot assay, future research should be 
conducted to determine the actual size of the Ac145, Ac149, and Ac150 transcripts. Several 
attempts were made using two different methods to determine the location of the transcription 
initiation sites for Ac145, Ac149, and Ac150. As the 5ʹ RACE data for these genes did not 
terminate at conserved baculovirus promoter motifs, follow up studies should be conducted to 
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determine if these RACE results were prematurely truncated, or if these genes employ non-
traditional promoter motifs. 
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6. CREATION AND CHARACTERIZATION OF KNOCKOUT AND 
REPAIR VIRUSES 
6.1. Introduction 
Determining the function of a specific gene can be quite difficult (121). The development of 
gene knockout constructs, in which a specific gene(s) is functionally deleted from the organisms 
genome, allows for the observation of changes in phenotype obtained from the loss of the 
individual gene(s) (121). Observable changes in phenotype can be compared to that of the wt, 
and inferences can be made about the function of the deleted-gene based on this comparison 
(121). A bacmid system, based on AcMNPV, has been developed and employed extensively in 
gene function studies (89-91). This system allows for the precise deletion of a specific gene(s), 
and provides an opportunity to study the function of individual AcMNPV genes. 
  
6.1.1 Baculovirus knockout and repair constructs using bacmid technology 
The bMON14272 bacmid (Invitrogen Corporation), which was introduced in Section 4.1.1, 
contains the entire AcMNPV genome and ORI for both bacterial and insect cells. It also has a 
modified Polh locus in which the native Polh ORF has been replaced with a mini-att Tn7 target 
site. Although designed for use as a protein expression vector, this bacmid has been used 
successfully as an efficient system for producing gene-knockout constructs in an AcMNPV 
backbone.  
An AcMNPV GOI is replaced with an antibiotic selection marker via homologous 
recombination. Recombinant clones are selected using medium containing this selection marker. 
In order for the recombinant bacmid to produce OB within infected cells, the native Polh gene 
must be re-inserted into the bacmid backbone. This is done using the transfer vector, pFAcT-
GFP (7.7 kbp) (122), which contains the native AcMNPV Polh gene, a GFP gene, and a second 
antibiotic resistance gene, all of which are flanked by Tn7L and Tn7R sites. When this vector is 
introduced into E.coli cells containing the recombinant bacmid and a helper plasmid, 
pMON7124 (13.2 kbp, Invitrogen Corporation) that carries a transposase gene, a Tn7-mediated 
transposition event occurs, in which the Polh, GFP, and antibiotic resistance gene are transferred 
from the pFAcT-GFP vector to the recombinant bacmid at the mini-att Tn7 target site. These 
recombinant knockout bacmids can be selected using the appropriate antibiotics and screened by 
PCR to confirm that the GOI has been deleted.  
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Repair constructs in which the native GOI has been re-inserted into the bacmid backbone are 
created using a similar technique. The pFAcT-GFP vector is modified so that in addition to the 
Polh, GFP, and antibiotic selection marker, it also contains the coding sequence for the GOI. 
This repair-pFAcT-GFP vector can be transformed into E.coli cells containing the recombinant 
knockout construct as described above to produce bacmids in which the GOI is replaced with an 
antibiotic selection marker, and has the native Polh, a GFP gene, a second antibiotic selection 
marker, and the GOI inserted at the mini-att Tn7 target site.  
Producing a repair construct in addition to each knockout construct is important to ensure 
that any change in the phenotype of the virus is due to the loss of the GOI and not due to any of 
the genetic manipulations to the bacmid backbone. The repair construct is expected to rescue the 
wt phenotype. If it does not, then the phenotype observed for the knockout construct may be due 
to an unintentional mutation elsewhere in the genome and cannot be attributed to the loss of the 
GOI. If the wt phenotype is rescued with the repair virus, then one has more confidence that any 
change in phenotype between the knockout and the wt or repair is due to the loss of the GOI and 
not due to altering another gene within the genome.  
Knockout constructs will be produced for AcMNPV ORF 145, ORF 150, or both together 
using the bMON14272 bacmid system. A range of repair constructs will be produced in which 
the GOI will be repaired with the native AcMNPV gene or with the MacoNPV homologue.  
 
6.2. Hypothesis 
The AcMNPV 11K genes, Ac145 and Ac150, are predicted to be involved in oral infectivity; 
therefore, deletion of ORF 145, ORF 150, or both together from the viral genome is not 
predicted to alter the level of, or timing of transcription of other genes within the AcMNPV 
genome. Deletion of the 11K genes is not predicted to have an effect on the rate of budded virus 
production or viral DNA replication. 
 
6.3. Materials and methods 
6.3.1. Primer design for gene knockout and repair bacmid constructs 
Special attention was required when designing the primers to produce the knockout and 
repair constructs as the intragenic regions in the AcMNPV baculovirus, and consequently the 
bMON14272 bacmid, are quite short, and in some cases adjacent ORF or transcripts overlap. 
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When disruption of a promoter, stop codon, or polyadenylation signal could not be avoided due 
to overlap with a GOI, these elements were engineered into the knockout primers to ensure that 
the expression of non-target genes was not altered.  
The AcMNPV ORF 145 gene resides within the intron of the IE0/IE1 gene – the only known 
spliced baculovirus gene (Figure 20). Care was taken to ensure that transcription of IE0 and IE1 
were not affected by knocking out ORF 145.  
 
 
 
 
Figure 20. The AcMNPV IE0/IE-1 gene region.  
AcMNPV ORF 145 is indicated by the red arrow. The IE-0/IE-1 primary transcript extends from 
exon 0 (IE-0/ORF 141) to exon 1 (IE-1/ORF 147). The intronic region of this transcript, 
indicated on the figure by a green bar, is spliced out to produce a mature IE-0 transcript (exon 0 
and exon 1). The IE-1 mature transcript consists of exon 1 only. As IE-0 and IE-1 share a 
common 3ʹ end (exon 1), they are indistinguishable from one another in this region (123).  
 
The transcriptional regulatory elements for the genes flanking ORF 145, ODV-EC27 and 
ORF 146, have been mapped (124, 125). There is a 6 bp overlap between the 3ʹ end of ORF 145 
and the 3ʹ end of ORF 146. The polyadenylation signal for ORF 146 (AATAAA) has been 
mapped to a location 299 bp downstream of the ORF 146 stop codon. This long 3ʹ UTR 
encompasses the entire ORF 145 (Figure 21). The polyadenylation signal (AATAAA) and the 
stop codon (TAA) for ODV-EC27 are immediately adjacent to one another (AATAAATAA) and 
do not overlap with ORF 145.  
 
Figure 21. Location of the AcMNPV ODV-EC-27 and AcMNPV ORF 146 polyadenylation 
signals.  
 
Fragment of AcMNPV bMON14272 DT (AcBac)
1824 bp (molecule 142208 bp)
Ac-odv-ec27
AcOrf-145
AcOrf-146
ODV-EC27 Poly A Signal
AcORF 146 Poly A Signal
Exon 0 Exon 1 
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To create the ORF 145 knockout cassette, the primer pair 1953 and 1954 (Table 6) were 
used. The forward primer, 1953, contains 50 nt at its 5ʹ end that are homologous to the extreme 
3ʹ end of ODV-EC27 (ORF 144). As there is no overlap between this ORF and ORF 145, the 
native ODV-EC27 polyadenylation signal and stop codon remain intact within this primer. The 
20 nt at the 3ʹ end of primer 1953 provide a priming region for the amplification of the 
chloramphenicol acetyl-transferase (CAT) gene.  
The reverse primer, 1954, includes 44 nt at the 5ʹ end that are homologous to the extreme 3ʹ 
end of ORF 146 including the ORF 146 native stop codon. As the native polyadenylation signal 
for ORF 146 is located in the knockout region between ORF 146 and ODV-EC27, a 
polyadenylation signal was engineered into primer 1954 immediately following the stop codon 
for ORF 146. The 18 nt at the 3ʹ end of primer 1953 provide a priming region for the 
amplification of the CAT gene. 
There is a 35 bp overlap at the 5ʹ ends of ORF 149 and ORF 150 (Figure 22). At the time of 
production of these knockout constructs, the temporal expression of ORF 149 was not known, 
nor was the location of the transcriptional regulatory elements for this gene. As it was unknown 
if ORF 149 was an early or late gene, transcriptional regulatory elements could not be engineered 
into the knockout primer without the risk of altering the temporal expression of this gene. To 
circumvent this problem, a double knockout construct was created in which both ORF 149 and 
ORF 150 were deleted. The function of ORF 149 was subsequently restored through the use of 
specially designed repair constructs. 
 
Figure 22. The AcMNPV ORF 149 and 150 gene region including the location of the AcMNPV 
ODV-E56 promoter and IE-2 polyadenylation signal.  
 
The promoter region for ODV-E56 (ORF 148) had been mapped previously (126), as had the 
polyadenylation signal of IE-2 (ORF 151) (127) (Figure 22). Primers 1955 and 1956 (Table 6) 
were designed to knockout both ORF 149 and ORF 150. Primer 1955 contains 43 nt at the 5ʹ 
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end, which are homologous to the region surrounding the ODV-E56 start codon and include the 
native ODV-E56 late promoter. The 3ʹ terminal 20 nt of primer 1955 provide a priming site for 
amplification of the Zeocin (Zeo) resistance gene. Primer 1956 has 40 nt at the 5ʹ end, which are 
homologous to the extreme 3ʹ end of IE-2 (ORF 151). A polyadenylation signal was engineered 
into 1956 and it overlaps with the native IE-2 stop codon (TAA). The remaining 24 nt at the 3ʹ 
end of this primer allow for amplification of the Zeo resistance gene.  
PCR primers were designed to produce repair cassettes containing the native Ac145 (primers 
1960 and 1961) or the MacoNPV homologue, Maco164 (primers 1985 and 1986). The forward 
primer for both cassettes comprise an Xho1 restriction site, followed by a late promoter (TAAG) 
motif and the 5ʹ UTR leader sequence from MacoNPV ORF 89 (enhancin). This leader sequence 
is quite short (14 bp) and has been used successfully in these types of repair constructs to replace 
native UTR regions, which can be up to 150 bp long. The reverse primer for both cassettes 
incorporates the sequence for the HA-epitope tag, an engineered stop codon and polyadenylation 
signal, as well as an Xba1 restriction site. A third set of primers (2001 and 2002) was produced 
to amplify Ac145 as described above, but these primers contain Not1 and Sst1 restriction sites 
instead of Xba1 and Xho1.  
A double repair construct to rescue function of both ORF 149 and ORF 150 was produced 
using primers 1958 and 1959. Primer 1958 contains sequence corresponding to the 3ʹ end of 
ORF 149, followed by the sequence for a c-MYC-epitope tag (derived from the myc family of 
transcription factors), an engineered stop codon and polyadenylation signal, and an Xho1 
restriction site. Primer 1959 contains sequence corresponding to the 3ʹ end of ORF 150, followed 
by the sequence for an HA-epitope tag, an engineered stop codon and polyadenylation signal, 
and an Xba1 restriction site.  
Primers for a second repair cassette were produced to amplify the MacoNPV homologue for 
Ac150, Maco118. Primer 1983 contains a Not1 restriction site followed by a late promoter motif, 
the leader sequence from enhancin, and sequence corresponding to the 5ʹ end of Maco118. 
Primer 1984 contains an Sst1 restriction site, an engineered polyadenylation signal and stop 
codon, the sequence corresponding to the HA-epitope tag, and sequence corresponding to the 3ʹ 
end of Maco118. Primers for a third repair cassette, which would restore the function of ORF 
149, but not ORF 150, were also designed. Primers 1989 and 1990, which are reverse 
complements of one another, contain three engineered stop codons in the coding region of ORF 
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150. The coding region of ORF 149 was unaltered. All primer pairs used to create the repair 
constructs are listed in Table 7. 
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Table 6. Primer pairs used to produce the gene knockout constructs.  
The regions of sequence that are underlined with a single line are homologous to the gene flanking the GOI. The region of the primer 
in bold black text is homologous to an antibiotic resistance cassette (chloramphenicol [Chl] or Zeo). Sequences in bold blue text are 
native transcriptional regulatory sequences. Sequences in bold black text and double underlined are native stop codons. The sequences 
in bold red text were engineered into the primer to maintain proper expression of non-target genes. The sequence AATAAA is a 
standard baculovirus polyadenylation signal.  
 
Primer 
Name 
Sequence Amplifies 
1953 
 
1954 
ACTCAAATTCTGTAACATCAGGGTTTAATATATATAATTTTAATAAATAAGTGTAGGCTGGAGCTGCTTC 
 
AAATCGATAATAGTGTTGTGCAACTGGAAACCCGCTCTTCATAGAATAAAATATGAATATCCTCCTTA 
ORF 145  
knockout cassette  
(Chl. resistance) 
1955 
 
1956 
TCACAGTAAAGGTTTTGCAAAACTGCCGTCGTCAATACAACACGGATCTCTGCAGCACGTGTT 
 
GATTTAGTTTCTAAGTTACAAACTGTTATGTCTAGACGTTAATAAAAGACATGATAAGATACATTGATGA 
ORF 149 and 150 
knockout cassette  
(Zeo. resistance) 
 
  
7
5
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Table 7. Primer pairs for creating the repair constructs. 
Restriction sites are in black, bold and underlined text. The late promoter sequence (TAAG) along with the 5ʹ UTR leader sequence 
from MacoNPV ORF 89 (enhancin) are in black, bold text. The sequence corresponding to the HA-epitope tag is in green bold text. 
Stop codons are in red bold text. Polyadenylation signals are underlined with a double line. The sequence corresponding to the c-
MYC-epitope tag is in purple bold text.  
 
Primer 
Names 
Sequences Amplifies 
1960 
1961 
CCGCTCGAGCCGTTAAGCCATTATTATCATTATGAATCAAATTCATCTAAA 
GCGTCTAGATTTATTTTAGGCGTAGTCGGGCACGTCGTAGGGGTATAGTAACAAGTTTCTATACATG 
AcMNPV ORF 145 
repair cassette 
1985 
1986 
CCGCTCGAGCCGTTAAGCCATTATTATCATTATGTGGTTGTTATTAGCACT 
GCGTCTAGATTTATTTTAGGCGTAGTCGGGCACGTCGTAGGGGTATAGTAACAGATTTTTGTAAAG 
MacoNPV ORF 164 
repair cassette 
1958 
1959 
GCGCTCGAGTTTATTTCAAAGATCTTCTTCAGAAATAAGTTTTTGTTCCAGTAAAGGTTTTGCAA 
GCGTCTAGATTTATTTTAGGCGTAGTCGGGCACGTCGTAGGGGTAGTTTTGGTTAGCGGTAC 
AcMNPV ORF 149 
and 150 repair cassette 
1958 
1989 
GCGCTCGAGTTTATTTCAAAGATCTTCTTCAGAAATAAGTTTTTGTTCCAGTAAAGGTTTTGCAA 
CGTCTGATTCGTCATCGTCACCTCATTAAGATTACAAAACAGTAAAAATAATTATTGA 
AcMNPV ORF 149 
repair cassette 
1959 
1990 
GCGTCTAGATTTATTTTAGGCGTAGTCGGGCACGTCGTAGGGGTAGTTTTGGTTAGCGGTAC 
TCAATAATTATTTTTACTGTTTTGTAATCTTAATGAGGTGACGATGACGAATCAGACGACGGGTTCAG 
1983 
1984 
GAATGCGGCCGCCCGTTAAGCCATTATTATCATTATGTCAAAACGACTCTACAAA 
GCGGAGCTCTTTATTTTAGGCGTAGTCGGGCACGTCGTAGGGGTAGGTTAATGCTGCGGCAATCG 
MacoNPV ORF 118 
repair cassette 
2001 
2002 
GAATGCGGCCGCCCGTTAAGCCATTATTATCATTATGAATCAAATTCATCTAAA 
GCGGAGCTCTTTATTTTAGGCGTAGTCGGGCACGTCGTAGGGGTATAGTAACAAGTTTCTATACATG 
AcMNPV ORF 145 
repair cassette (for use 
in the triple knockout) 
DT 882 
DT 891 
CGCACCACAAAGATGT 
TATTAGTTTGTGCGT 
Sequencing pFAcT-
GFP constructs 
  
7
6
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6.3.2. Production of knockout and repair bacmid constructs 
The preparation of the knockout bacmids is based the protocol developed by Datsenko and 
Wanner (128). An overview of the process is provided in Figure 23. The complete process is 
described below. 
 
Figure 23. Procedure for creating knockout and repair bacmids.  
Adapted from the Bacmid Knockout Protocol used in the Theilmann lab, AAFC, Summerland 
BC, Canada.   
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The preparation of electrocompetent E.coli cells using no salt media is based on Sharma and 
Schimke (129). E.coli K-12 strain BW25113 harboring the pKD46 (Amp
R
) recombination 
plasmid and the bMON14272 bacmid (Kan
R
) were grown on low salt LB plates supplemented 
with 100 µg/mL Amp and 50 µg/mL Kan overnight at 30
o
C. A single colony was selected and 
used to inoculate 5 mL of yeast extract and nutrient broth (YENB – 0.75% yeast extract, 0.8% 
nutrient broth) medium supplemented with 100 µg/mL Amp, 50 µg/mL Kan, and 1 mM of L-
arabinose. The cultures were incubated overnight at 30
o
C with shaking at 225 rpm. The 5 mL 
culture was used to inoculate 500 mL of YENB supplemented with 100 µg/mL Amp, 50 µg/mL 
Kan, and 1 mM of L-arabinose. The culture was incubated at 30
o
C for 4 h with shaking at 225 
rpm and the cells were pelleted at 3000 rpm for 10 min at 4
o
C in a Sorvall RC5C Plus centrifuge 
(Thermo Fisher Scientific). The cells were re-suspended in 100 mL of cold sterile distilled water 
and then re-pelleted by centrifugation. This wash process was repeated a second time. The wash 
process was carried out a third time with the cells being re-suspended in 20 mL of cold 10% 
glycerol. The cells were pelleted a final time and then re-suspended in 2 mL of cold 10% 
glycerol. The cells were divided into 40 µL aliquots and stored at -80
o
C.  
Recombination cassettes were produced by PCR. Primers 1953 and 1954 were used to 
amplify the CAT gene from the plasmid pKD3 (Appendix A). Primers 1955 and 1956 were used 
to amplify the Zeo resistance gene from the plasmid p2ZOp-2F (Appendix B). In a 25 µL 
reaction, 1 X Phusion HF buffer containing 1.5 mM MgCl2 (New England Biolabs Inc.) was 
mixed with 0.5 µM of forward primer, 0.5 µM of reverse primer, 0.4 mM dNTP mix, 0.25 U 
Phusion HF DNA polymerase, and 0.5 ng of template DNA. The PCR reactions were incubated 
at 98
o
C for 30 s, followed by 30 cycles of 98
o
C for 10 s, 65
o
C for 30 s, and 72
o
C for 15 s, 
followed by a final extension at 72
o
C for 10 min before holding at 20
o
C. The PCR products were 
separated in a 0.7% agarose gel in TAE buffer at 50 V for approximately 1 h and visualized by 
staining with ethidium bromide. The PCR products were excised from the gel and the DNA 
extracted using the E.Z.N.A. ® Gel Extraction Kit (VWR International, Radnor, PA) following 
the manufacturer’s protocol. The DNA was quantified using a BioPhotometer 6131 
spectrophotometer (Eppendorf, Mississauga, ON).  
One hundred nanograms of a recombination cassette were transformed into electrocompetent 
BW25113 cells containing the bMON14272 bacmid and the pKD46 plasmid. The cells were 
pulsed at 1.5 kV, 25 µF, and 200 Ω. One millilitre of low salt LB broth was added to the cells 
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immediately following the pulse. The cells were allowed to recover overnight at 37
o
C with 
shaking at 225 rpm. Two hundred microlitres of the transformation mixture were plated onto low 
salt LB plates supplemented with 50 µg/mL Kan and either 17 µg/mL Chl (for cells transformed 
with the 1953-1954 cassette) or 30 µg/mL Zeo (for cells transformed with the 1955-1956 
cassette). The plates were incubated at 37
o
C overnight. Colonies were replica plated onto low 
salt LB plates supplemented with 50 µg/mL Kan and either 17 µg/mL Chl or 30 µg/mL Zeo, as 
well as onto low salt LB plates supplemented with 100 µg/mL Amp. This step was done to select 
for clones that had lost the pKD46 plasmid (Amp
R
) during outgrowth at 37
o
C.  
Several colonies were selected from each transformation to inoculate 5 mL of low salt LB 
supplemented with appropriate selection antibiotics. The cultures were incubated overnight at 
37
o
C. Bacmid DNA was extracted from the E.coli cells using a standard alkaline lysis miniprep 
procedure (96) with an isopropanol precipitation of the bacmid DNA. Following the re-
suspension, the bacmid DNA was incubated at 65
o
C for 10 min to denature any nucleases. The 
DNA was allowed to cool to RT and was then stored at -80
o
C.  
Triple knockout constructs in which AcMNPV ORF 145, ORF 149, and ORF150 were all 
deleted were created using a similar approach, except that the 1955-1956 recombination cassette 
was transformed into electrocompetent E.coli BW25113 cells containing the pKD46 
recombination plasmid and the bMON14272
Ac145 null
 bacmid.  
PCR was used to produce each repair cassette using the following primer combinations: 
1960/1961, 1985/1986, 2001/2002, 1958/1959, and 1983/1984. In a 50 µL reaction, 1 X Phusion 
HF buffer containing 1.5 mM MgCl2, was mixed with 0.4 mM dNTPs, 0.2 μM forward primer, 
0.2 μM reverse primer, 0.25 U Phusion HF DNA polymerase, and 50 ng of vAcBac 887 DNA. 
The PCR reaction mixture was incubated at 98
o
C for 30 s, followed by 30 cycles of 98
o
C for 10 
s, 55
o
C for 30 s, and 72
o
C for 10 s. A final extension of 72
o
C for 10 min was followed by 
incubation at 4
o
C.  
The ends of the repair PCR cassettes were digested using either 3 U of Xba1 and 3 U of Xho1 
or 3 U of Sst1 and 3 U of Not1, depending on the restriction sites present in the primers. All 
digests were carried out in 60 µL reaction volume at 37
o
C for 2 h. The digested cassettes were 
separated in a 1% agarose gel in TAE buffer at 100 V for 40 min. The cassettes were excised 
from the gel and the DNA extracted using the QIAGEN Gel Extraction Kit.  
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Two PCR cassettes were produced using primer pairs 1958-1989 and 1959-1990. Primers 
1989 and 1990 are reverse complements of one another. They were engineered to introduce three 
stop codons into the coding sequence of ORF 150 while leaving the coding sequence of ORF 149 
intact. In a 50 µL reaction, 1 X Phusion HF buffer containing 1.5 mM MgCl2 was mixed with 0.4 
mM dNTPs, 0.2 μM forward primer, 0.2 μM reverse primer, 0.25 U Phusion HF DNA 
polymerase, and 50 ng of vAcBac 887 DNA. The PCR reaction mixture was incubated at 98
o
C 
for 30 s, followed by 30 cycles of 98
o
C for 10 s, 55
o
C for 30 s, and 72
o
C for 10 s. A final 
extension of 72
o
C for 10 min was followed by incubation at 4
o
C. The PCR products were 
separated in a 1% agarose gel in TAE buffer at 100 V for 40 min. The PCR cassettes were 
excised from the gel and DNA extracted using the QIAGEN Gel Extraction Kit. The gel purified 
PCR products were used as templates for a second PCR reaction. Seventy-five nanograms of 
each PCR product were mixed with 1 X Phusion HF buffer containing 1.5 mM MgCl2, 0.4 mM 
dNTPs, and 0.25 U Phusion HF DNA polymerase in a 50 µL reaction. The samples were 
incubated at 98
o
C for 30 s, followed by 5 cycles of 98
o
C for 10 s, 55
o
C for 30 s, and 72
o
C for 20 
s. A final elongation step was conducted at 72
o
C for 5 min before cooling the samples to 20
o
C 
for 1 min. This short reaction lacking primers allowed the ends of the overlapping PCR products 
to anneal to one another and produce a full-length PCR cassette. Primers 1958 and 1959 (0.1 µM 
each) were then added to the PCR reaction mixture and it was incubated at 98
o
C for 30 s, 
followed by 25 cycles of 98
o
C for 10 s, 55
o
C for 30 s, and 72
o
C for 20 s, followed by a final 
elongation at 72
o
C for 10 min. The PCR products were separated in a 1% agarose gel in TAE at 
100 V for 40 min. The PCR amplicon (1958-1959
Mut
) was excised from the gel and the DNA 
extracted using the QIAGEN Gel Extraction Kit. The PCR amplicon was digested with Xba1 and 
Xho1 as described above. 
The plasmid pFAcT-GFP (7.7 kbp), which contains genes to confer resistance to Amp and 
Gen, the native AcMNPV Polh gene, and a GFP gene was used to create the repair constructs. 
The Gen
R
, Polh, and GFP genes are flanked by Tn7L and Tn7R sites. The sequences between 
these two sites are transferred into the mini-attTn7 site in the Polh locus of the bMON14272 
bacmid via Tn7 mediated transposition. There are Xba1 and Xho1 restriction sites located 
between Polh and GFP that allows for insertion of a repair gene in this region. 
Five hundred nanograms of pFAcT-GFP plasmid were digested with Xho1 and Xba1 as 
described above. One unit of CIP was added directly to the restriction digest and incubated at 
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37
o
C for 5 min to dephosphorylate the ends of the plasmid DNA. EDTA was added to the 
mixture to a final concentration of 10 mM and the mixture incubated at 65
o
C for 15 min to 
inactivate the CIP. The CIP-treated DNA was separated in a 1% agarose gel in TAE buffer at 
100 V for 40 min. The plasmid DNA was excised from the gel and the DNA extracted using the 
QIAGEN Gel Extraction Kit.  
The digested 1960/1961, 1985/1986, 1958/1959, and 1958/1959
Mut
 repair cassettes were 
ligated in separate reactions into the pFAcT-GFP plasmid in a 3:1 ratio in 1 X T4 DNA ligase 
buffer with 1 U of T4 DNA ligase in a 10 µL reaction. The reaction mixtures were incubated 
overnight at 4
o
C. Five microlitres of each ligation was used to transform 25 µL aliquots of E.coli 
DH10B cells as described in above. Aliquots of 25 and 250 µL of each transformation were 
plated onto low salt LB supplemented with 100 µg/mL Amp, 50 μg/mL X-gal, and 95.2 μg/mL 
IPTG. The plates were incubated overnight at 37
o
C. Single, isolated colonies were selected from 
the transformation plates and used to inoculate 3 mL of low salt LB supplemented with 100 
µg/mL Amp. The cultures were incubated overnight at 37
o
C with shaking at 225 rpm. Plasmid 
DNA was extracted from the E.coli cells following a standard alkaline lysis miniprep procedure. 
The plasmid DNA was digested with Xba1 and Xho1 as described above to select for clones that 
contained inserts of the correct size. These clones were sequenced at PBI using primers DT 882 
and DT 891 (Table 7).  
Three additional repair constructs were produced: 1983/1984 + 1958/1959
Mut
 pFAcT-GFP, 
2001/2002 + 1958/1959 pFAcT-GFP, and 2001/2002 + 1958/1959
Mut 
pFAcT-GFP. The 
1958/1959 pFAcT-GFP and 1958/1959
Mut
 pFAcT-GFP plasmids and 1983/1984 and 2001/2002 
PCR cassettes were digested with Not1 and Sst1 as described above. The PCR products were 
ligated to the digested plasmid DNA as described above. These constructs were transformed into 
DH10B cells and screened by restriction digest and sequencing as described above.  
Electrocompetent E.coli DH10B cells containing the pMON7124 plasmid were prepared as 
described by Sharma and Schimke (129) using YENB media supplemented with 10 µg/mL Tet. 
Five hundred nanograms of a knockout bacmid were transformed into the competent cells by 
electroporation using the method described above. Aliquots of 25 and 250 µL of the 
transformation mixture were plated onto low salt LB plates supplemented with 50 µg/mL Kan, 
10 µg/mL Tet, 50 μg/mL X-gal, and 95.2 μg/mL IPTG. The plates were incubated for 48 h at 
37
o
C. Several colonies were re-streaked onto low salt LB plates supplemented with 50 µg/mL 
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Kan, 10 µg/mL Tet, 50 μg/mL X-gal, 95.2 μg/mL IPTG, and either 17 µg/mL Chl, 30 µg/mL 
Zeo, or 17 µg/mL Chl and 30 µg/mL Zeo. These plates were incubated at 37
o
C for 48 h. A single 
colony was used to inoculate 5 mL of YENB supplemented with appropriate selection 
antibiotics. The cultures were incubated at 37
o
C overnight with shaking at 225 rpm. Two 
millilitres of overnight culture were used to inoculate 50 mL of YENB supplemented as 
described above. This culture was incubated for 6 h at 37
o
C with shaking at 225 rpm. The cells 
were made competent following the protocol of Sharma and Schimke (129) to produce 
competent E.coli cells containing the knockout bacmid and the pMON7124 helper plasmid. 
To create a knockout construct with the native Polh repaired and tagged with GFP, the native 
pFAcT-GFP plasmid (without a repair cassette) was transformed into the competent E.coli cells 
harbouring the pMON7124 plasmid and a knockout bacmid following the method described 
above. The cells were allowed to recover overnight at 37
o
C with shaking at 225 rpm. Aliquots of 
1, 10, and 100 µL of each transformation mixture were plated onto low salt LB plates 
supplemented with 50 µg/mL Kan, 10 µg/mL Tet, 7 µg/mL Gen, 50 μg/mL X-gal, 95.2 μg/mL 
IPTG, and either 17 µg/mL Chl, or 30 µg/mL Zeo, or 17 µg/mL Chl and 30 µg/mL Zeo. The 
plates were incubated at 37
o
C for 48 h. Several colonies were selected and re-streaked onto low 
salt LB plates supplemented as described above, but lacking Tet. The Tet is not included in this 
medium to promote the loss of the pMON7124 plasmid.  
Overnight cultures were established for several putative positive clones in 3 mL low salt LB 
supplemented as described above. The cultures were grown overnight at 37
o
C with shaking at 
225 rpm. The bacmid DNA was extracted from the E.coli cells following a standard alkaline 
lysis miniprep protocol. 
A repair construct in which the native Polh was repaired, the native GOI re-inserted back into 
the genome, and the GFP tag incorporated, was generated by transforming competent E.coli cells 
harbouring the pMON7124 plasmid and a knockout bacmid with the repair construct following 
the method described above. A full list of knockout and repair constructs and the primer pairs 
used to produce them is provided in Tables 8 and 9.  
A wt bacmid construct, vAcBac 887, which contains the full suite of AcMNPV genes, the 
native Polh gene, and GFP was kindly provided by Dr. David Theilmann (AAFC Summerland, 
BC, Canada). 
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Each knockout and repair bacmid was screened by PCR to confirm that the gene(s) of 
interest had been knocked out and that a repair construct had been inserted at the Polh locus. In a 
25 µL reaction, 1 X PCR buffer (Invitrogen Corporation) was mixed with 1.5 mM MgCl2, 0.2 
mM dNTP mix, 0.2 µM forward primer, 0.2 µM reverse primer, 2.5 U Taq Polymerase 
(Invitrogen Corporation), and 100 ng of bacmid DNA. The reaction mixture was incubated at 
95
o
C for 2 min, followed by 35 cycles of 95
o
C for 30 s, 62
o
C for 30 s, and 72
o
C for 1.5 min. A 
final elongation step was carried out at 72
o
C for 10 min. The PCR products were separated in a 
1% agarose gel in TAE buffer at 100 V for 40 min. A list of PCR primers, the regions they 
amplify, and the expected product sizes are provided in Table 10. A map showing the location of 
each primer is provided in Figure 24.  
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Table 8. Primer pairs used to create the knockout and repair constructs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Name of Construct Primers Used to Create Construct Antibiotic Resistance 
vAc
145null
 1953-1954 KO Kan, Chl, Gen 
vAc
145null-AC145-HA
 1953-1954 KO, 1960-1961 REP Kan, Chl, Gen 
vAc
145null-MC164-HA
 1953-1954 KO, 1985-1986 REP Kan, Chl, Gen 
vAc
149/150null
 1955-1956 KO Kan, Zeo, Gen 
vAc
149/150null-AC149-MYC
 1955-1956 KO, 1958-1989/1959-1990 REP Kan, Zeo, Gen 
vAc
149/150null-MC118-HA+AC149-MYC
 1955-1956 KO, 1983-1984/1958-1989/1959-1990 REP Kan, Zeo, Gen 
vAc
149/150null-AC149-MYC+AC150-HA
 1955-1956 KO, 1958-1959 REP Kan, Zeo, Gen 
vAc
145/149/150null
 1953-1954/1955-1956 KO Kan, Chl, Zeo, Gen 
vAc
145/149/150null-AC149-MYC
 1953-1954/1955-1956 KO, 1958-1989/1959-1990 REP Kan, Chl, Zeo, Gen 
vAc
145/149/150null-AC145-HA+AC149-MYC
 1953-1954/1955-1956 KO, 2001-2002/1958-1989/1959-1990 REP Kan, Chl, Zeo, Gen 
vAc
145/149/150null- AC149-MYC+AC150-HA
 1953-1954/1955-1956 KO, 1958-1959 REP Kan, Chl, Zeo, Gen 
vAc
145/149/150null- AC145-HA+AC149-MYC+AC150-HA
 1953-1954/1955-1956 KO, 2001-2002/1958-1959 REP Kan, Chl, Zeo, Gen 
vAcBac 887 None Kan 
7
4
 
8
4
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Table 9. List of deleted and repaired genes in the knockout and repair constructs.  
Name of Construct AcMNPV Deleted Gene(s)  Gene(s) Repaired 
vAc
145null
 ORF 145 Polh, GFP 
vAc
145null-AC145-HA
 ORF 145 AcMNPV ORF 145, Polh, GFP 
vAc
145null-MC164-HA
 ORF 145 MacoNPV ORF 164, Polh, GFP 
vAc
149/150null
 ORF 149 and 150 Polh, GFP 
vAc
149/150null-AC149-MYC
 ORF 149 and 150 AcMNPV ORF 149, Polh, GFP 
vAc
149/150null-MC118-HA+AC149-MYC
 ORF 149 and 150 MacoNPV ORF 118 and AcMNPV ORF 149, Polh, 
GFP 
vAc
149/150null-AC149-MYC+AC150-HA
 ORF 149 and 150 AcMNPV ORF 149 and 150, Polh, GFP 
vAc
145/149/150null
 ORF 145, 149, and 150  Polh, GFP 
vAc
145/149/150null-AC149-MYC
 ORF 145, 149, and 150 AcMNPV ORF 149, Polh, GFP 
vAc
145/149/150null-AC145-HA+AC149-MYC
 ORF 145, 149, and 150 AcMNPV ORF 145 and 149, Polh, GFP 
vAc
145/149/150null- AC149-MYC+AC150-HA
 ORF 145, 149, and 150 AcMNPV ORF 149 and 150, Polh, GFP 
vAc
145/149/150null- AC145-HA+AC149-MYC+AC150-HA
 ORF 145, 149, and 150 AcMNPV ORF 145, 149, and 150, Polh, GFP 
vAcBac 887 None Polh, GFP 
  
8
5
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Table 10. PCR primer pairs and resultant products used to confirm the knockout and repair constructs.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Primer Name Sequence Region Amplified Amplicon Size 
WT  1953-1954 KO 1955-1956 KO 
1962 
766 
ACCGTCGAACATGCCTAT 
CAAGGCGACAAGGTGCTGATGC 
5ʹ end of ORF 145 KO No product 439 bp No product 
1976 
1725 
GGCATGCTAGCGCACACGGA 
TACGCCCGGTAGTGATCT 
3ʹ end of ORF 145 KO No product 439 bp No product 
1962 
1963 
ACCGTCGAACATGCCTAT 
AATACGCCGTGCAATCAT 
Internal to ORF 145 394 bp No product 394 bp 
1982 
520 
ATTGACTGCGCGAAGATT 
CCGGAACGGCACTGGTCAACTT 
5ʹ end of ORF 150 KO No product No product 216 bp 
1978 
1919 
AGCTGCGAGCCAAGACCAGC 
GTCCACGAACTTCCGGGACGC 
3ʹ end of ORF 150 KO No product No product 611 bp 
1964 
1965 
GGATGTACCGCTAACCAA 
CTGTCGCCGAATTAGATT 
Internal to ORF 150 328 bp 328 bp No product 
pUC M13 rev 
1987 
AGCGGATAACAATTTCACACAGG 
AGCCATACCACATTTGTAGAGG 
5ʹ end of repair insert 593 bp 593 bp 593 bp 
pUC M13 for 
1988 
CCCAGTCACGACGTTGTAAAACG 
AGGTTTGAGCAGCCGCGTAGTGAG 
3ʹ end of repair insert 687 bp 687 bp 687 bp 86
 
 87 
 
Figure 24. Location of primer pairs for confirming the knockout and repair constructs.  
Panel A: Wt Ac145 and Ac150, panel B: Ac145 and Ac150 double knockout, panel C: repair 
locus. Primer names in in red text. ORF names and regulatory regions are in black text. 
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Bacmid DNA from each knockout and repair construct was introduced into TnHi5 cells by 
transfection using the Cellfectin II reagent following the protocol described in Section 4.3.2. The 
flasks were incubated at 27
o
C for 48 to 72 h until OB were visible in greater than 30% of the 
cells. The supernatant containing P1 BV and the cell pellet containing OB were collected as 
described in Section 4.3.2.  
To confirm the validity of the P1 BV, viral DNA was extracted from 100 µL of P1 BV as 
described in Section 4.3.2. The viral DNA was diluted 1:10 in sterile distilled water and 1 µL 
used per PCR reaction. The PCR primers (Table 10), reaction mixtures, and reaction conditions 
were as described above.  
The titre of the P1 BV stocks was determined using an end-point dilution assay, the tissue 
culture infectious dose 50% (TCID50). Five microlitres of a 4.0 X 10
5
 cells/mL stock of TnHi5 
cells were dispensed into each well of a 60-well Nunclon microwell tissue culture plate (VWR 
Canlab) using a Hamilton repeating syringe. Serial dilutions of each BV preparation were made 
from 10
-1
 to 10
-9
 in 150 µL total volume of GIM. Five microlitres of GIM were added to the first 
well in each column of the 60-well plates as a negative control. Five microlitres of a BV dilution 
were added to the second through tenth well of a particular column. The assay was performed in 
duplicate. The plates were placed in a Tupperware container with several sheets of damp paper 
towel to reduce evaporation and the container incubated at 27
o
C for 7 d.  
Each well was monitored for the presence of OB using a Nikon phase contrast LWD 0.52 
inverted microscope (10 X optical and 10 X objective power), as well as for GFP expression 
using a Zeiss Axiovert 100 fluorescent microscope (10 X optical, 40 X objective power). The 
number of infected wells was tallied and used to calculate the titre of the BV stock.  
To increase the viral titre, an infection was set up in TnHi5 cells using the P1 BV collected 
from the transfection assay following the protocol described in Section 4.3.2. The flasks were 
incubated at 27
o
C for 48 to 72 h. The supernatant containing the P2 BV and the cell pellet 
containing OB were harvested as described in Section 4.3.2. Viral DNA was extracted from the 
P2 BV, the validity of the construct was confirmed by PCR, and the titre of the P2 BV was 
determined by TCID50 assay as described above.  
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6.3.3. Confirmation of knockout and repair constructs 
Reverse transcriptase PCR (RT-PCR) was used to monitor the temporal transcription of 
Ac145, Ac149, and Ac150, as well as to confirm that transcription of non-target genes had not 
been affected during the creation of the knockout constructs.  
Infections were set up using P2 BV stocks for each viral construct at a MOI of 5 in 25 cm
2
 
cell culture flasks using 1.0 X 10
6
 TnHi5 cells as described in Section 4.3.2. Two flasks were set 
up per viral construct. The infected cells from one flask were harvested at 4 hpi, and were 
harvested from the second flask at 24 hpi following the method described in Section 4.3.2. Total 
RNA was extracted from the TnHi5 cells and converted to cDNA using the SuperScript III
TM
 
CellsDirect cDNA Synthesis System (Invitrogen Corporation). Briefly, the cells were gently 
scraped from the flask using a rubber scraper. The cells and media were transferred to a 15 mL 
Falcon tube and the cells were pelleted by centrifugation at 3000 rpm for 5 min in a bench top 
centrifuge. The supernatant was discarded and the cell pellet washed using 5 mL of cold PBS. 
The cells were washed once more and re-suspended in 1 mL of cold PBS. Two microlitres of the 
re-suspended cells were transferred to a 0.2 mL thin-walled PCR tube and mixed with 10 µL re-
suspension buffer (provided in the CellsDirect Kit) and 40 U of RNase OUT
TM
. The reaction 
mixture was incubated at 75
o
C for 10 min. Genomic DNA was removed from the reaction by 
treatment with 5 U of DNase1 in 1 X DNase1 buffer at RT for 5 min. EDTA was added to a final 
concentration of 1.5 mM and the reaction mixture incubated at 70
o
C for 5 min to inactivate the 
DNase1. An oligo (dT)20 primer was added at a final concentration of 4.2 mM along with 0.42 
mM of a dNTP mix. The reaction mixture was incubated at 70
o
C for 5 min and then immediately 
placed on ice for 2 min. 1 X RT Buffer, 40 U RNaseOUT
TM
, 200 U SuperScript
TM
 III RT, and 3 
mM Dithiothreitol (DTT) were added and the reaction mixture, and it was incubated at 50
o
C for 
50 min, followed by 85
o
C for 5 min. Two units of RNase H were added to each reaction and the 
tubes incubated at 37
o
C for 20 min, followed by 5 min on ice.  
PCR reactions were performed for each sample using the primer pairs listed in Table 11. In a 
25 µL reaction mixture, 1 X PCR buffer was mixed with 1.5 mM MgCl2, 0.2 µM forward 
primer, 0.2 µM reverse primer, 300 ng of template cDNA, and 2.5 U Taq Polymerase. The 
reaction mixtures were incubated at 95
o
C for 2 min, followed by 35 cycles of 95
o
C for 30 s, 58
o
C 
for 30 s, and 72
o
C for 30 s. A final elongation step was carried out at 72
o
C for 10 min. The PCR 
amplicons were separated in a 1% agarose gel in TAE buffer at 80 V for 1 h.  
 90 
Table 11. PCR primer pairs used to monitor transcript abundance of Ac145, Ac149, Ac150, 
GP64, Chitinase, Polh, IE-0, and IE-0/IE-1. 
Primer 
Pair 
Sequence Amplifies Amplicon 
Size 
1991 
1992 
AGGGTATTTTGGCCTCAACG 
ATACATGCGAGCCGTACACC 
AcMNPV ORF 145 169 bp 
1993 
1994 
TGCCGTCGTCAATACAACAC 
TTGCTTCATACGTCGAGATACC 
AcMNPV ORF 149 153 bp 
1995 
1996 
GAATCAGACGACGGGTTCAG 
TTTTGGTTAGCGGTACATCC 
AcMNPV ORF 150 197 bp 
1997 
1998 
GTTGGGCAATAAACGACCAG 
ACGACACGTTTTTGCTGATG 
AcMNPV ORF 128 (GP64) 243 bp 
850 
851 
TTTGGCAAGGGAACTTTGTC 
ACAAACCTGGCAGGAGAGAG 
AcMNPV ORF 126 (Chitinase) 100 bp 
1999 
2000 
CTTCTTAGCCAGGCTGATGC 
AACATGCGTCCCACTAGACC 
AcMNPV ORF 8 (Polh) 156 bp 
1414 
1446 
GGTGTACGACGCGTTAAAAT 
CCATATTCGTGCGAGGCAACG 
AcMNPV ORF 141 (IE-0) 126 bp 
1505 
1523 
GACAACAGCTATTCAGAGT 
CGAGTTGACGCTTGCCAAAAA 
AcMNPV ORF 147 (IE-0 and IE-1) 144 bp 
 
Quantitative real-time PCR (qPCR) was used to monitor the rate of BV production for each 
construct to ensure that BV was being produced at a rate similar to that of the wt construct. This 
was done to ensure that the production and transmission of BV was not altered by any of the 
genetic manipulations done to the bacmid DNA.  
A time course assay was set up in 6-well cell culture plates (Corning Incorporated) using 5.0 
X 10
5
 TnHi5 cells per well. P2 BV was used to inoculate each well at an MOI of 5 as described 
in Section 4.3.2. One 6-well plate was set up per construct. The cells from one well from each 
plate were harvested at 6, 12, 24, 48, 72, and 96 hpi following the protocol described in Section 
4.3.2. The infected cell pellets were stored at -80
o
C and the BV stocks stored at 4
o
C. The 
experiment was performed in duplicate.  
DNA was extracted from each BV sample as described in Section 4.3.2. Serial dilutions of a 
previously titred BV standard were prepared in GIM. DNA was extracted from these samples 
following the method described in Section 4.3.2. A qPCR reaction was set up in 96-well plates. 
In a 20 µL reaction, 1 X Finnzymes DyNAmo HS SYBR® Green master mix (Thermo 
Scientific) was mixed with 0.5 µM of primer 850, 0.5 µM primer 851 (Table 11), and 2 µL of 
diluted DNA. Each reaction was prepared in triplicate. The qPCR reaction was performed using 
a BioRad CFX96 thermal cycler using the following reaction profile: 15 min at 95
o
C, followed 
by 40 cycles of 95
o
C for 30 s, 58
o
C for 24 s, and 72
o
C for 30 s. The samples were then heated to 
95
o
C for 1 min and then held at 55
o
C for 20 min. The samples were again heated to 95
o
C and 
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then cooled to 65
o
C. The temperature was increased by 0.5
o
C every 5 s to 95
o
C to determine the 
melting temperature of the PCR amplicon. The data were analyzed using the BioRad CFX 
Manager 2.1 software using the standard curve method to determine the absolute titre of all 
samples.  
The rate of viral DNA replication was monitored for each construct using the infected cell 
pellets from the time course assay described above. The cells were re-suspended in 1 mL of lysis 
buffer (10 mM Tris-Cl pH 8.0, 1 mM EDTA, 0.5% SDS, and 20 μg/mL RNase A) and incubated 
at 37
o
C for 30 min. Fifty microlitres of the cell lysate was added to 250 µL of Tris-HCl pH 8.0 
with 80 µg/mL Proteinase K. The samples were incubated overnight at 50
o
C, followed by 
extraction with an equal volume of phenol:chloroform:isoamyl alcohol and then with 
chloroform:isoamyl alcohol as described in Section 4.3.2. The DNA was diluted 1:10 in sterile 
distilled water and 2 µL of the DNA preparation used in a qPCR reaction as described above.  
To determine if the biological titre of the BV stocks from each viral construct was 
comparable to the absolute titre obtained using qPCR, an end-point-dilution assay was set up 
using the 6 and 96 hpi BV samples from the time course assay. The experiment was performed in 
duplicate following the TCID50 protocol described in Section 6.3.2.  
 
6.4. Results 
6.4.1. Creation and confirmation of knockout and repair constructs 
To confirm that each knockout and repair construct lacked the GOI and/or contained a 
repaired GOI at the Polh locus, a series of PCR reactions were performed on the bacmid DNA, 
P1 BV and P2 BV stocks. The results from the bacmid confirmation PCR are shown in Figure 
25. The results for the P1 and P2 BV stocks were identical to the bacmid constructs.  
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Figure 25. PCR confirmation of the knockout and repair bacmid constructs.  
Each panel contains the PCR results for an individual knockout or repair construct. vAcBac 
887(A), vAc
145null
 (B), vAc
145null-AC145-HA 
(C), vAc
145null-MC164-HA
 (D), vAc
149/150null 
(E), 
vAc
149/150null-AC149-MYC+AC150-HA 
(F), vAc
149/150null-AC149-MYC 
(G), vAc
149/150null-MC118-HA+AC149-MYC
 
(H), vAc
145/149/150null 
(I), vAc
145/149/150null-AC149-MYC 
(J), vAc
145/149/150null-AC145-HA+AC149-MYC 
(K), 
vAc
145/149/150null-AC149-MYC+AC150-HA 
(L), vAc
145/149/150null-AC145-HA+AC149-MYC+AC150-HA 
(M). Primer 
pairs are listed at the top of the figure. The expected size of each PCR amplicon, along with the 
region of the bacmid that is amplified is provided in Table 10.  
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Reverse transcriptase-PCR was performed to confirm the temporal transcriptional patterns of 
the GOI Ac145, Ac149, and Ac150, as well as non-target genes GP64, Chitinase, Polh, IE-0, and 
IE0/IE-1. At the 4 hpi time point, Ac149, GP64, IE-0, and IE-1were expected to be transcribed. 
As expected, GP64 was transcribed at this time point for all constructs. Transcripts were detected 
for IE-0 and IE-1 at the 4 hpi time point for most, but not all of the constructs. The 
vAc
145/149/150null 
series of knockout and repair constructs in particular showed variability in the 
temporal transcription of these genes. The Ac149 transcript was not detected in any of the 
constructs at the early time point. At 24 hpi, Ac145, Ac149, Ac150, GP64, Chitinase, Polh, IE-0, 
and IE-1 were expected to be transcribed. As expected, the reference genes, GP64, Chitinase, 
Polh, IE-0, and IE-1, were transcribed in all constructs. Ac145 was not transcribed in vAc
145null
, 
vAc
145null-MC164-HA
, vAc
145/149/150null
, vAc
145/149/150null-AC149-MYC
, or vAc
145/149/150null-AC149-MYC+AC150-
HA
, but was transcribed in vAc
145null-AC145-HA
, vAc
145/149/150null-AC145-HA+AC149-MYC
, and 
vAc
145/149/150null-AC145-HA+AC149-MYC+AC150-HA
, as expected. Ac150 was not transcribed in 
vAc
149/150null 
or vAc
145/149/150null 
as expected, but was transcribed in vAc
149/150null-AC149-MYC
, 
vAc
149/150null-MC118-HA+AC149-MYC
, vAc
145/149/150null-AC149-MYC
, and vAc
145/149/150null-AC145-HA+AC149-MYC
. 
The results from this experiment are shown in Figure 26.  
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Figure 26. RT-PCR to monitor transcript abundance.  
Each panel contains the RT-PCR results for an individual knockout or repair construct. vAc
145null
 
(A), vAc
145null-AC145-HA 
(B), vAc
145null-MC164-HA
 (C), vAc
149/150null 
(D), vAc
149/150null-AC149-MYC+AC150-
HA 
(E), vAc
149/150null-AC149-MYC 
(F), vAc
149/150null-MC118-HA+AC149-MYC
 (G), vAc
145/149/150null 
(H), 
vAc
145/149/150null-AC149-MYC 
(I), vAc
145/149/150null-AC145-HA+AC149-MYC 
(J), vAc
145/149/150null-AC149-
MYC+AC150-HA
 (K), vAc
145/149/150null-AC145-HA+AC149-MYC+AC150-HA 
(L), vAcBac 887 (M). The predicted 
temporal expression patterns for each gene are: ORF 145 (late/very late), ORF 149 (early and 
late/very late), ORF 150 (late/very late), GP64 (early and late/very late), chitinase (late/very 
late), Polh (late/very late), IE-0 (early and late/very late), IE-0/IE-1 (early and late/very late). 
Primer pairs used and expected product sizes are listed in Table 11.  
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The rate of viral DNA replication (Figure 27) and BV production (Figure 28) were monitored 
using quantitative PCR. The results shown are the average of two independent infection 
experiments. The supernatant samples from the time course infection (containing BV) were used 
for the qPCR to monitor BV production, and the infected cell pellet fraction (containing OB) 
were used for the qPCR to monitor viral DNA replication. The three Ac145-deletion and repair 
constructs, vAc
145null
, vAc
145null-AC145-HA
, and vAc
145null-MC164-HA
, and the Ac150-deletion and 
repair constructs, vAc
149/150null
, vAc
149/150null-AC149-MYC+AC150-HA
, vAc
149/150null-AC149-MYC
, and 
vAc
149/150null-MC118-HA+ AC149-MYC
, all replicate at the same rate as the wt and produce similar 
numbers of viral genomes (Figure 27 A and B). The vAc
145/149/150null-AC149-MYC
, vAc
145/149/150null-
AC149-MYC+AC150-HA
, and vAc
145/149/150null-AC145-HA+AC149-MYC+AC150-HA 
constructs also replicate at the 
same rate as the wt. Two constructs, vAc
145/149/150null 
and vAc
145/149/150null-AC145-HA+AC149-MYC
, 
replicate at a substantially slower rate than the wt (Figure 27 C). vAc
145/149/150null
 replicate faster 
than the wt from 12 to 24 hpi before slowing to a rate similar to the wt. vAc
145/149/150null-AC145-
HA+AC149-MYC
 replicates slower than the wt, although the differences in starting quantity of virus 
make it difficult to confirm this. 
The Ac145 and Ac150 single deletion and repair constructs produce BV at a similar rate to 
the wt construct (Figure 28 A and B), whereas the Ac145/Ac149/Ac150 triple deletion constructs 
produced BV at a substantially slower rate than the wild type (Figure 28 C).  
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Figure 27. Rate of viral DNA replication as determined by qPCR. 
The number of copies of the Ac126 gene (chitinase) are measured. The averages of two 
independent biological replicates are shown. Technical replicates were performed in triplicate. 
Panel A (ORF 145 knockout and repair constructs): vAcBac 887 (wt; blue diamond), 
vAc
145null
 (red square), vAc
145null-AC145-HA 
(green triangle), vAc
145null-MC164-HA 
(purple cross). Panel 
B (ORF 150 knockout and repair constructs): vAcBac 887 (wt; blue diamond), vAc
149/150null 
(red square), vAc
149/150null-AC149-MYC+AC150-HA 
(green triangle), vAc
149/150null-AC149-MYC 
(purple 
cross), vAc
149/150null-MC118-HA+AC149-MYC 
(blue cross). Panel C (ORF 145 and 150 double 
knockout and repair constructs): vAcBac 887 (wt; blue diamond), vAc
145/149/150null 
(red square), 
vAc
145/149/150null-AC149-MYC 
(green triangle), vAc
145/149/150null-AC145-HA+AC149-MYC 
(purple cross), 
vAc
145/149/150null-AC149-MYC+AC150-HA 
(blue cross), vAc
145/149/150null-AC145-HA+AC149-MYC+AC150-HA
 
(orange circle). 
A B 
C 
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Figure 28. Rate of BV production as determined by qPCR. 
These are the averages of two independent biological replicates of this experiment. Technical 
replicates were performed in triplicate.  
Panel A (ORF 145 knockout and repair constructs): vAcBac 887 (wt; blue diamond), 
vAc
145null
 (red square), vAc
145null-AC145-HA 
(green triangle), vAc
145null-MC164-HA 
(purple cross). Panel 
B (ORF 150 knockout and repair constructs): vAcBac 887 (wt; blue diamond), vAc
149/150null 
(red square), vAc
149/150null-AC149-MYC+AC150-HA 
(green triangle), vAc
149/150null-AC149-MYC 
(purple 
cross), vAc
149/150null-MC118-HA+AC149-MYC 
(blue cross). Panel C (ORF 145 and 150 knockout and 
repair constructs): vAcBac 887 (wt; blue diamond), vAc
145/149/150null 
(red square), 
vAc
145/149/150null-AC149-MYC 
(green triangle), vAc
145/149/150null-AC145-HA+AC149-MYC 
(purple cross), 
A B 
C 
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vAc
145/149/150null-AC149-MYC+AC150-HA 
(blue cross), vAc
145/149/150null-AC145-HA+AC149-MYC+AC150-HA
 
(orange circle). 
As this qPCR reaction provided an estimate of the absolute numbers of BV particles, a 
TCID50 assay was performed using the 6 and 96 hpi samples from the same time course 
experiments to determine if the biological titres for each of the constructs were similar. At 6 hpi, 
all constructs produced biological titres between 10
2
 and 10
4
 TCID50 U / mL. At 96 hpi, all of the 
virus constructs produced biological titres of between 10
7
 and 10
9
 TCID50 U / mL. At 6 hpi, 
vAc
145/149/150null
 produced fewer infectious particles than the wt vAcBac 887 construct. At the 96 
hpi time point, vAc
145null-MC164-HA
, vAc
149/150null-MC118-HA+AC149-MYC
, vAc
145/149/150null
, 
vAc
145/149/150null-AC149-MYC
, and vAc
145/149/150null-AC145-HA+AC149-MYC
 produced fewer infectious 
particles than the wt construct. The results from this experiment are shown in Figure 29.  
 
 
Figure 29. TCID50 assay to determine biological titre of BV stocks at 6 and 96 hpi. 
These results are the averages of two independent biological replicates. The error bars represent 
the standard error for the two biological replicates for each construct.  
Lane A –vAcBac 887 (wt), lane B – vAc145null, lane C – vAc145null-AC145-HA, lane D – vAc145null-
MC164-HA
, lane E – vAc149/150null, lane F – vAc149/150null-AC149-MYC+AC150-HA, lane G – vAc149/150null-
AC149-MYC
, lane H – vAc149/150null-MC118-HA+AC149-MYC, lane I – vAc145/149/150null, lane J – 
vAc
145/149/150null-AC149-MYC
, lane K – vAc145/149/150null-AC145-HA+AC149-MYC, lane L – vAc145/149/150null-
AC149-MYC+AC150-HA
, lane M – vAc145/149/150null-AC145-HA+AC149-MYC+AC150-HA. 
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6.5. Discussion 
Lapointe et al. (87) produced a series of knockout and repair virus constructs using a two-
step homologous recombination process in insect cells. In order to keep all regulatory regions 
intact for the genes flanking Ac145 and Ac150, only partial deletions of each gene were created. 
Their Ac145 knockout construct kept the 31 bp at the 3ʹ end of Ac145 intact to not disturb the 
native Ac146 stop codon. Their Ac150 knockout construct kept 104 bp at the 5ʹ end of Ac150 
intact to not disturb the coding sequence for Ac149, and an additional 20 bp at the 3ʹ end of 
Ac150 were kept intact to not disturb the native IE-2 polyadenylation signal, resulting in 
approximately 57% of Ac150 being deleted. Lapointe et al. produced repair constructs for each 
of the single deletion viruses as well as an Ac145 single repair for the Ac145/Ac150 double 
deletion virus. In a follow-up study, Zhang et al. (86) created Ac150-deletion and repaired virus 
constructs using a similar method to Lapointe et al. Their knockout and repair constructs deleted 
approximately 60% of Ac150, ensuring that the coding sequence for Ac149 was not disturbed.  
Both the Lapointe and Zhang groups produced their gene knockout constructs in insect cells. 
Each of their constructs was subjected to multiple manipulations, followed by several rounds of 
plaque purification to obtain pure virus stocks. This approach could be problematic, as 
baculoviruses that undergo multiple rounds of amplification and purification in insect cells may 
rapidly acquire mutations within the viral genome (130-133). Production of knockout constructs 
in bacterial cells reduces the likelihood of accumulating mutations by keeping the viral passage 
number low, decreasing the amount of time required to produce a knockout, and allowing for 
confirmation of the construct validity by PCR, sequencing, or restriction digest at several stages 
throughout the production. The knockout and repair constructs for this study were analyzed by 
PCR and sequencing at the bacmid stage, and by PCR at the P1 BV, P2 BV, and P2 OB stages to 
ensure that the GOI was deleted and that a repair construct was inserted into the Polh locus. At 
each stage in development, the expected PCR products were produced for each of the knockout 
and repair constructs. These results suggest that the expected changes to the virus backbone were 
produced.  
Construct validity was further confirmed by RT-PCR to monitor transcript abundance. This 
was done to ensure that the GOI was not transcribed in the knockout construct and that 
transcription was restored in the repair construct. Several additional transcripts were monitored 
to ensure that undesired changes to the virus backbone had not occurred. At the 4 hpi time point, 
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Ac149, GP64, IE-0, and IE-1were expected to be transcribed. As expected, GP64 was 
transcribed at this time point for all constructs. Transcripts were detected for IE-0 and IE-1 at the 
4 hpi time point for most, but not all of the constructs. The vAc
145/149/150null 
series of knockout and 
repair constructs in particular showed variability in the temporal transcription of these genes. 
Lack of transcription of IE-0 or IE-1 at this early time point for the triple knockout constructs 
could be a result of size differences in the bacmid backbone. The vAc
145/149/150null 
series of 
constructs, which are larger in size than the single knockout constructs due to the presence of 
both a CAT and Zeo gene, could be uncoated more slowly, or transcription initiation could be 
delayed slightly compared to the other constructs. By 24 hpi, both IE-0 and IE-1 were 
transcribed for all constructs. The Ac149 transcript was not detected in any of the constructs at 
the early time point. This was an interesting result, as Ac149 was found to be an early gene, 
expressed as early as 4 hpi, by both RACE and northern blot. It is possible that only low levels of 
Ac149 are required during the early phases of infection. It is also possible that at 4 hpi, the level 
of Ac149 transcripts produced may be below the detection limit of this assay. By 24 hpi, Ac149 
was transcribed in all constructs except vAc
149/150null 
and vAc
145/149/150null
, as expected.  
At 24 hpi, Ac145, Ac149, Ac150, GP64, Chitinase, Polh, IE-0, and IE-1 were expected to be 
transcribed. As expected, all of the reference genes were transcribed in all constructs. Ac145 was 
not transcribed in any of the Ac145 single or double knockout constructs, as expected. Ac150 
was not transcribed in vAc
149/150null 
or vAc
145/149/150null 
as expected, but was transcribed in 
vAc
149/150null-AC149-MYC
, vAc
149/150null-MC118-HA+AC149-MYC
, vAc
145/149/150null-AC149-MYC
, and 
vAc
145/149/150null-AC145-HA+AC149-MYC
. These four virus constructs were produced using the 
1958/1959
Mut
 repair cassette. This cassette contains the coding region of Ac149 and a mutated 
Ac150 containing three stop codons at the 5ʹ end. This construct restores function of Ac149, but 
not Ac150. As the coding region for Ac150 was not removed from the virus construct, it is not 
surprising that the Ac150 transcript can still be detected. Due to the presence of the three stop 
codons, translation of Ac150 will not occur in these constructs.  
qPCR was used to confirm that neither the rate of BV production nor the rate of viral DNA 
replication was altered by any of the genetic manipulations made to the virus DNA. The Ac145-
deletion and repair constructs, the Ac150-deletion and repair constructs, and some of the 
Ac145/Ac149/Ac150- deletion and repair constructs (vAc
145/149/150null-AC149-MYC
, vAc
145/149/150null-
AC149-MYC+AC150-HA
, and vAc
145/149/150null-AC145-HA+AC149-MYC+AC150-HA
) replicate at the same rate as 
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the wt. The vAc
145/149/150null 
and vAc
145/149/150null-AC145-HA+AC149-MYC
 constructs replicate slower 
than the wt. The Ac145 and Ac150 single knockout and repair constructs also produce BV at a 
similar rate to the wt construct, whereas the Ac145/Ac149/Ac150 triple deletion constructs show 
more variability in the rate of BV production.  
qPCR provides an absolute measurement of the number of viral genomes or TCID50 U 
produced. All constructs produce between 10
5
 to 10
6
 viral genome copies and 10
9
 to 10
10
 TCID50 
U / mL. The number of TCID50 U estimated with this method is higher than is usually obtained 
from infection experiments, either in vitro or in vivo. Almost certainly, non-infectious virus 
particles are produced during the course of an infection and qPCR is not able to distinguish 
between infectious and non-infectious particles. A TCID50 assay using the same 6 hpi and 96 hpi 
BV samples as used in the qPCR experiment was performed to determine if equivalent biological 
titres were obtained for each virus construct. 
All constructs produced biological titres between 10
2
 and 10
4
 TCID50 U / mL at 6 hpi when 
measured using a TCID50 end-point dilution assay. At 6 hpi, vAc
145/149/150null
 produced fewer 
infectious particles than the wt vAcBac 887 construct based on non-overlapping 95% confidence 
intervals. However, vAc
145/149/150null
 produced the same number of infectious particles as 
vAc
145null-MC164-HA
 and vAc
145/149/150null-AC149-MYC
, which produced as many infectious particles as 
the wt construct, suggesting that there is no difference in the number of infectious particles 
produced by these constructs at 6 hpi. As BV is not expected to be produced by 6 hpi, these 
values likely represent BV originally bound to the cell membranes at the beginning of the 
infection but which did not enter the cell. At 96 hpi,  all of the virus constructs produced 
biological titres of between 10
7
 and 10
9
 TCID50 U / mL. These values are as much as an order of 
magnitude lower than the values obtained using qPCR, and support the hypothesis that non-
infectious particles are produced during the infection and are detected using qPCR.  
At 96 hpi, vAc
145null-MC164-HA
, vAc
149/150null-MC118-HA+AC149-MYC
, vAc
145/149/150null
, 
vAc
145/149/150null-AC149-MYC
, and vAc
145/149/150null-AC145-HA+AC149-MYC
 produced fewer infectious 
particles than the wt construct. Each of these constructs produced similar numbers of infectious 
particles based on overlapping 95% confidence intervals, and produced the same number of 
infectious particles as Ac
145null
, vAc
149/150null-AC149-MYC+AC150-HA
, and vAc
149/150null-AC149-MYC
, which 
were not significantly different from the wt construct.  
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Although the Ac145/Ac149/Ac150-deletion constructs replicate and produce BV at a slower 
rate than the wt, there is no clear pattern of rate reduction based on the presence or absence of a 
particular gene(s). From this data, it is difficult to determine which combination of these three 
genes is responsible for the change in BV production and/or viral DNA replication. It remains to 
be seen if the variations in DNA replication and BV production affect infectivity in vivo. The 
ability of each of the virus constructs to infect a susceptible host via the oral route and via 
intrahaemocelic injection will be assessed in Chapter 7 of this thesis.  
 
6.6. Summary and conclusions 
Knockout and repair constructs were produced for Ac145, Ac150, and Ac145 and Ac150 
using an established bacmid system. The genetic backbone of the constructs was confirmed by 
PCR analysis of the knockout and repair regions. RT-PCR was employed to ensure that 
transcription of the GOI was interrupted in the knockout constructs and restored in the repair 
constructs. Several non-target transcripts were also monitored to ensure that their transcription 
had not been altered by any of the genetic manipulations made to the constructs. Together, these 
results suggest that the knockout and repair constructs produced in this study were generated 
correctly. 
qPCR was used to monitor the rate of viral DNA replication, which was found to be 
consistent among the constructs. qPCR was also used to monitor the rate of BV production for 
each construct. The rate of BV production was more varied than the rate of viral DNA 
replication among the Ac145/Ac149/Ac150 constructs, and a follow-up TCID50 assay also 
indicated variation in number of infectious particles produced by these constructs. The variation 
in rate of DNA replication and BV production cannot be explained due to the presence or 
absence of any one particular gene or genes.  
Chapter 7 of this thesis aims to assess the ability of each of the virus construct described 
above to infect a susceptible host, and to determine if the variations in the rate of BV production 
and/or viral DNA replication affect levels of infectivity in vivo.  
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7. ORAL AND INJECTION BIOASSAYS 
7.1. Introduction 
7.1.1. Review of the baculovirus infection cycle and the predicted role of the 11K 
gene products 
The baculovirus infection cycle is biphasic with two types of virions, BV and ODV (35, 36). 
The BV and ODV are genetically identical, but phenotypically distinct and serve different roles 
in the infection cycle (35, 36). The ODV are released from viral OB and are responsible for 
initiating infection within the insect midgut (35, 36). The BV are released from infected cells and 
are responsible for sustaining a systemic infection within the host (35, 36).  
OB are ingested by a susceptible host and dissolve and release the ODV in the alkaline 
midgut lumen (35, 36). Virus entry into the midgut cells is challenged by the presence of the PM, 
a chitin and protein meshwork that lines the midgut and protects the epithelial cells from 
abrasion and pathogens (35, 36). In some instances, the ODV are able to transit the PM and the 
ODV envelope fuses with the brush border of the columnar epithelial cells of the midgut (35, 
36). The nucleocapsids are released into the epithelial cells and an infection occurs (35, 36).  
The mechanism by which the ODV pass through the PM is unknown, but it has been 
suggested (86, 87) that the 11K genes, which encode proteins with a peritrophin A CBD, may be 
involved in facilitating an interaction between the baculovirus ODV envelope and the chitin of 
the PM or the chitin-secreting cells of the midgut epithelium. Therefore, it was expected that the 
11K gene products may play a key role in initial oral infectivity of a host by a baculovirus.  
 
7.2. Hypothesis  
If the 11K gene products from AcMNPV, Ac145 and Ac150, facilitate an interaction 
between the ODV envelope and the chitin fibrils in the PM or chitin-secreting cells of the 
midgut, it is predicted that deleting one or both of the corresponding genes from the virus would 
reduce the ability of the virus construct to initiate infection in the midgut. It is predicted that the 
Ac145, Ac150, and Ac145 and Ac150 double-knockout constructs will have lower oral infectivity 
in vivo compared to the wt virus. Neither Ac145 nor Ac150 are predicted to play a role in 
systemic infection in the larval host, so it is predicted that each of the knockout constructs will be 
as infectious as the wt virus when BV is injected directly into the haemocoel.  
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7.3. Materials and methods  
7.3.1. Rearing Trichoplusia ni larvae 
T.ni larvae from two sources were used for the bioassays. Two batches of T. ni eggs were 
received from the Insect Production Services (IPS) lab at Natural Resources Canada in Sault Ste. 
Marie, Ontario. The eggs were incubated at 26.5
o
C with a 14 h light: 10 h dark photoperiod for 5 
d until all of the eggs had hatched and the larvae had moulted from the 1
st
 to the 2
nd
 instar. The 
larvae were transferred to cups with artificial diet (12.8% w/v pinto beans, 1.2% w/v agar, 1.01% 
w/v Wesson’s salt mixture, 1.6% w/v alfalfa meal, 3.73% w/v brewer’s yeast, 3.2% w/v wheat 
germ, 0.13% w/v linseed oil, 0.4% w/v corn oil, 0.32% w/v Tween 80, 0.11% w/v Nystatin, 
0.03% w/v alpha-tocopherol, 0.08% w/v sorbic acid, 1.6% w/v ascorbic acid, 0.05% w/v Tet, 
0.05% w/v Chl) and kept for an additional 2 d under the same temperature and photoperiod 
regimen.  
A second population of T.ni larvae was obtained from the T. ni colony at AAFC Saskatoon 
Research Centre, Saskatoon, Saskatchewan. The eggs were surface sterilized in 0.06% Javex 
bleach for 3 min then in 1.45% (w/v) thiosulfate for 1 min. The eggs were rinsed in sterile 
distilled water and allowed to dry. The eggs were transferred to 6 oz. Lily cups with artificial diet 
and were incubated at 26.5
o
C with a light: dark ratio of 14 h: 10 h until the larvae had emerged. 
The larvae were maintained on artificial diet following the same temperature and photoperiod 
regimen as described above. Larvae from IPS and AAFC were sorted based on their 
developmental stage and 4
th
 instar larvae, approximately 1 d post-molt, were used for the oral 
and injection bioassay experiments.  
 
7.3.2. Production and confirmation of OB stocks for oral bioassays 
P1 BV stocks for each of the knockout and repair constructs as well as the wt construct, 
vAcBac 887, were titred by TCID50 (see Section 6.3.2.). Each BV sample was diluted to 20 
TCID50 U /μL in 250 μL final volume of GIM.  
Fourth instar T. ni larvae from the AAFC population were chilled on ice for 10 min to reduce 
their activity. A Micro4 MicroSyringe pump controller and micro-applicator (World Precision 
Instruments) with a 100 μL glass syringe (Hamilton Company) and 29 gauge needle (Hamilton 
Company) was used to dispense 5 μL of BV (100 TCID50 U per larva) at a rate of 1 µL per s. 
Twelve larvae were injected per virus construct. The larvae were injected through the body wall 
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on the ventral surface, near the base of one of the prolegs. The needle was inserted into the insect 
until the tip was approximately one body segment past the insertion point. The larvae were held 
on the needle for approximately 5 s following the injection to ensure that the BV entered the 
haemocoel. The larvae were transferred to 12-well Costar plates (Corning Life Sciences) and 
kept on artificial diet at 25
o
C. Any deaths within 3 d of the injection were assumed to have been 
caused by the injection and these cadavers were discarded. The remainder of the cadavers for 
each construct were pooled and homogenized in sterile distilled water using a small plastic 
pestle.  
OB were harvested from the cadaver homogenate by filtering through four layers of 
cheesecloth and centrifugation at 4000 rpm for 15 min in a Megafuge 1.0R (Heraeus 
Instruments) to pellet the virus OB and cellular debris. The supernatant was discarded and the 
OB pellets re-suspended in purification buffer (0.12% w/v Tris, 0.04% w/v Na2EDTA, 0.1% v/v 
Triton X-100) using 1 mL of buffer per homogenized cadaver. The suspension was incubated at 
30
o
C for 2 h with gentle shaking. The suspension was filtered through four layers of cheesecloth 
and centrifuged at 4000 rpm for 15 min to pellet the virus OB and any remaining cellular debris. 
The supernatant was discarded. The pellet was re-suspended in 15 mL of sterile distilled water 
and then centrifuged at 4000 rpm for 15 min. This wash step was repeated three times. The OB 
were then re-suspended in 1 mL of sterile distilled water for each homogenized cadaver. 
Dilutions of 1/1000 were prepared for each OB stock and were counted using a haemocytometer 
(Neubauer Improved DIN, Depth 0.100 mm, 0.0025 mm
2
) and a Zeiss Standard 25 microscope at 
10 X optical and 10 X objective powers.  
The authenticity of each viral construct OB stock was confirmed by PCR prior to using the 
OB in oral bioassays. To extract DNA from the OB stocks, 50 μL of OB were dissolved by 
adding 1 μL of 1 M Na2CO3 and incubating at 37
o
C for 15 min. The samples were checked 
microscopically to ensure that the majority of the OB had dissolved and ODV released. Five 
microlitres of 10% SDS were added to each sample and the reaction incubated at 37
o
C for 30 
min. The ODV DNA was extracted once using an equal volume of phenol:chloroform:isoamyl 
alcohol (25:24:1) and then once with an equal volume of chloroform:isoamyl alcohol (24:1) 
following the procedure in Section 4.3.2. The DNA was precipitated overnight at -20
o
C in two 
volumes of 95% ethanol. Following the overnight precipitation, the DNA was pelleted by 
centrifugation at 14,000 rpm for 20 min at RT in a bench top microcentrifuge. The supernatant 
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was discarded and the DNA pellet allowed to dry for 5 min at RT. The pellet was re-suspended 
in 25 μL of 10 mM Tris, pH 7.5. One microlitre of this DNA preparation was used in a PCR 
reaction to confirm the presence of the antibiotic resistance genes at the knockout locus (or loci) 
and the repair construct at the Polh locus. The primer pairs, reaction mixes, and thermo profiles 
used for the confirmation PCR were as described in Section 6.3.2.  
 
7.3.3. Oral bioassay 
A dilution series constituting 5 OB/µL, 25 OB/µL and 125 OB/µL were prepared in sterile 
distilled water containing 0.05% Triton X-100 for each of the knockout and repair constructs. 
Twenty four-well NuTrend trays (Corrigan & Co., Jacksonville, FL) were set up with 1 mL per 
well of 1% laboratory grade agar (Fisher Scientific) prepared in sterile distilled water. The agar 
was allowed to set at RT for approximately 1 h. Canola (cv. AC Excel) leaf discs were prepared 
using a #1 cork borer. A single leaf disc was placed in each of the wells of the 24-well plates. 
Two microlitres of an OB preparation were pipetted onto each leaf disk, giving final OB doses of 
10, 50, or 250 OB per leaf disk. The discs were allowed to dry overnight at 4
o
C.  
One larva per well was added to the NuTrend plates. A piece of polyester Mylar film was 
heat sealed to the plates using a hot iron. Small holes were punched into the Mylar film above 
each well to allow moisture to escape. The larvae were allowed to eat for 4 h at RT and all larvae 
that had completely consumed the leaf disk were transferred to 12-well Costar plates containing 
artificial diet. The larvae were kept at 25
o
C and checked daily for mortality. Two replicates of 
the oral bioassay were performed with insects from the IPS population using 12 larvae per dose 
per construct.  
 
7.3.4. Injection bioassay 
P2 BV stocks of each knockout and repair construct were produced in TnHi5 cells and titred 
by end-point-dilution assay as described in Section 6.3.2. Each BV stock was diluted to 3 TCID50 
U/µL in GIM with 0.3% blue food colouring (McCormick Canada Inc, London, Ontario, 
Canada). Five microlitres of this diluted BV stock were injected into 4
th
 instar T. ni larvae from 
the IPS population following the injection protocol described in Section 7.3.2., resulting in a 
final dose of 15 TCID50 U per larva. Twenty-four larvae were injected per construct and the 
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experiment was performed in duplicate. The larvae were transferred to 12-well Costar plates 
containing artificial diet and kept at 25
o
C. The larvae were monitored daily for mortality.  
 
7.4. Results  
7.4.1. Single dose injection bioassays (15 TCID50 U/larva) 
Percent mortality data (Table 12) from the injection bioassay were arcsine-transformed using 
Microsoft Excel (Microsoft Corporation) to normalize the data. This process removes the 
limitations imposed on percentage data, namely that the data points must be between 0% and 
100%, and it allows the data points to vary around the mean. One-way analysis of variance 
(ANOVA) was performed using Microsoft Excel to determine if there was any significant 
difference in mortality when BV from each of the constructs was injected directly into the 
haemocoel of a susceptible host insect. The control sample was omitted from this analysis. An 
alpha level of 0.05 was used for all statistical tests. 
 
Table 12. Percent mortality for each construct at a dose of 15 TCID50 units per larva.  
All experiments were performed using 4
th
 instar T.ni larvae (1 d post-molt). The sample size (n) 
is listed in brackets beside the percent mortality. Two replicate infection experiments (Rep 1 and 
Rep 2) were performed using two different cohorts of insects from the IPS population.  
 
 Percent Mortality (n) 
Construct Rep 1 Rep 2 
Control            0.00  (23) 0.00  (17) 
vAc
145null
 91.3  (23) 95.0  (20) 
vAc
145null-AC145-HA
 100   (23) 100   (22) 
vAc
145null-MC164-HA
          86.7  (15) 85.0  (20) 
vAc
149/150null
 95.2  (21) 85.0  (20) 
vAc
149/150null-AC149-MYC+AC150-HA
 81.8  (22) 91.3  (23) 
vAc
149/150null-AC149-MYC
           95.5  (22) 100   (18) 
vAc
149/150null-MC118-HA+AC149-MYC
           95.2  (21) 91.3  (23) 
vAc
145/149/150null
 100   (19) 88.9  (18) 
vAc
145/149/150null-AC149-MYC
 82.6  (23) 100   (22) 
vAc
145/149/150null-AC145-HA+AC149-MYC
 100   (20) 100   (20) 
vAc
145/149/150null-AC149-MYC+AC150-HA
 86.4  (22) 81.0  (21) 
vAc
145/149/150null-AC145-HA+AC149-MYC+AC150-HA
 100   (20) 72.7  (22) 
vAcBac 887        91.3  (23) 95.2  (21) 
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The results of the one-way ANOVA indicated that there was no statistical difference between 
mortality rates for insects injected with budded virus from the different virus constructs (F(12, 13) 
= 1.00, p = 0.496).  
 
7.4.2. Multiple dose oral bioassay (10, 50, 250 OB per larva) 
Percent mortality for each construct at doses of 10, 50, and 250 OB are shown in Table 13. 
Data from two replicates from two different cohorts of insects from the IPS population were used 
to determine if there were any differences in oral infectivity between the virus constructs or at 
the various doses. 
The statistical analysis program SAS (SAS Institute Inc.) was used to analyze the oral 
bioassay data. Percent mortality data were arcsine-transformed using SAS to normalize the data. 
The data was analyzed using a general linear model (PROC GLM) in SAS. Three constructs, 
vAc
149/150null-AC149-MYC+AC150-HA
, vAc
149/150null-AC149-MYC
, and vAc
149/150null-MC118-HA+AC149-MYC
, were 
omitted from the analysis as these constructs gave 100% mortality at all three doses tested. A 
two-way ANOVA, with mortality as the dependent variable, indicated that construct (F(9,59) = 
6.52, p = 0.0007), dose (F(2,59) = 6.52, p = <0.0001), and the construct-dose interaction, construct 
X dose (F(18,59) = 6.52, p = 0.0383), each had a statistically significant effect on mortality. There 
was no statistically significant differences between the two replicates (F(1,59) = 6.52, p = 0.6626). 
An analysis of covariance (ANCOVA) using dose as the covariate, was performed to evaluate if 
mortality levels were equivalent between constructs at a given dose. Construct (F(9,59) = 3.27, p = 
0.0050) and dose (F(1,59) = 3.27, <0.0001) both had a statistically significantly effect on mortality, 
while the interaction between dose and construct (F(9,59) = 3.27, p = 0.3501) was not significant. 
These results indicate that the linear relationship between dose and mortality is equivalent 
between the constructs (i.e., the lines are parallel). This suggests that the degree of increase in 
mortality observed with increasing dose is consistent between the constructs.  
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Table 13. Percent mortality for each construct at doses of 10, 50, and 250 OB per larva. 
All experiments were conducted using 4
th
 instar T.ni larvae (1 d post-molt). The sample size (n) 
for all experiments is 10 – 12 larvae. Two replicate infection experiments (Rep 1 and Rep 2) 
were performed using two different cohorts of insects from the IPS population.  
 
Construct Dose 
(OB / larva) 
Rep 1 Rep 2 
Control --- 0.00        0.00        
vAc
145null
 10 50.0     41.7     
50 100    100   
250 100    100    
vAc
145null-AC145-HA
 10 16.7      80.0      
50 83.3      100    
250 100    100    
vAc
145null-MC164-HA
 10 66.7      66.7      
50 50.0      83.3      
250 100    91.7      
vAc
149/150null
 10 63.6      83.3      
50 100    91.7      
250 100   100    
vAc
149/150null-AC149-MYC+AC150-HA
 10 100    100   
50 100    100   
250 100    100    
vAc
149/150null-AC149-MYC
 10 100    75.0      
50 100    100    
250 100   100    
vAc
149/150null-MC118-HA+AC149-MYC
 10 100    91.7      
50 100    100    
250 100   100   
vAc
145/149/150null
 10 8.33        8.33        
50 81.8      33.3      
250 100    91.7      
vAc
145/149/150null-AC149-MYC
 10 60.0      63.6      
50 100    83.3      
250 100   100    
vAc
145/149/150null-AC145-HA+AC149-MYC
 10 41.7      33.3      
50 83.3      75.0 
250 100 100 
vAc
145/149/150null-AC149-MYC+AC150-HA
 10 50.0 41.7 
50 83.3 58.3 
250 100 100 
vAc
145/149/150null-AC145-HA+AC149-MYC+AC150-HA
 10 58.3 41.7 
50 100 91.7 
250 100 100 
vAcBac 887 10 91.7 66.7 
50 100 91.7 
250 100 100 
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The results from the ANCOVA suggest that the relationship between dose and mortality is 
equivalent between the constructs, but that dose and construct still significantly affect mortality. 
A one-way ANOVA was performed using the arcsine-transformed mortality data (excluding 
vAc
149/150null-AC149-MYC+AC150-HA
, vAc
149/150null-AC149-MYC
, and vAc
149/150null-MC118-HA+AC149-MYC
) at the 
10 OB / larva dose.
 
At this dose, the effect of construct on mortality (F(12,25) = 5.11, p = 0.0029) 
was significant, suggesting that one or more of the constructs produced mortality levels different 
from that of the wt. A test of least significant differences (LSD) and a Tukey’s Studentized 
Range Test were performed using this data set to determine which constructs produced 
significantly different mortality rates at this dose. The mean of the arcsine-transformed mortality 
data for vAc
145/149/150null
 was significantly different from the other constructs with the LSD test, 
suggesting that this construct is less infectious than the wt; however, this finding was not 
supported by the Tukey’s Studentized Range Test, which found that all constructs were equally 
as infectious (Table 14). One-way ANOVA using the 50 OB/larva dose revealed that at that 
dose, the effect of construct on mortality is no longer significant (F(12,25) = 1.95, p = 0.1160), 
suggesting that all constructs were as infectious as the wt at that dose.  
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Table 14. LSD and Tukey’s mean groups for the knockout and repair constructs at a dose of 10 
OB/larva. 
Means were calculated using the arcsine-transformed mortality data from the two oral bioassay 
bioreplicates. Constructs with the same mean group letter (A-E) or symbol (# or *) are not 
significantly different from one another (i.e., these constructs are equally as infectious in 4
th
 
instar T.ni larvae).  
 
Construct Mean Mean 
Groups 
(LSD) 
Mean 
Groups 
(Tukey’s) 
vAc
149/150null-AC149-MYC+AC150-HA
 0.10017 A    #  
vAc
149/150null-MC118-HA+AC149-MYC
 0.09803 A    #  
vAc
149/150null-AC149-MYC
 0.09344 A B   #  
vAcBac 887 0.08882 A B C  #  
vAc
149/150null
 0.08564 A B C D #  
vAc
145null-MC164-HA
 0.08174 A B C D #  
vAc
145/149/150null-AC149-MYC
 0.07870 A B C D #  
vAc
145/149/150null-AC145-HA+AC149-MYC+AC150-HA
 0.07052  B C D # * 
vAc
145/149/150null-AC149-MYC+AC150-HA
 0.06768   C D # * 
vAc
145null
 0.06768   C D # * 
vAc
145null-AC145-HA
 0.06520   C D # * 
vAc
145/149/150null-AC145-HA+AC149-MYC
 0.06118    D # * 
vAc
145/149/150null
 0.02887     E  * 
 
 
7.5. Discussion 
One-way ANOVA was performed to determine if there was a difference in mortality between 
the knockout, repair, and the wt constructs when they were injected directly into the haemocoel. 
The control construct was omitted from this analysis, as it produced 0% mortality across all 
replicates, as expected. The ANOVA indicated that there was no significant difference (F(12,13) = 
1.00, p=0.496) in mortality rates between the constructs. This agrees with the hypothesis that 
Ac145 and Ac150 may be involved in oral infectivity by facilitating an interaction between the 
envelope of the baculovirus ODV and the chitin of the PM or chitin-secreting cells of the midgut 
epithelium, and are not likely to be involved in cell-to-cell spread of the virus. This also agrees 
with the findings of Lapointe et al. (87) and Zhang et al. (86) who found that there was no 
difference in mortality rates of their knockout and repair constructs compared to the wt construct 
when injected directly into the haemocoel. This finding is supported by the results provided in 
Chapter 6 of this thesis that indicate that deletion of Ac145, Ac150, or both together had a 
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minimal effect on the rate of BV production or viral DNA replication (Figures 27 and 28), both 
of which could affect the ability of the virus to propagate in the host.  
The oral bioassays were performed using two independent cohorts of insects from the IPS 
population. Mortality data from the oral bioassays was analyzed using a general linear model in 
the statistical analysis program, SAS. Two-way ANOVA was performed, with mortality as the 
dependent variable, to determine if dosage or construct significantly affected mortality. The 
construct (F(9,59) = 6.52, p = 0.0007), dose (F(2,59) = 6.52, p = <0.0001), and the construct-dose 
interaction, construct X dose (F(18,59) = 6.52, p = 0.0383), were all found to have significant 
effects on insect mortality. As the construct X dose interaction was found to have a significant 
effect on mortality, ANCOVA was performed, using dose as the covariate, to evaluate if 
mortality levels were equivalent between constructs at a given dose. This test controls for one of 
the independent variables (dose) and can determine if the linear relationship between mortality 
and dose is equivalent between constructs (i.e., determine if the lines are parallel). Construct 
(F(9,59) = 3.27, p = 0.0050) and dose (F(1,59) = 3.27, <0.0001) both had a significant effect on 
mortality, while the interaction term, dose X construct (F(9,59) = 3.27, p = 0.3501) did not. These 
results suggest that the dose administered and the construct used have a significant effect on 
mortality and that the linear relationship between mortality and dose is equivalent between 
constructs (i.e., the lines are parallel).  
One-way ANOVA was performed using the mortality data from the 10 OB per larva dose. At 
this dose, the construct used had a significant effect on mortality (F(12,25) = 5.11, p = 0.0029). 
Two post-hoc statistical tests, LSD and Tukey’s Studentized Range Test, were performed to 
determine which of the constructs produced mortality levels that were statistically different from 
the wt construct. The LSD test indicated that the vAc
145/149/150null
 construct was less infectious 
than the other constructs at a dose of 10 OB per larva, but the Tukey’s Studentized Range Test 
did not support this finding. The LSD test consists of multiple pairwise comparisons between 
sample means. This test controls for Type 1 (false-positive) comparisonwise errors, but not Type 
1 experimentwise errors. The Tukey’s Studentized Range Test controls for Type 1 
experimentwise errors and is a more robust analysis. It takes into account the total number of 
comparisons made in the experiment and corrects for this in each of the pairwise comparisons 
made. This results in fewer Type 1 errors being made on an experiment-wide scale. The results 
from the Tukey’s Studentized Range Test suggest that the statistical difference in mortality for 
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the vAc
145/149/150null 
construct at a dose of 10 OB per larva is likely a false-positive result, caused 
by the multiple pairwise comparisons made in the LSD test. Based on these results, it does not 
appear that any of the constructs produce statistically different mortality rates than the wt 
construct at a dose of 10 OB per larva. At a dose of 50 OB per larva, a one-way ANOVA 
indicated that all of the constructs were statistically as infectious as the wt construct (F(12,25) = 
1.95, p = 0.1160). An ANOVA was not performed using the 250 OB per larva dose as all 
constructs produced 100% mortality at this dosage. 
As no reduction in infectivity was observed for the Ac145 or Ac150-deletion viruses, it is 
impossible to determine at this point if the MacoNPV homologues were able to restore the 
function of the deleted AcMNPV gene. Further work is required to determine if the 11K genes in 
MacoNPV have overlapping functions with the 11K genes from AcMNPV.  
The loss of Ac149 does not appear to affect the ability of an AcMNPV-like virus to initiate or 
sustain infection. As Ac149 is not highly conserved among baculovirus species (115), it is not 
surprising that virus constructs lacking Ac149 were as infectious as the wt virus in T. ni larvae. 
The function of Ac149 in the baculovirus infection cycle remains unclear.  
Based on these results, deletion of Ac145, Ac150, or both together, has no effect on mortality 
in 4
th
-instar T. ni larvae when the virus construct is administered via the haemocoel or via the 
oral route. These results differ from the findings of both Lapointe et al. (87) and Zhang et al. 
(86). The Lapointe group determined that deletion of Ac145 resulted in a 6-fold decrease in oral 
infectivity compared to the wt virus in T. ni larvae, but not in H. virescens larvae (two-way 
ANOVA, p < 0.05). Although there was a significant change in infectivity between the wt virus 
and the Ac145-deletion virus, all other virus constructs (Ac145-repaired, Ac150-deletion and -
repaired, Ac145/Ac150-double deletion, and Ac150-deletion/Ac145-repaired), were as infectious 
as both the wt virus and as the Ac145-deletion virus. This suggests that as an isolated pairwise 
comparison, the Ac145-deletion virus is less infectious than the wt construct; however, when a 
comparison is made between all deletion and repair viruses, the Ac145-deletion virus is as 
infectious as all other viruses in T. ni neonate larvae. The Lapointe group also demonstrated that 
the Ac145/Ac150-double deletion virus was 39-fold less infectious than the wt in H. virescens 
larvae, but as infectious as the Ac145-deletion virus in T. ni larvae. This result is consistent with 
the findings of this study that suggest that the vAc
145/149/150null-AC149-MYC
 construct, which is 
similar to an Ac145/Ac150-double deletion virus, is as infectious as the wt in T. ni larvae. The 
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significance of the 39-fold reduction in infectivity in H. virescens larvae is not clear, but suggests 
that Ac145 and Ac150 have overlapping roles in this host (87). Lapointe et al. also found no 
difference in oral infectivity with the Ac150-deletion virus in either T. ni or in H. virescens 
larvae, which is consistent with the results of this study.  
The Zhang group, who did not produce an Ac145-single deletion or Ac145/Ac150-double 
deletion virus, determined that their Ac150-deletion virus was as infectious as the wt virus when 
BV was injected into the haemocoel of 4
th
-instar Spodoptera exigua, H. virescens, and T. ni 
larvae. An Ac150-repaired virus was also produced, but the infectivity of BV from this virus 
construct was not tested by intrahaemocoelic injection. Oral infectivity was monitored for both 
the Ac150-deletion and –repaired viruses. Purified OB from each virus construct were injected 
through the mouth, and directly into the larval midgut using a blunt needle. The infectivity of the 
Ac150-repaired virus was monitored at a dose of 10 OB per larva. Zhang et al. found that at this 
dose, the wt virus produced 48%, 39%, and 57% mortality in H. virescens, T. ni, and S. exigua, 
respectively, whereas the Ac150-repaired virus produced 50%, 47%, and 40% mortality, 
respectively. Based on this data, they suggest that the Ac150-repaired virus produces similar 
infectivity levels to the wt virus. Zhang et al. used a multi-dose oral assay to determine that the 
Ac150-deletion virus was 4.1-, 5.6-, and 18-fold less infectious than wt virus in 4
th
-instar S. 
exigua, H. virescens, and T. ni larvae, respectively. As a follow-up to this experiment, the Zhang 
group injected purified ODV from the wt or the Ac150-deletion virus directly into the midgut of 
H. virescens and T. ni larvae. They found that there was no difference in infectivity between the 
wt and deletion virus ODV. Zhang et al. suggest that Ac150 was lost from the wt ODV or 
inactivated during purification.  
Proteomic analysis of the AcMNPV ODV (80) did not identify either Ac145 or Ac150 as 
ODV-associated proteins, but Lapointe et al. (87) identified both Ac145 and Ac150 as OB-
associated. This difference in localization could explain why Zhang et al. found the Ac150-
deletion virus was less infectious than the wt when OB were injected into the midgut, but as 
infectious as wt when purified ODV was injected. Further proteomic analysis is required to 
determine the localization of these proteins.  
Feeding trials in lepidopteran larvae conducted by Zhang et al. (86), indicated that 
administering a 1% Calcofluor solution along with OB from an Ac150-deletion virus does not 
restore oral infectivity levels to that of wt AcMNPV. As Calcofluor is known to disrupt the 
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structure of the PM (110), this result, in combination with the chitin-binding studies presented in 
Chapter 4 of this thesis, suggests that although Ac145, Ac150, Maco118, and Maco164 are all 
able to interact with chitin they likely do not interact with the chitin in the PM. 
Lapointe et al. and Zhang et al. suggest that Ac145 and Ac150 play a role in oral infection of 
a susceptible host by AcMNPV, and likely do so in a host-dependent manner. As the 
experiments conducted for this thesis only studied infectivity in T. ni larvae, it is possible that 
Ac145 and Ac150 are required for oral infectivity in other hosts, but neither appears to be 
required for infection to occur in T. ni.  
 
7.6. Conclusions and future research 
Neither Ac145 nor Ac150 are required for the initiation of an infection within the midgut 
cells of T. ni larvae, nor are they required for systemic infection to occur. The loss of Ac149 in 
addition to Ac150 also does not affect infectivity. As no reduction in infectivity was observed for 
the Ac145, Ac150, or Ac145/Ac150-double deletion virus, the function of the MacoNPV 
homologues cannot be determined at this time.  
Further studies to determine the localization patterns of Ac145 and Ac150 are warranted. 
Discrepancies in infectivity between Ac150-deletion virus OB and ODV as determined by Zhang 
et al. suggests that Ac150 localizes to the OB calyx or other structure that is liberated from the 
ODV following alkali-treatment. Determining the localization patterns for these proteins within 
the OB or virions could provide insight into possible functions. In addition, localization studies 
using fluorescently tagged Ac145 and 150 could also be used to determine which structure these 
proteins interact with, within a susceptible host, during the infection cycle.  
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8. SUMMARY AND CONCLUSIONS 
The 11K group of genes, which are highly conserved among insect-infecting viruses, produce 
small proteins, each of which contains a conserved 6 cysteine motif known as a peritrophin A 
CBD. It has been proposed that the 11K proteins may facilitate an interaction between a virus 
particle and the chitin fibrils of the PM or the chitin-secreting cells of the midgut epithelium and 
may therefore be required for infectivity.  
The 11K proteins from two baculovirus species, Ac145 and Ac150 from AcMNPV, and 
Maco118 and Maco164 from MacoNPV, were expressed in a baculovirus expression system. In 
vitro binding studies using chitin beads indicated that all four of these proteins interact with 
chitin. The binding is mediated by hydrophobic interactions or hydrogen bonding, as some of the 
bound protein was released by the application of a 2% SDS solution. This is consistent with the 
binding patterns of a known chitin-binding protein, WGA. However, there appears to be other 
mechanism(s) involved in the interaction between the 11K proteins and the chitin beads, as the 
SDS solution does not liberate all of the bound protein.  
To determine the function of the 11K genes in the infection cycle, gene knockout constructs 
were produced using a bacmid system. Deletion of Ac145 or Ac150 has no effect on the timing or 
level of transcription of other genes within the genome, nor does it effect on the rate of BV 
production or viral DNA replication. Deletion of Ac145, Ac149, and Ac150 together had a minor 
effect on immediate early gene transcription, the rate of BV production, and the rate of viral 
DNA replication. These changes could not be attributed to the loss of any one particular gene.  
Deletion viruses produced equivalent levels of mortality as the wt virus in T. ni larvae when 
the virus was injected directly into the haemocoel. This agreed with the findings of two 
independent laboratories that determined that neither of the AcMNPV 11K proteins affects 
infectivity when injected and agrees with the hypothesis that these proteins are not involved in 
cell-to-cell transmission. In oral feeding trials, there was no statistical difference between any of 
the knockout constructs and the wt virus, suggesting that loss of one or both of the 11K genes 
does not affect initial oral infection of T. ni larvae. Based on the results of this study and the 
accepted definition of a PIF gene, it is suggested that Ac145 and Ac150 not be classified as PIF 
genes. It is evident that they are not essential for, nor do they appear to mediate, the oral 
infectivity process in a susceptible insect host. Further work is required to determine the exact 
role of these proteins in the baculovirus infection cycle.   
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10. APPENDICES  
 
A. pKD3 plasmid. For amplification of the chloramphenicol acetyl transferase (CAT) gene 
(blue arrow). Construct map kindly provided by Dr. David Theilmann, AAFC, 
Summerland, B.C. 
 
 
 
  
613 pKD3 (AY048742)
2804 bp
Chloramphenicol R Tn9
distal 34-nt of of natural FRT site
distal 42-nt of natural FRT site
bla; ampicillin resistance
R6K gamma replication origin
rrnB transcription terminator
Hin dIII (1172)
Hin dIII (2794)
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B. p2ZOp-2F plasmid. For amplification of the Zeocin resistance gene (orange arrow). 
Construct map kindly provided by Dr. David Theilmann, AAFC, Summerland, B.C. 
 
 
 
 
 
 
p2ZOP-2F
27 68 bp
Zoecin ORF
OpMNPV IE2 pA
OpMNPV IE2 promoter
OpMNPV IE2 promoter
BamHI (588)
EcoRI (581)
HindIII (556)
